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The first chapter provides an overview of the use of biocatalysis for the synthesis of pharmaceutical 
intermediates and natural products. This review focuses, in particular, on the impact of recent 
developments in technologies which enable the increased use of biocatalysts. These developments 
include: 
• the immobilisation of biocatalysts to enhance stability and ease of use, and enabling use in 
combination with metal and organocatalysts leading to dynamic kinetic resolution, as well 
as in continuous flow. 
• discovery and development of novel enzymes using molecular biology for enzyme 
engineering and metagenomics.  
The second chapter describes the lipase-mediated kinetic resolution of 2-phenylalkanols by tuning 
the steric properties of the acyl group to control the efficiency and selectivity of the resolution. In 
contrast to literature reports, efficient resolution was achieved using short-chain acyl groups 
through careful process control and substrate modification. The effect of increased steric demand 
at the stereocentre was also explored. 
Chapter three describes proof of concept that a hydrolase-catalysed dynamic kinetic resolution of 
a lactol is possible. By taking advantage of the spontaneous racemisation of the unreacted starting 
material, the dynamic kinetic resolution was carried out without the need for a separate 
racemisation catalyst. While the kinetic resolution was effective in a model system, the 
biotransformation was inhibited by the introduction of a second, remote stereocentre. 
Chapter four describes a dynamic kinetic resolution of synthetically versatile nitroalcohols by 
combination of a lipase-mediated resolution and the reversible intramolecular nitroaldol (Henry) 
reaction. Significant challenges in effecting the combination of the base-mediated racemisation 
step and the lipase-mediated resolution step were encountered. Reaction engineering allowed 
design of a sequential one-pot reaction system which furnished the products with excellent 
enantioselectivity, and good diastereoselectivity. 
Chapter five describes the use of novel transaminases in the kinetic resolution of model amine 
substrates and pharmaceutical intermediates by oxidative deamination, including exploration of 
the substrate scope of these novel biocatalysts. While transaminase-mediated reductive amination 
is an attractive method for asymmetric synthesis of chiral amines, the reductive amination is 
vi 
generally thermodynamically disfavoured. Preliminary investigation of approaches to favour the 
reductive amination is described. 
The final chapter contains the full experimental details, including spectroscopic and analytical data 
of all the compounds synthesised in this project; details of chiral phase HPLC analysis are included 









"Creativity is combining facts no one else has connected before." 
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By tuning the steric properties of the acyl group to control the efficiency and selectivity of the 
resolution, 2-phenyl-1-propanol 1 was prepared by lipase-catalysed hydrolysis using a short-
chain acyl group, with E-values of up to 66 (ee up to 95%). 2-Phenylbutan-1-ol 2 was similarly 
resolved (up to 86% ee) using the optimised conditions, while the ester of the more sterically 
demanding 3-methyl-2-phenylbutan-1-ol 3 proved resistant to enzymatic hydrolysis under 
these conditions.  
Results & Discussion 
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2.1 Introduction  
The use of biocatalysts in organic synthesis is a growing and attractive method for achieving 
chemical transformations.1 Enzymes, by their nature, have excellent chemo-, regio- and 
enantioselectivity, which, if utilised correctly can give superior results to chemical catalysts.2 
Hydrolases are the most studied biocatalysts and have found application in many industrial 
processes.1 Lipases are ubiquitous enzymes belonging to the family of serine hydrolases and 
can be found in animals, plants, bacteria, and fungi.3 Lipases naturally catalyse the reversible 
hydrolysis of the ester bonds in triacylglycerols for example 4, producing glycerol 5 and the 
free fatty acids 6 (Scheme 2.1) and are highly enantioselective in the kinetic resolution of 
carboxylic acids, alcohols, and related derivatives. Lipases are the most frequently used 
enzymes in organic synthesis, due in part to being inexpensive, commercially available, and 
stable, but also due to their wide substrate scope and high regio-, stereo-, and 
chemoselectivity. The fact that lipases do not require cofactors is a significant advantage when 
used for biocatalysis. They are also very useful because they naturally act on the lipid water 
interface, thus increasing their substrate scope beyond water soluble compounds.  
 
Scheme 2.1 Lipases naturally catalyse the reversible hydrolysis of triacylglycerols such as palmitate 5 
Many different strategies can be employed to increase the selectivity of the lipases including, 
but not limited to: addition of organic solvents,4-6 changing temperature,7,8 immobilisation and 
modification of the enzyme,9,10 the presences of additives,11-13 and, in the case of 
(trans)esterification, modification of the acyl donor.14-20  
Studies on the selectivity of lipases usually focus on compounds where the chiral centre is 
adjacent to the site of reaction, e.g. α-alkyl carboxylic acids or secondary alcohols (Scheme 
2.2). Secondary alcohols are so well studied that there are size based rules for predicting 
stereochemical outcome with well-known lipases.1 Extension of these systems, where the 
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chiral centre is more remote, e.g β-or γ-alkyl carboxylic acids or primary alcohols (Scheme 
2.3), can lead to challenges in terms of efficiency and selectivity, and they are therefore less 
studied than their secondary alcohol counterparts.21-24  
 
Scheme 2.2 Hydrolysis and transesterification of chiral secondary alcohols (left), size-based rules for predicting 
stereochemical outcome (right) 
 
 
Scheme 2.3 Hydrolysis and transesterification of primary alcohols 
2.1.1 Importance of 2-phenylalkanols as synthetic intermediates 
Chiral primary alcohols can be used as building blocks in many drugs, such as the profenols, 
but are also important in the flavour industry and for the synthesis of natural products 
including 7–10 (Scheme 2.4).25 
 
Scheme 2.4 Synthesis of natural products from 2-aryl alkanols 
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Chiral primary alcohols, having a benzylic stereocentre, can be used in the synthesis of 
2-arylpropionic acids, a common class of non-steroidal anti-inflammatory drugs (NSAIDs) 
(Scheme 2.5), 26,27 as well as in the synthesis of fragrance molecules,28,29 and substituted 
coumarins.25 In most cases, only one form (R or S) of the drug is active, but the drug may still 
be produced and sold racemically. For example, (S)-ibuprofen (S)-11 is pharmacologically 
active but it is sold as a racemic mixture. (S)-Naproxen (S)-12 was the first NSAID marketed as 
a single enantiomer.30 For fragrance or flavour molecules, the different enantiomers can have 
different smells or tastes e.g (R)-(–)-carvone (spearmint) 13 and (S)-(+)-carvone (caraway) 
13.31 The fragrance of Pamplefleur 14 changes only when the stereocentre at C2 changes.28,29  
Previous work involving 2-aryl and 2-aryloxy propionic acids (being classes of non-steroidal 
anti-inflammatory drugs, and herbicides, respectively, (Scheme 2.5) achieved the resolution 
of esters 11, 12 and 15-18 bearing the stereocentre at the α-position,32-37 where the 
conditions were optimised using cosolvents, and immobilising the lipases, as well as 
mechanistic studies to determine the best conditions for the reactions. 
 
Scheme 2.5 Resolution of 2-aryl and 2-aryloxyalkanoic acid esters 
2.1.2 Previous work in our group 
Previous work within our group on the lipase mediated kinetic resolution of chiral 3-aryl 
alkanoic acids, bearing the stereocentre on the carboxylic acid moiety, showed hydrolase 
recognition of stereocentres β to the reacting site (Scheme 2.6).38,39 While under standard 
conditions, the outcomes were modest, excellent enantioselectivities were achieved for both 
the ester substrate and acid product through extensive process optimisation. This study 
showed the effect of changing substitution on the chiral centre, by systematically varying first 
the alkyl group, followed by the aryl group; as the size of the alkyl group was increased, the 
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resolution required more forcing conditions in order to hydrolyse the ester.38,39  The electronic 
effects through substitution of the aromatic ring were also investigated;39 this showed that 
the effect of the aryl substitution on the resolution was minimal, having little effect on the 
outcome of the resolution. 
 
Scheme 2.6 Resolution of carboxylic acids containing remote stereocentres – the effect of substitution. 
These compounds are synthetically important within our group; enantiopure 3-aryl alkanoic 
acids are precursors to α-diazoketones, which are used as substrates in the Buchner 
cyclisation reaction (Scheme 2.7). The reaction has been shown to proceed with very high 
diastereoselectively when using an enantiopure carboxylic acid starting material (Scheme 
2.7).40,41 The development of enzymatic methods to resolve compounds of this type,38,39 could 
replace the use of the chiral oxazolidinone 19 directing group when accessing these 
compounds. Advantages of this include the use of a readily available carboxylic acid starting 
material 20, the removal of the need to add and remove the chiral auxilary, as well as the use 
of mild conditions (Scheme 2.7). 
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Scheme 2.7 Buchner cyclisation 
Extension to this work, using derivatives with the chiral centre on the alcohol moiety, removed 
from the reacting site is the focus of this project. Both the hydrolysis and transesterification 
reactions can potentially provide access to a series of enantioenriched alcohols and esters 
(Scheme 2.8). This work focuses on the exploitation of the excellent chemo, regio- and 
enantioselectivity associated with lipases in the synthesis of 2-phenyl-1-propanol 1, studying 
both transesterification and hydrolysis reactions of 2-phenyl-1-propanol 1 and derivative 
esters 21–24, respectively, as well as derivative alcohols containing larger alkyl groups 2 and 
3 and esters thereof 25 and 26 (Scheme 2.8). 
Scheme 2.8 Hydrolysis and transesterification of chiral primary alcohols and esters 
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2.1.3 Previous enzymatic resolution of 2-phenyl-1-propanol 1 
The resolution of 2-phenyl-1-propanol 1 has previously been reported, where good 
selectivities and conversions were attained, using both 2-phenylpropyl benzoate 21 (up to 
88% eep, E = 29) (Scheme 2.9), and 2-phenylpropyl acetate 22 (up to 80% ee, E = 14).17 In 
general, high enantioselectivity can be achieved in the hydrolysis of 2-phenyl-1-propanol 1 
but with the disadvantage of using larger acyl chains (some examples 27–29 shown in Figure 
2.8).17,18,25,42-45 While these chains have the advantage of conferring excellent selectivity, 
removing the carboxylic acid by-products could lead to problems. The study of short chain 
acyl groups, aside from acetate, is uncommon in this specific resolution; very few examples 
are reported.24,46,47 In the case of smaller carboxylic acid groups, they are usually removed in 
the work-up and are left in the aqueous layer, leaving only a two-component system in the 
organic layer, giving an easier separation. In this work small, alkyl groups are used, which is 
more atom economical in addition to the more convenient work-up. 
 
Scheme 2.9 Lipase-catalysed resolution of 21 and 22  
 
Figure 2.8 Product esters from the transesterification of 2-phenyl-1-propanol 1 using long chain acyl chains 
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For transesterification of 2-phenyl-1-propanol 1, the acylating agent has been extensively 
studied, including the effect of a phenyl group on the resolution (phenyl group at β-position 
is favourable), the length of the alkyl chains (longer chains tend to give better selectivity), and 
the electronic effects of the acyl chain (with isomeric pentenoic acids as acyl donors it was 
shown that the position of the double bond is important).14,18 
2.1.4 Enantioselective synthesis of 2-phenyl-1-propanol 1 – other 
chemoenzymatic methods 
2-Phenyl-1-propanol 1 has previously been prepared enantioselectively from styrene, 
followed by a lipase catalysed transesterification to further enhance ee (Scheme 2.10).48 
 
Scheme 2.10 Use of porcine pancreas lipase (PPL) to enhance ee 
There have been several reports of resolution of racemic alcohols using biocatalysts as shown 
in Scheme 2.11.49,50 The mixture is racemised on oxidation, and resolved on reduction. 
However, while this is a dynamic kinetic resolution, theoretically giving 100% conversion, a 
disadvantage is that a cofactor is required, and with that, a cofactor regeneration system. 
 
Scheme 2.11 Resolution of chiral primary alcohols using alcohol dehydrogenase (ADH) as biocatalyst 
Gotor et al. reported the deracemisation of 2-phenyl-1-propanol 1 by non-selective oxidation 
of the racemic alcohol to the aldehyde, which undergoes spontaneous racemization, using 
laccase from T. versicolor and TEMPO as an oxidant, followed by enantioselective reduction 
using an immobilized alcohol dehydrogenase (ADH) (Scheme 2.12).51 Laccase is a biocatalyst 
which utilizes molecular oxygen as an oxidant. The enzymes used are active at different pHs. 
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64 
Both enantiomers were accessible (>94% ee) through the use of stereocomplimentary 
enzymes. 
Scheme 2.12 One-pot stereoselective synthesis of 2-phenyl-1-propanol 1 
The advantage of this synthesis is the use of a cheap racemic starting material. However, 
because an oxidoreductase (ADH) is employed a cofactor is also required, which is 
regenerated by the addition of ethanol or 2-propanol 32 as a co-substrate (Scheme 2.11). 
Smart cosubstrate selection, such as diol 34, can improve the efficiency of reactions of this 
type by producing an inert by-product 35 (Scheme 2.13).52 
 
Scheme 2.13 Smart co-substrate selection can improve the conversion of the reactions 
2.1.5 Non-chemoenzymatic synthesis of enantiopure 2-phenyl-1-propanol 1  
There are a number of recently reported routes to substituted β-aryl alcohols. There are 
several reports of non-stereoselective reduction of the corresponding aldehydes, catalysed 
by iron, immobilised ruthenium, and silver.53-55 Beller et al. reported the synthesis using two 
ruthenium catalysts cooperatively.56 Ley et al. prepared a series of racemic alcohols from 
terminal alkenes through a continuous flow hydroboration-oxidation reaction.57 
Stereoselective synthesis of aldehydes from terminal alkenes has been reported, giving the 
internal aldehyde (R)-31 in a stereoselective fashion (up to 95% ee) with only minor amounts 
(7%) of the regioisomer 37. Reduction of (R)-31 could allow access to the alcohol (R)-1 
(Scheme 2.14).58 
Results & Discussion 
65 
 
Scheme 2.14 Asymmetric hydroformylation to give aldehyde (R)-31 
Zhuang and Du reported a one pot, stereoselective synthesis of 2,2-substituted alcohols from 
alkenes through a sequential epoxidation, Brønsted-acid catalysed rearrangement to a chiral 
aldehyde, and reduction with retention of stereochemistry, which gave up to 50% ee (Scheme 
2.15).59  
 
Scheme 2.15 Asymmetric rearrangement of racemic epoxides 
Feringa et al. reported a copper catalysed asymmetric allylic alkylation of 38, using 
organolithium reagents, followed by either reductive ozonolysis, which furnished the 
2-substituted alcohols (up to 99% ee) (Scheme 2.16), or hydroboration-oxidation, which 
extended the chain by one carbon, and gave 3-substituted alcohols.60 
 
Scheme 2.16 Copper-catalysed asymmetric allylic alkylation 
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Zhao and Weix reported the nickel catalysed coupling of epoxide 39 and arylhalides. The 
regiochemical outcome of this coupling can be controlled by an additive, either iodide or 
titanium (Scheme 2.17).61 
 
Scheme 2.17 Regiochemistry controlled by iodine or titanium additives 
Each of the above stereoselective reactions involved the use of complex chiral ligands to 
induce stereoselectivity. Biocatalytic routes to enantiopure or enantioenriched compounds 
would avoid the use of complex chiral ligands or metal catalysts, as well as extremes of 
temperature and the use of organic solvents.  
Results & Discussion 
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2.2 Objectives of this project 
The overall objective of this project is to explore the effect of variation of the acyl group on 
the resolution of 2-phenyl-1-propanol 1, focusing specifically on the effect of smaller acyl 
chains which are poorly represented in the literature. 
The specific objectives of this study can be summarised as follows: 
• To prepare a series of esters of 2-phenyl-1-propanol 1. 
• To develop chiral HPLC conditions which will separate both enantiomers of the 
alcohol and the ester 
• To screen these esters against a library of lipases in order to assess their activity in 
the resolution of 2-phenyl-1-propanol 1 by variation of the following factors: 
o Variation of biocatalyst. 
o Alteration of the ester group. 
o Changing the mode of reaction. 
o Alteration of the reaction conditions (e.g. temperature, cosolvent addition, 
reaction time). 
• To conduct a preparative scale synthesis of 2-phenyl-1-propanol 1. 




2.3 Synthesis of substrates 
The aim of this section of the project was to synthesize a series of chiral esters to test against 
lipase enzymes. The compounds varied by having different ester groups (R′), as well as 
different substituents (R) at the β-position of that ester (Figure 2.9) 
 
Figure 2.9 General structure of the target ester substrates 21 – 26 
The key starting materials for the synthesis of the ester substrates are chiral primary alcohols, 
2-phenylpropan-1-ol 1, 2-phenylbutan-1-ol 2 and 3-methyl-2-phenylbutan-1-ol 3, Figure 2.10, 
of which two are commercially available, 1 and 2. Alcohol 3 is not commercially available, and 
was synthesised for this investigation  
 
Figure 2.10 Starting alcohols 1–3. 
2.3.1 Alcohol synthesis 
3-Methyl-2-phenyl-1-butanol 3 was synthesized by two methods (Scheme 2.18). The first 
method used a Grignard reaction, and the second approach used a substitution reaction 
followed by a reduction. 
 
Scheme 2.18 Synthesis of 3-methyl-2-phenylbutan-1-ol 3 
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2.3.1.1 Method 1 – Grignard reaction 
The first attempted route was through a Grignard reaction, using styrene oxide 44 as the 
electrophile, and in situ generated isopropyl magnesium bromide 40 as the nucleophile.62 
The reaction uses approx. 1.2 equivalents of magnesium and 1.1 eq. of the alkyl halide to 
prepare the Grignard reagent. The disappearance of styrene oxide 44 by TLC is used to 
monitor the reaction progress and is generally complete within 30 minutes. 
There are many reported methods to enhance the efficiency of the initiation of the Grignard 
reaction.63-65 In this case the magnesium was activated before use by vigorous stirring in ~1 mL 
of solvent in the presence of a crystal of iodine for 1–1.5 h. To initiate the reaction, the neat 
alkyl halide 45 was added slowly to the solution, until the reaction had started, which is 
evident by a colour change from brown to grey. Once the reaction was initiated, the alkyl 
halide was diluted with the required amount of solvent for the reaction and added at such a 
rate as to maintain reflux without external heating. As the presence of even minor amounts 
of water has a detrimental effect on Grignard reagents freshly opened bottles of diethyl ether 
were used in this reaction.63,66-69 
The addition of the Grignard reagent to the styrene oxide can give rise to two isomeric 
products. However, the second expected product 46, was not observed; instead a 
rearrangement product 47 was isolated (Table 2.1). The reaction was also carried out using 
commercially available isopropyl magnesium chloride 41 (2.0 M in THF), in this case the ratios 
of products formed were different, this is due to solvent induced change in the Schlenk 
equilibrium. This reactivity has been previously reported and the product ratios can be altered 





Table 2.1 Preparation of alcohol 3 
 
Entry X Solvent Ratio 46:3:47 Yield 3 (%) Yield 47 (%) 
1 
Br 
(in situ generated) 




2.0M in THF) 
THF, 
distilled 
0:66:34 30 12b 
aCarried out by fourth year student; bmaterial was recovered from the column, made up of compound 3 and 47 (63:37) 
coeluting, and was equivalent to approximately 25% yield, it was not separated as sufficient material was isolated. 
 
Figure 2.11 shows the 1H NMR spectrum of the crude material from the Grignard reaction 
using the commercially available Grignard reagent 41. The spectra of the two expected 
products 46 and 3 are also shown. Alcohol 46 was synthesised independently by a Grignard 
reaction which would not give rise to isomeric products (Scheme 2.19); the reaction was 
low-yielding due to incomplete formation of the Grignard reagent; a freshly opened bottle of 
benzaldehyde was used but it was not distilled. Sufficient material was isolated for analysis. 
The absence of the 1H dd at 4.75 ppm, corresponding to the proton at the chiral centre of 46 
(CHOH) indicates that this product was not formed in the Grignard reaction using styrene 
oxide 44. 
 
Scheme 2.19 Synthesis of 46 
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The product formed was analysed by 1H and 13C NMR and DEPT experiments; 2D experiments 
were carried out in order to identify the product 47. It is thought that the product arose from 
a Lewis acid catalysed (MgBr2) Meinwald rearrangement, via aldehyde intermediate 49 
(Scheme 2.20).70 Data for 47 matches previously reported data.72 All alcohol products are 
known compounds and spectroscopic data is consistent with previous reports.  
 
Scheme 2.20 Meinwald rearrangement 
The rearrangement of epoxides in the presence of Lewis or Brønsted acids has been previously 
reported.59,73-75 In particular the rearrangement of styrene oxide under Grignard conditions 
Expected 
Figure 2.11 1H NMR spectra, showing the crude material (blue), the rearrangement product 47 (red), the 






has been reported, and the regiochemical outcome can be modified by changing the order of 
addition of reagents i.e. adding styrene oxide 44 to the Grignard reagent can give different 
ratios of regioisomers to adding the Grignard reagent to the styrene oxide.70,71 
The yield of the desired alcohol 3, after column chromatography, was 21%. While this could 
be scaled up to provide a reasonable amount of material from cheap starting materials, it is 
inefficient, and so another route was explored. 
2.3.1.2 Alternative route 
The synthesis of alcohol 3 via a known synthetic route was carried out in accordance with 
previously reported procedure (Scheme 2.21).76  
 
Scheme 2.21 Alternative route to alcohol 3 
The first step involved deprotonation of the methyl 2-phenylacetate 43 by potassium 
tert-butoxide in DMF, and the subsequent alkylation using isopropyl bromide 45. Complete 
removal of the DMF required extensive washing, as described in the experimental section. 
After column chromatography, 42 was reduced using lithium aluminum hydride, according to 
literature procedure, and required no purification.76 Using this method, multigram quantities 
of alcohol 3 could be readily prepared. 
2.3.2 Ester synthesis 
The initial route to the esters, used in the synthesis of 21, required the use of an excess of 
alcohol (1.2 equivalents) in the presence of the appropriate acid chloride. When this amount 
was reduced (to 1.04 eq.) the efficiency of the reaction dropped (Scheme 2.22, method A). In 
the synthesis of 2-phenylpropyl benzoate 21, this resulted a slightly decreased yield from 70% 
to 66%. 
The introduction of a nucleophilic catalyst, DMAP, increased the efficiency of the reaction, 
utilising only one equivalent of the alcohol and, in general, gave complete conversion to the 
ester (Scheme 2.22, method B).77 The products obtained were of excellent purity, but were 
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subjected to column chromatography as very pure material was needed for the enzymatic 
reactions. 
 




2.4 Hydrolase-mediated kinetic resolution – analytical screens 
2.4.1 Screening protocol – hydrolysis of esters 
The hydrolysis screening reactions were carried out at approx. 50 mM scale (50 mg of ester in 
4.5 mL buffer). The reaction mixture was subjected to a mini work-up, and filtered through 
Celite®. No drying agent was used. If conversion was detected, the crude mixture was 
analysed by chiral HPLC analysis. Purification was not necessary before HPLC analysis, as the 
reactions produce no by-products. The crude material contained only ester substrates and 
alcohol product. This allowed us to carry out the screening reactions on a small scale; this 
reduced the amount of material necessary for screening. Generally, when both the alcohol 
and the ester separated on a given chiral column, then other esters of the same alcohol would 
also separate on that column.  
Transesterification reactions were carried out in neat vinyl ester (0.5 mL) using 150 mM 
(10 mg) of 2-phenyl-1-propanol 1. The reaction solution was simply filtered through a plug of 
Celite® before analysis, and analysed like the hydrolysis reactions.  
2.4.2 Screening – initial target 2-phenylpropyl benzoate 21 
Ester 21 was initially screened against a targeted panel of lipases supplied by Almac in a 
previous study carried out by Gavin.78 Of the 52 enzymes tested, 15 gave no conversion, 22 
gave conversion under 10%, 4 gave 100% conversion; a selection of the results are shown in 
Table 2.2 (Entries 1–11). Using the lipase from Pseudomonas cepacia, excellent 
enantioselectivity toward the alcohol 1 was achieved (93% ee) (Entry 4). Lipases C, D, E and F 
from Alcaligenes sp. showed similar selectivities towards the product, with similar E values 
(Entries 7, 9, 2 and 10, respectively). 
When the work was progressed in this study, a small selection of commercially available 
lipases was screened for activity towards the chosen substrate (Table 2.2, Entries 12–16) and 
subsequently used for other substrates. The commercially available lipases used were: Hog 
pancreas lipase, CAL-B (immob), Pseudomonas fluorescens (immob), Amano PS Lipase, and 
Lipase from Candida cylindracea. 
During this study the lipase from Candida cylindracea (Table 2.2, entry 15) gave a good 
conversion but without selectivity. This hydrolysis was subjected to a small solvent screen, 
including 1-octanol (Table 2.2, entry 16), which furnished us with eep = 27%, ees = 20%, c = 
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42%. While this is poorly selective overall, it does show a drastic increase in selectivity 
compared to the absence of the organic cosolvent (Entry 15). While the use of Pseudomonas 
fluorescens (Entry 3) gave 30% conversion with moderate enantioselectivity, the use of the 
immobilised lipase (Entry 13) gave <5% conversion. 
Table 2.2 Hydrolysis of 2-Phenyl-1-propyl Benzoate 21 
 
Entry Lipase 
Conversion (%) eea (%) 
E NMR Ecalc ees eep 
1 Lipase A from Burkholderia cepacia 47 48 66 71 11 
2 Lipase E from Alcaligenes sp 30 33 23 46 3.4 
3 Lipase from Pseudomonas fluorescens 29 29 28 69 7.1 
4 Lipase from Pseudomonas cepacia 23 32 44 93 42 
5 Lipase from Aspergilus niger 22 24 8 26 1.8 
6 Porcine Pancrease type II 17 19 7 30 2 
7 Lipase C from Alcaligenes sp 15 32 18 39 2.7 
8 Candida antartica lipase B (immob) 15 19 21 87 17 
9 Lipase D from Alcaligenes sp. 14 11 8 64 4.9 
10 Lipase F from Alcaligenes sp. 11 7 4 57 3.8 
11 Lipase from Candida antarctica 10 18 20 89 20 
12 Hog pancreas lipase 4 -b -c -c -b 
13 Pseudomonas fluorescens (immob) 2 -b -c -c -b 
14 Amano PS lipase 9 -b -c -c -b 
15 Lipase from Candida cylindracea 48 -d 0 0 -d 
16 Lipase from Candida cylindracea with 
17% v/v 1-octanol 
-e 42 27 
(R) 
20 2 
Entries 1 to 11 were carried out by D. Gavin. aEnantiomeric excess values determined by chiral HPLC analysis; bEcalc and E values 
were not determined, as ee values were not measured when conversion <10%; cenantiomeric excess values were not 
determined when coversion was <10%; dEcalc and E values were not determined, as enantioselectivity was <1% ee; econversion 
was not determined by 1H NMR due to the presence of 1-octanol which was not effectively removed by rotary evaporation 
because of high b.p. (195°C). 
 
The resolution was also attempted using the transesterification reaction (Scheme 2.23), as the 
selectivity can be changed by changing the mode of reaction.79 Unfortunately, the 
transesterification reaction with vinyl benzoate gave no conversion when Hog Pancreas lipase, 
CAL-B (immob), Pseudomonas fluorescens (immob), or Amano PS Lipase were used; Lipase 
from Candida cylindracea gave 100% conversion after 72 hours. 
 
Scheme 2.23 Transesterification of 1 using vinyl benzoate 
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Lipase from Candida cylindracea does not give selectivity for our compounds. It has been used 
for transesterification of secondary alcohols to esters having alkyl chains on the acyl moiety 
and for transesterification of secondary amines.80,81 
2.4.3 Screening – small acyl group: acetate 
To explore the steric demands of the acyl group, it was decided to test the commercial 
enzymes against a much smaller ester group, the acetate group. Resolution by hydrolysis has 
previously been reported but was poorly selective (E = 4) for 2-phenyl-1-propyl acetate 22.82 
More common however, is the resolution of the acetate 22 by transesterification.25,44,83,84 
Resolution of 2-phenyl-1-propanol 1 was attempted using both hydrolysis and 
transesterification reactions, and the reaction times were adjusted to ensure the optimum 
kinetic resolution conversion ~50%. Five lipases tested gave >50% hydrolysis product after 65 
hours (Table 2.3 and Table 2.4, additional timepoints are shown in Appendix III).  
The presence or absence of molecular sieves had little effect on the transesterification 
reactions, with molecular sieves increasing the conversion, but having very little effect on the 
E value.21  
Following these experiments, and with reference to the literature,17,25,44,82,83,85 it was clear that 
the acetate group was not bulky enough to give good enantioselectivity at 30°C. One option 
would be to carry out the reaction at a lower temperature, which is known to aid selectivity. 
Looking at the time screens, where lower reaction times did not necessarily furnish better 
selectivity, it was decided to change the ester to a bulkier group.  
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Table 2.3 Hydrolysis of 2-phenylpropyl acetate 22 
 
Entry Lipase Time (h) 
Conversion (%) eea (%) 
E 
NMR Ecalc ees eep 












































































In the absence of an enzyme, the reaction gave no product after 48 hours. aEnantiomeric excess values were determined by 
chiral HPLC analysis. 
 
Table 2.4 Transesterification of 2-phenyl-1-propanol 1 using vinyl acetate as acyl source 
 
Entry Lipase Time (h) 
Conversion (%) eea (%) 
E 
NMR Ecalc ees eep 
























































































Lipase from Candida cylindracea gave conversion > 80% even after only 2 hours (E = 1). Reactions carried out in the absence 
of a lipase, gave no product after 24 hours. aEnantiomeric excess values were determined by chiral HPLC analysis; bcarried out 
in the presence of 4Å molecular sieves; cwhen conversion was 100%, enantiomeric excess was not measured, and Ecalc and E 
were not determined. 
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2.4.4 Screening – larger acyl group: pivalate  
The pivalate ester, 2-phenylpropyl pivalate 23, was synthesised and screened against the 
lipases for hydrolysis and transesterification. The hydrolysis reactions gave excellent 
enantioselectivity towards the alcohol 1, when Amano PS Lipase was used, albeit coupled with 
poor conversion (Table 2.5, Entry 4). Other lipases tested gave little to no conversion; those 
which gave conversion showed poor enantioselectivity for the product 23. 
Table 2.5 Hydrolysis of 2-Phenylpropyl pivalate 23 
 
Entry Lipase 
Conversion (%) eea (%) 
E 
NMR Ecalc ees eep 
1 Hog Pancreas lipase 3 29 4 10 (S) 1 
2 Candida antarctica lipase B 
(immob) 
0 - b -c - c -b 
3 Pseudomonas fluorescens lipase 
(immob) 
0 - b - c - c - b 
4 Amano PS lipase 15 13 14 90 (S) 22 
5 Lipase from Candida cylindracea 9 11 0 8 (R) 1 
Reaction carried out using no enzyme gave no conversion. aEnantiomeric excess values were determined by chiral HPLC analysis; 
bEcalc conversion and E were not determined as this requires ee > 1; cenantiomeric excess values were not determined as conversion 
was 0%. 
Transesterification reactions (Table 2.6) were poorly selective, giving up to 62% enantiomeric 
excess of the ester 23. Candida antarctica lipase B (immobilised) gave complete conversion in 
the reaction time (72 h). 
The hydrolytic reaction catalysed by Amano PS Lipase was subjected to a solvent screen (Table 
2.7). The temperature was increased to 50 °C, as the lipase is stable to this temperature, and 
the conversion in the absence of a cosolvent was low; it was hoped that the conversion would 
increase with increased temperature. 
The increased temperature gave a slight decrease in the enantioselectivity towards the 
alcohol 1 (Table 2.7, Entry 1 vs. Table 2.5, Entry 4). A moderate increase in conversion was 
observed in the absence of a cosolvent at the higher temperature. The addition of cosolvents 
gave excellent enantioselectivity, albeit with very poor conversion. It should be noted that in 
some cases the conversion could not be calculated, as this requires the % ee to be >1%; 
similarly, the E value could not be determined when using methyl tert-butyl ether, n-heptane 
and acetonitrile as solvents. 
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At this stage, the reaction time could have been extended but this process would not be 
synthetically useful, as the extended time would make the process unattractive. It was 
decided to try a different substrate. 
Table 2.6 Transesterification of 1 using vinyl pivalate 
 
Entry Lipase 
Conversion (%) eea (%) 
E 
NMR Ecalc ees eep 
1 Hog Pancreas lipase 0 - b -c - c -b 
2 Candida antarctica lipase B 
(immob) 
100 - b -d -d -b 
3 Pseudomonas fluorescens lipase  
(immob) 
37 33 31 (R) 62 6 
4 Amano PS lipase 8 39 3 (R) 5 1 
5 Lipase from Candida cylindracea 18 13 4 (S) 28 2 
Reaction carried out using no enzyme gave no conversion. aEnantiomeric excess values were determined by chiral HPLC 
analysis; bEcalc conversion and E were not determined as this requires ee > 1; cenantiomeric excess values were not determined 
as conversion was 0%; denantiomeric excess values were not determined as full conversion was observed. 
 
Table 2.7 Hydrolysis of 2-Phenylpropyl pivalate 23 -Introduction of solvents and increasing temperature 
 
Entry Cosolvent 
Conversion (%) eea (%) 
E 
NMR Ecalc ees eep 
1 -b 21 19 20 88 (S) 20 
2 Methyl tert-Butyl Ether <1 -c 0 81 (S) -c 
3 2-Propanol -d 4 4 91 (S) 22 
4 n-Heptane <1 -c 0 >99 (S) -c 
5 Acetonitrile 2 -c 0 >99 (S) -c 
Initial reactions were carried out at 30°C using the following enzymes, which gave conversion <10%: Hog pancreas lipase, 
Lipase from Candida cylindracea. The following enzymes gave no conversion: Pseudomonas fluorescens (immobilised), 
Candida antarctica lipase B (immobilised). aEnantiomeric excess values were determined by chiral HPLC analysis; bcarried 
out at 30°C, all other reactions carried out at 50°C; cEcalc conversion and E were not determined as this requires ee > 1; 
dconversion by NMR could not be determined because of the presence of the solvent peak 
2.4.5 Screening – isobutyrate 
As a result of the high selectivity but poor conversion using the pivalate ester 23 the 
isobutyrate ester 24 was selected, as a compromise between the small acetate ester group, 
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which gave good conversion and poor selectivity, and the bulky pivalate ester group, which 
gave poor conversion but excellent selectivity (Figure 2.12). 
 
Figure 2.12 2-Phenylpropyl Isobutyrate 24: A compromise between ester groups 
Transesterification reactions were not carried out, partly because the vinyl ester was not 
commercially available. Possible synthetic routes are either low yielding, use complex or 
gaseous reagents or require high pressure, which would not be sufficient to access the 
amount of reagent required for screening reactions.86 Scheme 2.24 shows a recently reported 
synthetic route to various aromatic vinyl esters through transvinylation of anhydrides or mixed 
anhydrides as reagents.87 
 
Scheme 2.24 Synthetic route to enol ethers 
Candida antarctica Lipase B (immobilised) showed excellent enantioselectivity in hydrolysis 
leading to both the ester 24 and the alcohol 1 in good enantiopurity (  
Results & Discussion 
81 
Table 2.8, Entry 2); the reaction was repeated several times and shows the reproducibility of 
the reaction. Amano PS Lipase also gave excellent enantioselectivity for the recovered ester, 




Table 2.8 Hydrolysis of 2-phenylpropyl isobutyrate 24 
 
Entry Lipase 
Conversion (%) eea (%) E88 
NMR Ecalc ees eep  
1 Hog Pancreas lipase 17 15 11 60 (S) 4 




















3 Pseudomonas fluorescens lipase (immob) 9 8 4 51 (S) 3 















5 Lipase from Candida cylindracea 100 - - - - 
Reaction carried out with no enzyme present resulted in no conversion. aEnantiomeric excess values were determined by 
chiral HPLC analysis using Chiralcel OBH, 0.5 ml/min, 99:1 hexane:IPA; bconversion was not determined by 1H NMR. 
 
The biocatalysed hydrolysis was subjected to an organic solvent screen (Table 2.9). E-values 
of up to 66 were achieved, with up to 95% ee. Water miscible and immiscible solvents were 
chosen and used as a 17% v/v mixture with the buffer. Only moderate conversions were 
attained using water miscible 2-propanol, acetone, and acetonitrile (Entries 3-5). The 
hydrocarbons pentane, hexane and heptane (entries 14, 8 and 6, respectively) gave similar 
conversions and enantioselectivities; interestingly, cyclohexane (entry 13) had much higher 
conversion than the acyclic n-hexane (Entry 8) (33% vs 12% conversion). Methyl tert-butyl 
ether (MTBE) and diisopropyl ether (Entries 7 and 9), two ether solvents having the same 
molecular formula, gave similar enantioselectivities (94% ee and 92% ee) but MTBE gave 
higher conversion (34% vs. 8%). Enantioselectivity towards the alcohol 1 was consistently high 
(87–95%). 
Although tert-butanol is miscible with water, an interface was observed on addition of 17% 
tert-butanol to the reaction mixture; presumably, the buffer solution was sufficient to change 
the solubility of the solvent in the aqueous medium. 
Recent literature has suggested that less polar solvents have a positive effect on the 
performance of Candida antarctica Lipase B, but no correlation was observed here; it should 
be noted, however, that the concentrations of solvents used were different in the literature 
report.89  
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Table 2.9 Solvent screen of 24 with CAL-B (immob.) 
 
Entry Cosolvent Conversiona (%) 
eeb (%) 
E 
ees (R) eep (S) 
1 - 46 76 90 (S) 44 
2 1-Octanol 2 2 89 (S) 17 
3 2-Propanol 21 24 93 (S) 33 
4 Acetonec 33 47 95 (S) 60 
5 Acetonitrilec 33 47 95 (S) 63 
6 n-Heptanec 14 15 92 (S) 29 
7 Methyl tert-butyl etherc 34 48 94 (S) 53 
8 Hexanec 10 10 92 (S) 27 
9 Diisopropyl ether 8 8 92 (S) 26 
10 tert-Butanol 48 85 91 (S) 59 
11 2-Methyltetrahydrofuran 14 15 95 (S) 41 
12 Toluene 41 62 87 (S) 28 
13 Cyclohexane 33 46 95 (S) 66 
14 Pentanec 12 12 93 (S) 29 
aEcalc conversion; benantiomeric excess values were determined by chiral HPLC analysis; cHPLC grade solvent 
used. 
2.4.6 Preparative scale synthesis of (S)-2-phenyl-1-propanol (S)-1 and (R)-2-
phenylpropyl isobutyrate (R)-24 
Following on from this successful resolution screen, and as a conclusion to the study, the 
resolution of 2-phenyl-1-propanol 1 was carried out on a preparative scale. The solvent 
chosen for scale up was tert-butanol on the basis of both efficiency and selectivity (Table 2.9, 
Entry 10) furnishing 2-phenyl-1-propanol 1 in 34% isolated yield, and the ester 24 in 54% yield, 
after column chromatography, accompanied by 90% ee and 70% ee, respectively (Scheme 
2.25). The literature rotation agrees with the measured rotation.25  
 
Scheme 2.25 Preparative scale synthesis of (S)-2-phenyl-1-propanol 1 and (R)-2-phenyl-1-propyl isobutyrate 24.  
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The isobutyric acid by-product was removed in the aqueous work-up, and was not detected 
in the crude 1H NMR spectrum of the reaction mixture (expect singlet at 11.8 ppm, multiplet 
at 2.6 ppm and doublet at 1.22 ppm)90 (Figure 2.13); only peaks corresponding to the alcohol 
product 1 and the ester substrate 24 were present. This is a clear advantage as this meant 
that only two components needed to be isolated from the crude mixture. 
2.4.7 Determination of stereochemistry 
The stereochemistry was determined by comparison to the reported optical rotation data and 
the HPLC trace of a sample of enantiopure (–)-(S)-2-phenyl-1-propanol (S)-1 (Figure 2.14), 
purchased from Sigma Aldrich.25 A sample of the racemic alcohol 1 was run on the HPLC, and 
a sample of enantiopure (S)-1. To confirm that the correct elution order had been identified a 
mixture of the racemic alcohol and the enantiopure alcohol was also run. The first peak was 
Crude: 43% 
conversion 
Figure 2.13 1H NMR spectrum of the crude preparative scale reaction (top), the purified ester 24 (middle), and 
the purified alcohol 1 (bottom) (CDCl3, 300 MHz) 
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enhanced relative to the racemic mixture, confirming that the (S)-enantiomer was eluted first. 
This was necessary, as it is known that the retention times of compounds can vary slightly, 
even under the same conditions. 
 
Figure 2.14 HPLC trace showing racemic 2-phenyl-1-propanol 1 (red), (S)-1 enriched material (green), and 
enantiopure (S)-1 (blue) (Chiralcel OB-H, 0.5 mL/min, 0.5:99.5 2-propanol/hexane) 
2.4.7 Follow up – change lipase concentration 
In order to ascertain if the reaction was a true resolution, the screen was repeated under the 
same conditions as the preparative scale resolution, for 24 h, 72 h and 120 h, except that the 
lipase concentration was doubled. The reactions attained 64% conversion, by 1H NMR, after 
24h, showing that the reaction proceeded faster with higher enzyme concentration. However, 
the reaction continued past 50% conversion. In this case, the ester selectivity was excellent, 
97–99% ee as expected for conversion over 50%, with the alcohol selectivity decreasing with 
increasing conversion (Table 2.10). This shows us that ester 24 can be prepared with excellent 
enantioselectivity, when using a greater concentration of enzyme, in a much shorter time. 
However, the higher concentration of the lipase combined with a shorter time is unsuitable 
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for the preparation of the enantiopure alcohol 1 as the enantioselectivity is lower due to the 
greater extent of conversion (Table 2.10). 
Table 2.10 Hydrolysis of 2-phenylpropyl isobutyrate 24 
 
Entry Time 
Conversion (%) eea (%) 
E88 
NMR Ecalc ees eep 
1 120 77 80 97 25 5.7 
2 72 89 77 >99 29 7.6 
3 24 64 56 >99 78 40 
Reaction carried out with no enzyme present resulted in conversion <1% after 120 h. aEnantiomeric excess values were 
determined by chiral HPLC analysis. 
 
Overall, these results indicate that by careful control of the reaction conditions and acyl group, 
the lipase-mediated hydrolysis can lead efficiently to highly enantioenriched 2-phenyl-1-
propanol 1 and 2-phenylpropyl isobuyrate 24 in a synthetically useful process. The key to this 
was choosing the isobutyrate group as a compromise between the pivaloyl (highly selective, 
poorly efficient) and the acetyl (poorly selective and highly efficient) groups. 
2.4.8 Follow up – substrate scope 
Encouraged by the excellent results using 2-phenylpropyl isobutyrate 24, the effect of 
increasing alkyl substituent size was briefly explored. Esters 25 and 26 (Figure 2.15) were 
subjected to hydrolysis using the optimised conditions for ester 24 [Candida antarctica lipase 
B (immobilised), 72 h, 750 rpm]. 
 
Figure 2.15 Esters 25 and 26, substrate scope. 
Ester 25 showed encouraging results for the initial screen using Candida antarctica lipase B 
(immobilised) (Table 2.11, Entry 1) and was subjected to a small solvent screen, using the 
solvents which gave the highest E-values for hydrolysis of 2-phenylpropyl isobutyrate 24. 
Acetonitrile (Entry 4) showed the highest product enantioselectivity (86% ee), which was 
similar to the result for 24 (Table 2.9, entry 5). Previously, the highest reported %ee of 2 by 
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lipase-catalysed resolution (transesterification) was 69% ee, using vinyl acetate as the acyl 
source.79 The more sterically demanding ester 26 was not hydrolysed either in neat buffer or 
with tert-butanol (17% v/v). The use of the ester having a tert-butyl substituent at the benzylic 
position was not explored. 
Table 2.11 Hydrolysis of 2-phenylpropyl isobutyrate 25 with CAL-B (immob) 
 




1 - 47 66 74 13 
2 tert-Butanol 33 37 74 9.6 
3 Acetonec 21 21 77 9.2 
4 Acetonitrilec 24 28 86 17 
5 Methyl tert-butyl etherc 19 19 82 12 
6 Cyclohexane 18 17 82 12 




2.5 Project conclusion 
A series of esters of 2-phenyl-1-propanol 1 was prepared, including two novel esters, 23 and 
24, and subjected to lipase-catalysed transformations. By manipulation of the reaction 
conditions, as well as modification of the substrate, the resolution of 2-phenyl-1-propanol 1 
was optimised. 
2-Phenyl-1-propanol 1 was resolved with excellent enantioselectivity, up to 96% ee and up to 
48% conversion, using a commercially available lipase and a small, alkyl ester group, making 
the transformation selective and atom economical. E values of up to 63 were obtained; while 
this is lower than some reported values, it uses a much smaller ester group, making it much 
more atom economical, and easier to purify on scale up. A preparative scale resolution was 
also performed, giving 43% conversion after 72 hours, coupled with 34% yield of alcohol 1 
with 88% ee and 54% yield of ester 24, with 68% ee. 
It was shown that the ester can also be resolved with excellent enantioselectivity (97–99% ee) 
by increasing the lipase concentration.  
The influence of the size of the alkyl substituent at the chiral centre was also investigated. The 
ester 25, bearing an ethyl group at the stereocentre, was subjected to lipase-catalysed 
hydrolysis, giving the alcohol 2 with up to 86% ee, the highest reported from a lipase catalysed 
transformation. On further increasing the size of the alkyl substituent to iPr, the substrate 26 
proved resistant to hydrolysis under the conditions used. 
  
Results & Discussion 
89 
2.6 References 
1. Bornscheuer, U.; Kazlauskas, R. J. Hydrolases in Organic Synthesis: Regio- and 
Stereoselective Biotransformations, 2006. 
2. Wolfenden, R.; Snider, M. J. Acc. Chem. Res. 2001; 34:938-45. 
3. Ghanem, A. Tetrahedron 2007; 63:1721-54. 
4. Nakamura, K.; Kinoshita, M.; Ohno, A. Tetrahedron 1995; 51:8799-808. 
5. van Tilbeurgh, H.; Egloff, M.-P.; Martinez, C.; Rugani, N.; Verger, R.; Cambillau, C. 
Nature 1993; 362:814-20. 
6. Chen, C.-S.; Sih, C. J. Angew. Chem. Int. Ed. 1989; 28:695-707. 
7. Sakai, T.; Kishimoto, T.; Tanaka, Y.; Ema, T.; Utaka, M. Tetrahedron Lett. 1998; 
39:7881-4. 
8. Sakai, T.; Kawabata, I.; Kishimoto, T.; Ema, T.; Utaka, M. J. Org. Chem. 1997; 62:4906-
7. 
9. Sabbani, S.; Hedenstrom, E.; Nordin, O. J. Mol. Catal. B: Enzym. 2006; 42:1-9. 
10. Jung, S.; Park, S. ACS Catal. 2017; 7:438-42. 
11. Itoh, T.; Mitsukura, K.; Kanphai, W.; Takagi, Y.; Kihara, H.; Tsukube, H. J. Org. Chem. 
1997; 62:9165-72. 
12. Berglund, P.; Holmquist, M.; Hult, K.; Högberg, H.-E. Biotechnol. Lett. 1995; 17:55-60. 
13. Itoh, T.; Hiyama, Y.; Betchaku, A.; Tsukube, H. Tetrahedron Lett. 1993; 34:2617-20. 
14. Irimescu, R.; Saito, T.; Kato, K. J. Mol. Catal. B: Enzym. 2004; 27:69-73. 
15. Ardhaoui, M.; Falcimaigne, A.; Ognier, S.; Engasser, J. M.; Moussou, P.; Pauly, G.; 
Ghoul, M. J. Biotechnol. 2004; 110:265-71. 
16. Ema, T.; Maeno, S.; Takaya, Y.; Sakai, T.; Utaka, M. Tetrahedron: Asymmetry 1996; 
7:625-8. 
17. Goto, M.; Kawasaki, M.; Kometani, T. J. Mol. Catal. B: Enzym. 2000; 9:245-50. 
18. Kawasaki, M.; Goto, M.; Kawabata, S.; Kometani, T. Tetrahedron: Asymmetry 2001; 
12:585-96. 
19. Prabhakar, S.; Vives, T.; Ferrieres, V.; Benvegnu, T.; Legentil, L.; Lemiegre, L. Green 
Chem. 2017; 19:987-95. 
20. Hirose, K.; Naka, H.; Yano, M.; Ohashi, S.; Naemura, K.; Tobe, Y. Tetrahedron: 
Asymmetry 2000; 11:1199-210. 
21. Sabbani, S.; Hedenstrom, E.; Andersson, J. Tetrahedron: Asymmetry 2007; 18:1712-
20. 
22. Nordin, O.; Nguyen, B.-V.; Vörde, C.; Hedenström, E.; Högberg, H.-E. J. Chem. Soc., 
Perkin Trans. 1 2000; 3:367-76. 
23. Isleyen, A.; Tanyeli, C.; Dogan, O. Tetrahedron: Asymmetry 2006; 17:1561-7. 
24. Meng, X.; Guo, L.; Xu, G.; Wu, J.-P.; Yang, L.-R. J. Mol. Catal. B: Enzym. 2014; 109:109-
15. 
25. Serra, S. Tetrahedron: Asymmetry 2011; 22:619-28. 
26. Gotor-Fernández, V.; Brieva, R.; Gotor, V. J. Mol. Catal. B: Enzym. 2006; 40:111-20. 
27. Basak, A.; Nag, A.; Bhattacharya, G.; Mandal, S.; Nag, S. Tetrahedron: Asymmetry 
2000; 11:2403-7. 
28. Abate, A.; Brenna, E.; Fuganti, C.; Gatti, F. G.; Serra, S. J. Mol. Catal. B: Enzym. 2004; 
32:33-51. 
29. Abate, A.; Brenna, E.; Fuganti, C.; Gatti, F. G.; Giovenzana, T.; Malpezzi, L.; Serra, S. J. 
Org. Chem. 2005; 70:1281-90. 




31. Leitereg, T. J.; Guadagni, D. G.; Harris, J.; Mon, T. R.; Teranishi, R. J. Agric. Food. Chem. 
1971; 19:785-7. 
32. Ammazzalorso, A.; Amoroso, R.; Bettoni, G.; De Filippis, B.; Fantacuzzi, M.; 
Giampietro, L.; Maccallini, C.; Tricca, M. L. Chirality 2008; 20:115-8. 
33. Berglund, P.; Vallikivi, I.; Fransson, L.; Dannacher, H.; Holmquist, M.; Martinelle, M.; 
Björkling, F.; Parve, O.; Hult, K. Tetrahedron: Asymmetry 1999; 10:4191-202. 
34. Moreno, J.; Sinisterra, J. J. Mol. Cat. A: Chem. 1995; 98:171-84. 
35. Moreno, J.; Samoza, A.; del Campo, C.; Llama, E. F.; Sinisterra, J. J. Mol. Cat. A: Chem. 
1995; 95:179-92. 
36. Arroyo, M.; Sinisterra, J. V. J. Org. Chem. 1994; 59:4410-7. 
37. Hernáiz, M. J.; Sánchez-Montero, J. M.; Sinisterra, J. V. J. Mol. Cat. A: Chem. 1995; 
96:317-27. 
38. Deasy, R. E.; Brossat, M.; Moody, T. S.; Maguire, A. R. Tetrahedron: Asymmetry 2011; 
22:47-61. 
39. Deasy, R. E.; Moody, T. S.; Maguire, A. R. Tetrahedron: Asymmetry 2013; 24:1480-7. 
40. Foley, D. A.; O'Leary, P.; Buckley, N. R.; Lawrence, S. E.; Maguire, A. R. Tetrahedron 
2013; 69:1778-94. 
41. Han, G.; Lewis, A.; Hruby, V. J. Tetrahedron Lett. 2001; 42:4601-3. 
42. Jaeger, K. E.; Reetz, M. T. Trends Biotechnol. 1998; 16:396-403. 
43. Avila, T. C.; Reginato, M. M.; Di Vitta, C.; Ducati, L. C.; Andrade, L. H.; Marzorati, L. 
Tetrahedron Lett. 2016; 57:2152-7. 
44. Sakai, T.; Hayashi, K.; Yano, F.; Takami, M.; Ino, M.; Korenaga, T.; Ema, T. Bull. Chem. 
Soc. Jpn 2003; 76:1441-6. 
45. Kawasaki, M.; Goto, M.; Kawabata, S.; Kodama, T.; Kometani, T. Tetrahedron Lett. 
1999; 40:5223-6. 
46. Jaeger, K.-E.; Schneidinger, B.; Rosenau, F.; Werner, M.; Lang, D.; Dijkstra, B. W.; 
Schimossek, K.; Zonta, A.; Reetz, M. T. J. Mol. Catal. B: Enzym. 1997; 3:3-12. 
47. Chen, C. S.; Liu, Y. C. J. Org. Chem. 1991; 56:1966-8. 
48. Huang, Z.; Tan, Z.; Novak, T.; Zhu, G.; Negishi, E.-i. Adv. Synth. Catal. 2007; 349:539-
45. 
49. Galletti, P.; Emer, E.; Gucciardo, G.; Quintavalla, A.; Pori, M.; Giacomini, D. Org. 
Biomol. Chem. 2010; 8:4117-23. 
50. Quaglia, D.; Pori, M.; Galletti, P.; Emer, E.; Paradisi, F.; Giacomini, D. Process Biochem. 
2013; 48:810-8. 
51. Díaz-Rodríguez, A.; Ríos-Lombardía, N.; Sattler, J. H.; Lavandera, I.; Gotor-Fernández, 
V.; Kroutil, W.; Gotor, V. Catal. Sci. Technol. 2015; 5:1443-6. 
52. Kara, S.; Spickermann, D.; Schrittwieser, J. H.; Leggewie, C.; van Berkel, W. J. H.; 
Arends, I. W. C. E.; Hollmann, F. Green Chem. 2013; 15:330. 
53. Mazza, S.; Scopelliti, R.; Hu, X. Organometallics 2015; 34:1538-45. 
54. Gao, Y.; Jaenicke, S.; Chuah, G.-K. Appl. Catal., A 2014; 484:51-8. 
55. Liu, M.; Zhou, F.; Jia, Z.; Li, C.-J. Org. Chem. Front. 2014; 1:161. 
56. Li, Y.; Li, H.; Junge, H.; Beller, M. Chem. Commun. 2014; 50:14991-4. 
57. Souto, J. A.; Stockman, R. A.; Ley, S. V. Org. Biomol. Chem. 2015; 13:3871-7. 
58. Morimoto, T.; Fujii, T.; Miyoshi, K.; Makado, G.; Tanimoto, H.; Nishiyama, Y.; Kakiuchi, 
K. Org. Biomol. Chem. 2015; 13:4632-6. 
59. Zhuang, M.; Du, H. Org. Biomol. Chem. 2013; 11:1460-2. 
60. Guduguntla, S.; Fananas-Mastral, M.; Feringa, B. L. J. Org. Chem. 2013; 78:8274-80. 
61. Zhao, Y.; Weix, D. J. J. Am. Chem. Soc. 2014; 136:48-51. 
62. Ramage, R.; Blake, A. J.; Florence, M. R.; Gray, T.; Raphy, G.; Roach, P. L. Tetrahedron 
1991; 47:8001-24. 
Results & Discussion 
91 
63. Scott, Natalie M.; Schareina, T.; Tok, O.; Kempe, R. Eur. J. Inorg. Chem. 2004; 
2004:3297-304. 
64. Steib, A. K.; Thaler, T.; Komeyama, K.; Mayer, P.; Knochel, P. Angew. Chem. Int. Ed. 
2011; 50:3303-7. 
65. Piller, F. M.; Metzger, A.; Schade, M. A.; Haag, B. A.; Gavryushin, A.; Knochel, P. Chem. 
Eur. J. 2009; 15:7192-202. 
66. Campos, J.; Espada, M. F.; Lopez-Serrano, J.; Carmona, E. Inorg. Chem. 2013; 52:6694-
704. 
67. Padial, J. S.; de Gelder, R.; Fonseca Guerra, C.; Bickelhaupt, F. M.; Mecinovic, J. Chem. 
Eur. J. 2014; 20:6268-71. 
68. Nakamura, M.; Oki, M. Bull. Chem. Soc. Jpn 1980; 53:2977-80. 
69. Francisco, M. A.; Kurs, A.; Katritzky, A. R.; Rasala, D. J. Org. Chem. 1988; 53:4821-6. 
70. Rose, C. B.; Taylor, S. K. J. Org. Chem. 1974; 39:578-81. 
71. Ciaccio, J. A.; Volpi, S.; Clarke, R. J. Chem. Edu. 1996; 73:1196-8. 
72. Rioz-Martinez, A.; de Gonzalo, G.; Torres Pazmino, D. E.; Fraaije, M. W.; Gotor, V. J. 
Org. Chem. 2010; 75:2073-6. 
73. Karamé, I.; Tommasino, M. L.; Lemaire, M. Tetrahedron Lett. 2003; 44:7687-9. 
74. Robinson, M. W. C.; Pillinger, K. S.; Mabbett, I.; Timms, D. A.; Graham, A. E. 
Tetrahedron 2010; 66:8377-82. 
75. Umeda, R.; Muraki, M.; Nakamura, Y.; Tanaka, T.; Kamiguchi, K.; Nishiyama, Y. 
Tetrahedron Lett. 2017; 58:2393-5. 
76. Adam, W.; Bosio, S. G.; Turro, N. J.; Wolff, B. T. J. Org. Chem. 2004; 69:1704-15. 
77. Corberan, R.; Mszar, N. W.; Hoveyda, A. H. Angew. Chem. Int. Ed. 2011; 50:7079-82. 
78. Foley, A. M.; Gavin, D. P.; Joniec, I.; Maguire, A. R. Tetrahedron: Asymmetry 2017; 
28:1144-53. 
79. Sih, J. C.; Gu, R. L. Tetrahedron: Asymmetry 1995; 6:357-60. 
80. Kovács, B.; Megyesi, R.; Forró, E.; Fülöp, F. Tetrahedron: Asymmetry 2017; 28:1829-
33. 
81. Strohalm, H.; Dold, S.; Pendzialek, K.; Weiher, M.; Engel, K. H. J. Agric. Food. Chem. 
2010; 58:6328-33. 
82. Takemura, T.; Saito, K.; Nakazawa, S.; Mori, N. Tetrahedron Lett. 1992; 33:6335-8. 
83. Naemura, K.; Murata, M.; Tanaka, R.; Yano, M.; Hirose, K.; Tobe, Y. Tetrahedron: 
Asymmetry 1996; 7:3285-94. 
84. Naemura, K.; Fukuda, R.; Konishi, M.; Hirose, K.; Tobe, Y. J Chem Soc Perk T 1 1994; 
10:1253-6. 
85. Bianchi, D.; Battistel, E.; Bosetti, A.; Cesti, P.; Fekete, Z. Tetrahedron: Asymmetry 1993; 
4:777-82. 
86. Mondal, M. A. S.; Van Der Meer, R.; German, A. L.; Heikens, D. Tetrahedron 1974; 
30:4205-7. 
87. Kaliyaperumal Appaye, S.; Pandurang Nikumbh, S.; Reddy Govindapur, R.; Banerjee, 
S.; Bhalerao, D. S.; SyamKumar, U. K. Helvetica Chimica Acta 2014; 97:1115-22. 
88. Chen, C. S.; Fujimoto, Y.; Girdaukas, G.; Sih, C. J. J. Am. Chem. Soc. 1982; 104:7294-9. 
89. Dutta Banik, S.; Nordblad, M.; Woodley, J. M.; Peters, G. H. ACS Catal. 2016; 6:6350-
61. 















Resolution of 6-methylchroman-2-ol: 
towards the hydrolase-mediated 






Results & Discussion 
95 
Contents 
Overview ................................................................................................................................ 96 
3.1 Introduction...................................................................................................................... 97 
3.1.1 Routes to tolterodine 58 & fesoterodine 59.............................................................. 99 
3.1.2 Enzymatic resolution ............................................................................................... 101 
3.1.3 Acylating agents ...................................................................................................... 101 
3.2 Objectives ....................................................................................................................... 104 
3.3 Synthesis model lactol substrate 51 ............................................................................... 105 
3.3.1 Reduction of the alkene moiety .............................................................................. 105 
3.3.2 Reduction of the lactone 75 .................................................................................... 105 
3.3.3 Acylated lactol reference standard.......................................................................... 108 
3.4 Resolution of lactol 51 .................................................................................................... 109 
3.4.1 Enzymatic screen of lactol substrate – background on related substrate ............... 109 
3.4.2 Analysis of reactions ................................................................................................ 109 
3.4.3 Initial 24-hour screen .............................................................................................. 110 
3.4.4 Candida Antarctica lipase experiments ................................................................... 112 
3.4.5 Solvent screen ......................................................................................................... 113 
3.5 Conclusion ...................................................................................................................... 116 






Hydrolase-catalysed kinetic resolution is a powerful tool for the resolution of chiral 
compounds, although it suffers from a maximum theoretical yield of 50%. Combining the 
kinetic resolution with a racemisation step, either through use of an external catalyst or 
through selection of a substrate which will racemise under the reaction conditions, furnishes 
a dynamic system, which is synthetically more powerful. 
Hydrolase-catalysed dynamic kinetic resolutions of chroman-2-ol 50 and 6-methyl chroman-2-
ol 51 was effected with up to 88% conversion and 92% ee through the use of organic solvents. 
Extension to the resolution of the tolterodine precursor 52 proved more challenging. The 
presence of the remote phenyl substituent had a significant impact on the resolution and it 
was not possible to achieve high enantioselectivity together with efficient conversion from the 
focused panel of enzymes screened. 
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3.1 Introduction 
Coumarins, or benzo-α-pyrones, are a class of molecules made up of a benzene ring fused to 
a pyrone ring. They are present in many naturally occurring compounds and their derivatives 
have been used in pharmaceuticals such as anticoagulants,1 and anti-cancer agents.2 The 
numbering system is shown in Figure 3.1. 
 
Figure 3.1 Numbering of Coumarins 
Coumarins 52 and 53 have been used as substrates for enzymatic reduction giving the primary 
alcohols 54 and 55, as a result of the reduction of the intermediate aldehyde (Scheme 3.1).3 
However, there are no reports of enzymatic resolution of the anomeric centre of the 
corresponding lactol compounds 56 and 57 so initially a model substrate was used in order to 
show that this centre could be resolved.4 Previous reports of resolution of anomeric centres 
use monocyclic sugars as substrates (Scheme 3.2).5-11  
 
Scheme 3.1 Enzymatic reduction of coumarins 52 and 53 by C. capsici; corresponding lactols 56 and 57. 
 
Scheme 3.2 Examples of lipase-catalysed resolution of the anomeric centres of sugar molecules 
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The lactol moiety is present in potential intermediates in the synthesis of muscarinic 
antagonists, tolterodine 58 and fesoterodine 59 (Figure 3.2). It is envisioned that the lactol 
alcohol could be dynamically resolved using lipase-catalysed transesterification, taking 
advantage of the dynamic ring-opening and ring-closing, which happens in solution. Once it 
has been shown that the dynamic resolution is possible, using the model lactol 50 and 51, 
work can then follow looking at the kinetic resolution of the remote stereocentre in the 
Tolterodine and Fesoterodine intermediates 60 and 61. 
 
Figure 3.2 Intermediate lactols 60 & 61, and the model lactol, 6-methylchroman-2-ol 51 
 
 
Scheme 3.3 Dynamic equilibrium of the lactols with the ring-opened hydroxyaldehyde 
The main goal here has been the synthesis and resolution of the title compound 51 as a 
preliminary step in the investigation of the resolution of intermediates in the synthesis of the 
tolterodine 58 and fesoterodine 59 (Figure 3.2). 
The lactols exists in a dynamic equilibrium with the corresponding acyclic hydroxyaldehydes 
(Scheme 3.3). This is important, because it theoretically allows for complete conversion, via a 
dynamic kinetic resolution. The resolution of the lactol intermediates in the synthesis of 
tolterodine 58 and fesoterodine 59 will require, in addition, recognition of a stereocentre 
remote from the hemiacetal reacting site. Lipases have been shown to recognize remote 
stereocentres in compounds with an OH group (e.g. 3-arylalkanols).12,13 
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This preliminary research was subsequently extended within the team to the resolution of the 
API intermediates 60 and 61 (Figure 3.3).4 The use of enzymes to resolve these intermediates 
represents a move towards a greener synthesis of these compounds. 
 
R = H 60: Tolterodine intermediate 
R = OH 61: Fesoterodine intermediate 
Figure 3.3 Target compounds: intermediate in the synthesis of tolterodine 58 and fesoterodine 59 
There have been many reports of lipase mediated kinetic resolution of key synthetic 
intermediates, such as α-hydroxyamides,14 chiral diols,15,16 and other drug products and 
intermediates (Scheme 3.4).17-19 
 
Scheme 3.4 Some key synthetic intermediates which have been resolved by lipases 
3.1.1 Routes to tolterodine 58 & fesoterodine 59 
There is no shortage of routes to coumarins, dihydrocoumarins and lactols, each with 
advantages and disadvantages, including substrate scope and positions of substitution.20-29 
The current route to fesoterodine 59 is by an amine-catalysed Friedel–Crafts alkylation of the 
substituted phenol 63 with cinnamaldehyde, followed by a reductive amination of the 
resulting lactol 61, and resolution by crystallisation with an enantiopure acid in order to 
resolve the mixture of enantiomers (Scheme 3.5).30 Enantiopure compounds are expensive, 
so the use of cheaply produced enantioenriched material potentially represents a more 




Scheme 3.5 Synthesis of fesoterodine 59 
The route to tolterodine 58 has been optimized more extensively. First patented in 1998, the 
original synthetic route relies on the use of a diastereomeric salt to separate the two 
enantiomers of tolterodine 58 and obtain the active enantiomer, (R)-58.31,32 Early work used 
chiral auxiliaries, such as N-oxazolidinones33 and enol ethers,34 in conjunction with cinnamic 
acid 20, and o-quinone methides, respectively. This allowed introduction of the stereocentre 
early in the synthesis and gave excellent enantioselectivity (>99%). Later, the use of SEGPHOS 
ligands was reported, with excellent results (Scheme 3.6). The reactions used either coumarins 
unsubstituted at the 4-position, with the ruthenium mediated stereoselective 1,4-addition of 
aryl boronic acids to give the lactone 64, or had the substituent present already and used a 
copper hydride catalyst to stereoselectively reduce the double bond.35,36 The latter route had 
the advantage of furnishing the lactol product 60, eliminating the need for a separate 
reduction. The use of alternative ligands has also been reported for the synthesis of (R)-64 
including ligands where an early synthetic step in the synthesis of the ligand includes a lipase-
catalysed resolution.37 
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Scheme 3.6 Enantioselective synthesis of Tolterodine intermediates 64 & 60 using Rh35 & Cu36 catalysis 
3.1.2 Enzymatic resolution 
Although enzymatic resolution of the hemiacetal moiety has been reported previously,5-11 
hydrolase-mediated resolution of aromatic fused hemiacetals has not previously been 
reported. A model substrate (dihydrochroman-2-ol 51) was previously synthesized and 
screened within our group achieving up to 95% ee through hydrolase-mediated acylation.4 
This will be discussed with Table 3.3. 
3.1.3 Acylating agents  
The choice of acylating agent in these reactions is important from a synthetic perspective, 
because one challenge with enzymatic acylation is the reversibility. The use of an acylating 
agent such as vinyl acetate 65 can overcome this challenge because the enol by-product 66 is 
unstable and tautomerises to acetaldehyde 67, rendering the reaction irreversible (Scheme 
3.7).38 The use of vinyl acetate also has the advantage that there is only a small amount of 
non-selective background acylation. Isopropenyl acetate 68, which is a stronger acylating 
agent than 65, was also used during this study.39 Much stronger acylating agents, such as 
acetic anhydride, would be expected to give higher conversion but lower selectivity. Succinic 
anhydride has been used in conjunction with lipases giving good selectivity in the resolution 
of alkyl alcohols.40,41 The use of 1-ethoxyvinyl furoate has been reported for the resolution of 
1,2- and 1,3- diols.35 
 
Scheme 3.7 Acetylation using 68 or 65 and generation of 33 or 67 as a side product 
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The use of longer-chain acylating agents has been reported to improve selectivity and 
conversion.42-44 This is attributed to interaction of the alkyl chain with a hydrophobic channel 
near the binding site.44 
Chênevert et al. investigated the resolution of 1-phenylethanol using a series of different 
acylating agents in order to assess the viability.13 The ability to use different acylating agents 
could expand the utility of these reactions, not only allowing the resolution of the compounds 
but also the introduction of functional groups, which would be especially useful in the 
synthesis of natural products. Scheme 3.8 shows the synthesis of macrolide natural product 
(R)-phoracantholide J (R)-69, where the use of a carefully chosen acyl source 70 allowed the 
introduction of a synthetic handle. A prochiral diol 71, with a remote stereocentre, was 
resolved using vinyl pivalate, allowing the simultaneous resolution of the compound and 
introduction of a pivalate group, which was retained in the final compound (S)-72. 
 
Scheme 3.8 Retention of acyl group used in resolution in the synthesis of protein kinase ligand (S)-72 (bottom) 
Hirose et al. found that when a chiral acyl donor, such as 73, was used in the resolution of 
2-phenyl-1-propanol 1, one enantiomer was inactive (Scheme 3.9).45 When the inactive 
enantiomer (R)-73 was screened, it furnished no acylated product. Using the active 
enantiomer (S)-73 did not improve selectivity over the racemic mixture, but it did give greater 
conversion, which is attributed to less competition within the binding site. 
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Scheme 3.9 Use of chiral acyl donors to resolve 2-phenyl-1-propanol 1; one enantiomer of acyl donor 73 was 




The specific objectives of this project are: 
• To prepare the model lactol, 6-methylchroman-2-ol 51 and prepare the acyl derivative 
62 and develop analytical conditions to determine enantiomeric excess of the acyl 
derivatives. 
• Use the model lactol 51 as a substrate for lipase-mediated transesterification screens, 
using a targeted panel of lipases. 
• Identify lead enzymes and carry out a solvent screen. 
• To conduct a preparative scale resolution of the compound and identify the 
enantiomer formed. 
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3.3 Synthesis of the model lactol substrate 51 
The lactol substrate 51 was synthesized using a two-step method, first reducing the alkene 
bond of 74 with H2, Pd/C, followed by reduction of the carbonyl double bond of 75 using 
DIBAL.46,47 Commercially available 6-methyl coumarin 74 was used as starting material 
(Scheme 3.10). 
 
Scheme 3.10 Synthesis of 6-methyl lactol 51 
3.3.1 Reduction of the alkene moiety 
The first attempt at reduction of the alkene used acetic acid as a solvent and was complete in 
12 h (Scheme 3.11). Unfortunately the yield was much lower than expected (25% vs >95% 
reported).46 The lower yield may be caused by base-catalysed hydrolysis of the lactone, which 
would then remain in the aqueous layer. 
 
Scheme 3.11 Reduction of the alkene 
The reduction of the alkene using ethyl acetate as the solvent, proceeded with 97% yield, gave 
a very clean product after drying and required no purification, albeit 48 h was required for 
complete consumption of the starting material.48,47 Despite the longer reaction time, this 
method was found to be high yielding and gave a pure product 75 (Scheme 3.11). The same 
reaction was reported using a Parr hydrogenator at 57 psi, giving the product after only 3 h 
but it was not attempted in this investigation.49 
3.3.2 Reduction of the lactone 75 
The reduction of the lactone 75 was performed under anhydrous conditions, at low 
temperature, with 1.1 eq. of DIBAL, as a 1M solution in toluene, using freshly distilled toluene 
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as solvent (Scheme 3.12). Several different sets of conditions were used to optimize the yield 
(Table 3.1). 
 
Scheme 3.12 Reduction of lactone 75 to lactol 51 
For the first attempt, TLC showed that, even after 4 h, starting material still remained. In this 
case, an extra 0.55 equivalents of DIBAL were added and stirred at low temperature until the 
starting material had disappeared. In this case, however, two products were recovered after 
column chromatography in a ratio of ~2:1. The major product was the desired lactol product 
51, and the minor was identified as the over-reduction product, diol 76 (Scheme 3.13).  
 
Scheme 3.13 Reduction of the lactol 51 to the diol 76 via the aldehyde intermediate 
Figure 3.4 1H NMR showing aldehyde peak and lactol 1H peak, expansions are not to scale (CDCl3, 300 MHz) 
The lactol product exists in an equilibrium with the ring opened aldehyde 77. The aldehyde is 
present in a very small amount (<1%, in CDCl3) and appears in the 1H NMR at 9.8 ppm (Figure 
3.4). In the case above, the aldehyde form of the lactol 51 is further reduced to the 
corresponding alcohol 76 (Table 3.1, Entry 1). The data obtained for the diol 51 matched 
previously reported data for the compound.3 
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Further experiments required up to 6 h for the reaction to occur, but it was decided that after 
this time, that the reaction would be worked up, allowing the recovery of starting material 
which could be reused, along with the product, due to the challenge of maintaining the 
temperature for extended times overnight. The overall conversion after 6 h was calculated 
from the 1H NMR spectrum and was ~80% (Table 3.1, Entry 2). 
Purification of 51 was generally difficult, requiring several columns to effectively separate the 
starting material 75 and product 51. The unreacted dihydrocoumarin 75 eluted off the column 
first, then fractions containing a mixture of the unreacted dihydrocoumarin 75 and the 
product 51 (generally composed of 70–80% product), followed by the product. Immediately 
after concentration, the product was analysed and dried under vacuum overnight. 
The addition of molecular sieves, to remove water during the reaction, gave much better 
conversion, resulting in no unreacted starting material 75, after 6 h reaction (Table 3.1, Entry 
3). The material obtained from this reaction was obtained in high purity, but chromatography 
was undertaken prior to enzymatic reactions as the material was required in very high purity. 
The synthesis of  lactol 51 has been previously reported.49 
Table 3.1 Synthesis of lactol 51 
 
Entry Conditions % 75a % 51a % 76a 
1 
DIBAL (1.1 eq.), toluene, 
−78°C, 4 h 
DIBAL (0.55 eq.), 2 h 
0 57 43 
2 
DIBAL (1.1 eq.), toluene, 
−78°C, 6 h 
20 80 0 
3 
DIBAL (1,1 eq.), Toluene, 
−78°C, 6 h 
4Å molecular sieves 
0 100 0 




3.3.3 Acylated lactol reference standard 
In order to develop analytical methods for the reactions, it was necessary to prepare the 
acylated lactol 62 (Scheme 3.14). The acylation of the lactol 51 was carried out using a general 
acylation method previously used in our group employing acetic anhydride as the acylating 
agent, distilled DCM as solvent, N,N-dimethylaminopyridine (DMAP) as nucleophilic catalyst 
(5 mol %), and pyridine as a base (4.5 eq.).50 The reaction proceeded at room temperature, 
and gave full conversion on stirring overnight. This was evident by the disappearance of the 
1H signal at 5.58 ppm, and the appearance of a 1H signal at 6.50 ppm. Aqueous copper sulfate 
solution was employed during the work-up to remove pyridine, and any excess, which was not 
removed by the work-up, was removed by azeotrope with heptane. Although the 1H NMR 
spectrum showed complete acylation to the pure acetate 62, the product was subjected to 
column chromatography as it was required in very high analytical purity. This compound is 
novel and was fully characterized in the course of this investigation. 
 
Scheme 3.14 Preparation of acylated lactol 62 
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3.4 Resolution of lactol 51 
3.4.1 Enzymatic screen of lactol substrate – background on related substrate 
Previously, up to 95% ee was achieved for the unsubstituted lactol 50, using neat vinyl acetate 
65 (100 eq.) (Scheme 3.15).4 However, it was observed that >70% ee was always coupled with 
low conversion, and that there was reduced enantioselectivity when the conversions were 
higher. Most enzymes which were screened furnished no acetylated product 78. An 
investigation into the effect of organic solvents on the conversion and selectivity had also been 
conducted on this compound in which up to 91% ee was obtained, albeit with a low conversion 
(13%). Within this study, conversions of up to 81% were achieved, coupled with 56% ee. In 
general, it was observed that use of non-polar solvents gave better conversion and 
enantioselectivity. It should be noted that only 4.2 equivalents of the acylating agent were 
used in the solvent screen for this compound, but a higher loading of vinyl acetate was used 
in the screens using 6-methylchromanol 51 as substrate. 
 
Scheme 3.15 Resolution of unsubstituted lactol 50 
3.4.2 Analysis of reactions 
The reaction completion (conversion) was determined by 1H NMR. The peaks for the C(2) 
protons of the starting material 51 and the desired (acylated) product 62 were sufficiently 
separated on the 1H NMR spectrum (Figure 3.5) and were not overlapping with any other 
peaks. The enantiomeric excess was determined by chiral HPLC and the HPLC conditions are 
listed in Appendix I. The reactions were worked up by simply filtering the reaction solution 
through Celite® and removing the solvent by rotary evaporation. The 1H NMR analysis was 
carried out on the crude material, which only contained the unreacted lactol 51 and the 
acylated product 62. 
The results of the initial screens are shown in Table 3.2, and the results of the solvent screen 




Figure 3.5 1H NMR spectra for the lactol 51 and acetate 62 (CDCl3, 300 MHz) 
 
3.4.3 Initial 24-hour screen 
The initial 24 h screens were carried out using vinyl acetate as solvent and acylating agent 
(Table 3.1). The lactol substrate 51 was dried prior to the reactions, and the vinyl acetate, 
which was stored in the fridge, was allowed to warm to room temperature before opening to 
minimize the ingress of water. The presence of water in these reactions could lead to the 
hydrolysis of the product, although strictly anhydrous conditions were not used. Control 
reactions were carried out, and, in the absence of an enzyme, there was no background 
acylation evident. 
Several lead enzymes were identified for the solvent screen. Enzymes were chosen mainly on 
the basis of activity, but those with poor selectivity were disregarded, as high selectivity is 
important in this investigation. Lipase E from Alcaligenes sp. gave the highest conversion, 
coupled with moderate enantioselectivity (Table 3.1, Entry 1). Lipase from Candida cylindracea 
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and lipases A and B from Candida rugosa1 performed similarly, with a slightly lower conversion, 
with moderate selectivity. The lipase from Thermomyces lanuginosus gave excellent selectivity 
(97% ee), albeit coupled with lower conversion than the other lead enzymes (Entry 7).  
Table 3.2 Initial lactol screening results using vinyl acetate as acylating agent 
 
Entry Hydrolase Source Conversion (%)a ee (%)b 
1 Lipase E from Alcaligenes sp. 30 70 
2 Lipase from Candida cylindracea 28 65 
3 Lipase A from Candida rugosa 26 64 
4 Candida antarctica Lipase A 26 8 
5 Lipase B from Candida rugosac 20 59 
6 Lipase from Pseudomonas stutzeri 19 33 
7 Lipase from Thermomyces lanuginosus 12 97 
8 Lipase B from Candida rugosac 7 79 
9 Lipase D from Alcaligenes sp. 6 66 
10 Lipase F from Alcaligenes sp. 5 39 
11 Lipase B from Burkholderia cepacia 5 74 
12 Lipase from Pseudomonas fluorescens 
(immob) 
5 83 
13 Lipase from Candida antarctica 4 93 
14 Lipase from Pseudomonas cepacia 3 80 
15 Lipase C from Alcaligenes sp. 3 61 
16 Lipase B from Alcaligenes sp. 3 71 
17 CAL-B (immob) 3 94 
18 Candida antarctica Lipase B (liq.) 0 -d 
The following lipases gave conversion <2% and were not subjected to HPLC analysis: Hog pancreas lipase, Acid protease A, 
Protease from Aspergillus niger, Lipase from Aspergillus niger, Lipase A from Alcaligenes sp, Neutral Protease A, Lipase 
from Rhizomucor miehei. The following enzymes gave no conversion: Lipase from fungal source, Protease A from Bacillus 
subtilis, Phytase, Alkaline protease A, Alkaline Lipase A, Lipase from Bromeliaceae sp, Lipase from Carica papaya, Protease 
A from Aspergillus oryzae, Protease B from Bacillus subtilis, Acylase from Aspergillus sp, Lipase from Rhizopus niveus, 
Protease from Bacillus stearothermophilus, Lipase from Penicillum roquefort, Protease from Aspergillus melleus, Lipase 
from Penicillum camembertii, Protease B from Aspergillus oryzae, Protease A from Bacillus sp, Protease B from Bacillus sp, 
Lipase A from Rhizomucor miehei, Lipase Porcine Pancrease type II, Lipase from Penicillum roquefort, Protease C from 
Bacillus subtilis, Alkaline protease B, Proteax, Lipase from Pseudomonas fluorescens, Lipase A from Burkholderia cepacia. 
aConversion was determined by 1H NMR comparing the signals for the C(2) proton in each compound; benantiomeric excess 
was determined by chiral HPLC and is the excess of the second enantiomer detected in all cases which has retention time 
of approx. 6.4 mins; ctwo different samples of Candida rugosa lipase B were tested; dcompounds with conversion <2% 
were not subjected to chiral HPLC analysis. 
 
  
                                                          
1Candida rugosa has been renamed to Candida cylindracea but will be referred to as Candida rugosa in 
this work, as two different samples of lipases were used. 
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Candida antarctica lipase B (CAL-B) (immobilised) furnished excellent selectivity (94% ee, Entry 
17) albeit with very low conversion. The non-immobilised Candida antarctica lipase B (Entry 
18) gave no conversion, but the mixture of lipases from this organism (Entry 13) performed 
similarly to the immobilised CAL-B, in terms of both selectivity (93% ee) and conversion. 
Interestingly, Lipase A from Candida antarctica (Entry 4), which is present in the mixture of 
lipases from this organism, gave good conversion but with poor selectivity. A follow-up 
investigation was carried out, where the acylating agent was varied, in order to see if this 
would affect the selectivity and conversion. 
Interestingly, for the enzymes shown in Table 3.3, the enantioselectivities are very similar 
across the two compounds 50 and 51, but the conversions are lower for the substituted 
compound 51, showing that the methyl group may not be easily accommodated in the active 
site. 




Conv. (%)b ee (%)c Conv. (%)b ee (%)c 
1 CAL-B (immob) 20 95 3 97 
2 Lipase E from Alcaligenes sp. 47 77 30 70 
3 Lipase A from Candida rugosa 25 60 26 64 
4 Lipase from Thermomyces lanuginosus -d -d 12 97 
5 Lipase B from Burkholderia cepacia 44 78 5 74 
6 Lipase from Pseudomonas cepacia 19 65 3 80 
  
aReported by Gavin et al.;4 bconversion was determined by 1H NMR; cenantiomeric excess was determined by chiral HPLC 
analysis; dthis enzyme was not tested for activity against 50. 
 
3.4.4 Candida Antarctica lipase experiments 
Disappointingly CAL-B (immob) gave poor conversion, but showed excellent enantioselectivity 
(Table 3.1, Entry 17). As a result of the poor conversion, when using the Candida antarctica 
lipases, it was decided to repeat the 24 h screens using different acylating agents, shown in 
Figure 3.6. The acylating agents used were vinyl acetate 65, ethyl acetate 79, isopropyl acetate 
80, and isopropenyl acetate 68.  
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Figure 3.6 The structures of acylating agents used in this study 
Changing the acylating agent showed a slight improvement in conversion values in some cases 
but no reaction in other cases (Table 3.4). Overall the different acylating agents showed little 
to no enhancement of the reaction over the use of vinyl acetate 33. Acetaldehyde 67 is known 
to inactivate some lipases through formation of a Schiff base with the lysine residues of the 
protein.51 
3.4.5 Solvent screen 
Following the initial screens, enzymes which showed good conversion and enantioselectivity 
were subjected to further screens, using a range of organic solvents. Organic solvents are 
known to increase lipase selectivity by interfacial activation. 
Six solvents were screened: hexane (HPLC grade), heptane (HPLC grade), diisopropyl ether, 
tert-butyl methyl ether (HPLC grade), and toluene (dry, distilled). Four lead enzymes were 
selected for screening on the basis of activity. Enzymes which had poor selectivity were 
disregarded. The solvent screens were carried out at 30°C and 150 rpm. The results and 
conditions are shown in Table 3.5. 
The lipase from Thermomyces lanuginosus showed excellent selectivity (>92%) in the solvent 
screen, especially with the use of hexane and toluene (Entry 3). A preparative scale synthesis 
was carried out, using hexane as solvent (Scheme 3.16). After 96 h, the 1H NMR spectrum 
showed 65% conversion to the product, and, after chromatography, the acetate 62 was 
isolated in 32% yield with 94% ee. 
Scheme 3.16 Preparative scale resolution of 51 
In the case of the unsubstituted compound 50, the use of toluene and hexane gave the best 
results in the solvent screen, which was also observed here. With the exception of 
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Thermomyces lanuginosus the presence of the polar solvents, TBME and DIPE, decreased the 
conversion relative to the control reaction (vinyl acetate only), albeit, giving the highest 
enantioselectivities for these lipases. Previous reports of transesterification using vinyl acetate 
have shown that non-polar solvents, especially hexane, give superior results compared to 
polar solvents.52 
Thermomyces lanuginosus has previously used in the production of biodiesel from soybean 
oil,53 evolved for the use in the synthesis of pregabalin,54 and has been reviewed in the context 
of use in an industrial setting.55  







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3.5 Conclusion  
We have demonstrated lipase-mediated dynamic kinetic resolution of a fused lactol system.  
Extension to this work was carried out, wherein the tolterodine lactol 60, containing a remote 
stereocentre, was treated with hydrolases, which proved more challenging in terms of 
efficiency, while retaining high enantioselectivity (up to >98% ee).4 
 
Scheme 3.17 Resolution of the Tolterodine intermediate lactol 60 
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The work described in this chapter builds on the work carried out by Deasy during her PhD, 
and subsequent work carried out by Milner and Gavin.1,2 The introduction will consist of an 
overview of the work completed by Deasy, Milner and Gavin predating the work in this 
chapter, which, when combined, led to a publication.2 This chapter will outline the work 
completed and will be similar to the publication; synthesis of substrates will be discussed in 
more detail, and the material which had been moved to the supplementary material for 
publication will be discussed in more detail.  
Dynamic kinetic resolution (DKR) in the intramolecular nitroaldol reaction through coupling 
with lipase-mediated acetylation is described herein. Significant challenges in effecting the 
combination of the base-mediated reversible cyclisation of 6-nitroheptanal 81 with the 
selective enzyme-mediated transesterification were encountered. Ultimately, trans-2-
methyl-2-nitrocyclohexyl acetate 82b was isolated in excellent enantiopurity (>98% ee) via a 
sequential DKR sequence where the enzymatic resolution and base-mediated interconversion 
of the 2-methyl-2-nitrocyclohexanol 83 were effected alternately, demonstrating the 
feasibility of this approach for the first time. Further work showed, for the first time, evidence 
that a DKR-type system is possible: reaction engineering allowed design of a sequential one-
pot reaction system which furnished the products with excellent enantioselectivity, and good 
diastereoselectivity. 
Results & Discussion 
123 
4.1 Introduction 
The Henry reaction is an important base-mediated transformation in organic chemistry 
leading to vicinal nitro alcohols which can be converted to a wide variety of synthetic 
intermediates, such as 1,2-aminoalcohols and α-hydroxycarbonyl compounds (Scheme 4.1).3-
5 Although the reaction is known for over a century, stereo- and diastereoselective approaches 
leading to enantiopure nitroalcohols are still challenging. Principal approaches to the catalytic 
asymmetric nitroaldol reaction, including transition metal and organo-catalysed methods, 
have been reviewed in detail.5-7 The use of biocatalytic protocols to resolve the products of 
the Henry reaction has also been reviewed.8  
 
Scheme 4.1 Henry reaction and synthesis of 1,2-aminoalcohols & α-hydroxyalcohols 
There are two distinct biocatalytic methods: direct enzyme-catalysed asymmetric Henry 
reaction using hydroxynitrile lyases, or initial formation of the β-nitroalcohol product, 
followed by enzymatic kinetic resolution of the resulting stereoisomers.9 The latter kinetic 
resolution suffers the limitation of a maximum attainable yield of 50% of the desired product.  
Okamoto et al. reported the first bioresolution of the products of a Henry reaction (Scheme 
4.2). The use of various solvents was explored, and isopropyl ether was found to give good 
results.10 
 
Scheme 4.2 Resolution of Henry reaction products. 
Ramström et al. developed a procedure for the one-pot intermolecular dynamic kinetic 




nitroalkane 84 in order to shift the equilibrium towards the formation of the product (Scheme 
4.3).11,12 
 
Scheme 4.3 One-pot intermolecular Henry reaction and subsequent lipase catalysed resolution 
Previous work in the Maguire group had the added challenge of a second stereocentre, 
leading to potential complications in stereocontrol and diastereoselectivity (Scheme 4.4). We 
have previously reported efficient kinetic bioresolution for both the cis- and trans-2-
nitrocyclohexanols 85a and 85b via enzyme-mediated transesterification.13 
 
Scheme 4.4 Resolution of 2-nitrocyclohexanol 85b 
Initially, Milner reported the lipase-mediated resolution of nitrocyclohexanol 85a and 85b.13 
When the base-mediated interconversion was attempted using this substrate, stereochemical 
scrambling was only observed at one stereocentre. This was rationalised as base-catalysed 
epimerisation (Scheme 4.5). To overcome this problem, a methyl group was installed at the 
acidic site to block the epimerisation pathway. As a result, the base-catalysed interconversion 
through ring opening and closing was the only available reaction pathway, allowing the 
possibility of combining the two processes. 
 
Scheme 4.5 Epimerisation pathway versus the reversible nitroaldol reactions  
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Crucial to the success of the lipase-mediated DKR protocol is selection of the correct base. 
The fundamental requirements of the selected base are firstly to mediate effective ring 
closure of 6-nitroheptanal 81 and then catalyse the dynamic interconversion process between 
the diastereomeric alcohols 82a and 82b. It was then envisaged that combination with the 
diastereoselective lipase-mediated transesterification (as discussed above) would lead to a 
one-pot DKR of the intramolecular nitroaldol reaction through lipase catalysis.  
Deasy initially screened the substrate 83 against a variety of bases to identify the best base 
for the interconversion using vinyl acetate as the solvent; ultimately, combination of the two 
systems would require the use of the base and the acylating agent concurrently (Scheme 4.6).1 
 
Scheme 4.6 Investigation of the intramolecular nitroaldol reaction in a stepwise manner.  
Deasy showed that the use of piperidine (2 eq.) and aqueous sodium hydroxide (1M) gave no 
ring closure of the aldehyde 83. Diethylamine (DEA) and Hünig’s base gave <20% conversion 
to the alcohols 82a and 82b. Triethylamine and DABCO both catalysed the ring closing reaction 
but did not catalyse the reversible interconversion of 82a and 82b. 
The use of DBU (0.1 eq.) gave complete cyclisation of the aldehyde in 24 hours, albeit 
producing a large amount of the acetates 87a and 87b, racemically. When the loading was 
reduced to 0.05 eq. and the reaction time extended from 24 hours to 48 hours, 50% of 
aldehyde 1 remained, but only 3% of the mixture was acetates 87a and 87b. 
Tetramethylguanidine (TMG) was also used in the cyclisation, using 0.1 eq., resulting in a 




additional 2 equivalents of TMG gave better conversion, with only 6% of the aldehyde 
remaining after 48 hours, albeit with 5% of acetate 87a. 
Deasy also showed experimentally, that interconversion of the alcohol 82a to 82b and vice 
versa was taking place in the presence of 0.1 eq. DBU; this was carried out in CDCl3 so that the 
interconversion could be monitored by 1H NMR. After 24 hours, the alcohols 82a and 82b were 
in the ratio 33:67, regardless of which diastereomer was added initially. The interconversion 
was also carried out using TMG (2.0 eq.), however, it took 72 hours to get to the same ratio.  
The bioresolution of an intramolecular nitroaldol reaction of 6-nitroheptanal 81 was 
investigated in a stepwise manner (Scheme 4.6). The first step in this study involved 
independent examination of the lipase-mediated kinetic resolution of the racemic cis- and 
trans-2-methyl-2-nitrocyclohexanols 82a and 82b establishing the most efficient lipase to 
perform this biotransformation diastereoselectively. Ideally, for an efficient dynamic process, 
one enantiomer of either 82a or 82b would be efficiently and selectively acetylated. The 
optimum reaction conditions reported for the kinetic resolution of cis- and trans-2-
nitrocyclohexanol 85a and 85b employing vinyl acetate as both solvent and acyl donor were 
applied in this study for the lipase-mediated transesterification of 82.13 
Deasy examined the resolution of each alcohol diastereomer separately using a variety of 
lipases. A selection of the results is shown in Table 4.1 (cis-82a)2 and Table 4.2 (trans-82b). 
P. fluorescens furnished the product acetate cis-87a with good conversion (40%) with high 
enantiopurity (96% ee), compared to the trans-87b product, which had conversion <10%, 
under the same conditions (Table 4.1, Entry 3 and Table 4.2, Entry 3, respectively). The 
diastereoselectivity here was good, but the extended reaction time (113.5 h) was too long to 
be useful. P. stutzeri, after 48 hours, furnished trans-87b with 50% conversion, and excellent 
enantioselectivity (<98% ee), however, after the same period of time, its use gave the acetate 
cis-87b with 78% conversion, but with poor enantiopurity (27% ee), which was accompanied 
by excellent enantiopurity of the alcohol cis-87a (>98%) (Table 4.1, entry 2 and Table 4.2, entry 
2). 
                                                          
2Throughout this work “cis” and “trans” are used referring to “seq-cis” and “seq-trans” i.e. the 
assignment of stereochemistry is based on the sequence rule (Cahn-Ingold-Prelog rules).  
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Table 4.1 Lipase-mediated transesterification of cis-2-methyl-2-nitrocyclohexanol 82a in vinyl acetate 
 














1 CAL-B (immob) 72 33b 49 >98 159 




113.5 40b 64 96 95 
Adapted from Deasy.1 aEnantiomeric excess [ee (%)] was determined by chiral HPLC analysis; bconversion and the 
enantiomeric ratio (E value) were calculated from the enantiomeric excess of substrate alcohol 82a (ees) and product acetate 
87a (eep);15  
 
Table 4.2 Lipase-mediated transesterification of trans-2-methyl-2-nitrocyclohexanol 82b in vinyl acetate 
 













1 CAL-B (immob) 72 49b 96 >98 >200 




113.5 <10c − − − 
Adapted from Deasy.1 aEnantiomeric excess [ee (%)] was determined by chiral HPLC analysis; bconversion and the enantiomeric 
ratio (E value) were calculated from the enantiomeric excess of substrate alcohol 82b (ees) and product acetate 87b (eep);14 
cconversion was determined by 1H NMR spectroscopy of the crude products to be <10%, chiral HPLC analysis was not conducted. 
 
Candida antarctica lipase B (CAL-B) (immob) showed only moderate diastereoselectivity, 
furnishing trans-87b with 49% conversion, and cis-87a with 33% conversion, both with >98% 
ee, after 72 hours (Table 4.1, entry 1 and Table 4.2, entry 1). Further reaction using an 
equimolar mixture of both alcohols cis-82a and trans-82b showed that the diastereoselectivity 
was much better with short reaction times than after longer reaction times, albeit with lower 
conversion than longer reaction times (Table 4.3). This shows that one diastereomer, trans-
82b, can be acylated preferentially, with excellent enantioselectivity. In the case where this is 




two diastereomers, constantly regenerating the trans isomer, trans-82b, should effectively 
overcome decreased diastereoselectivity after extended reaction time. 
Table 4.3 Diastereoselective CAL-B (immob) mediated transesterification of cis-2a and trans-2b in vinyl acetate 
 
Having established a diastereoselective enzymatic resolution, attention next focused on the 
aldehyde cyclisation and the interconversion. Deasy tested a variety of bases, summarised in 
Table 4.4. Piperidine, aqueous sodium hydroxide, diethylamine (DEA), and 
N,N-diisopropylethylamine (Hünig’s base) showed little efficiency in the cyclisation of 81, even 
at 2.0 eq. loading (Table 4.4, Entries 1–5), and their use in the base-mediated dynamic 
interconversion process was not further pursued. 
Both triethylamine and DABCO (Entries 5 and 6) successfully catalysed the nitroaldol reaction, 
without any competing chemical acylation. When used in the base-catalysed interconversion 
of cis-82a and trans-82b there was no evidence of interconversion. 
The TMG-mediated dynamic interconversion process was also explored. On exposure of the 
more stable trans-82b diastereomer to TMG (2.0 eq.) the cis-82a diastereomer was observed 
within 1 h of the initial addition of the TMG and a thermodynamic ratio (cis-82a:trans-82b 
26:74) was attained after 5 h (Table 4.5). 
Using DBU as base successfully catalysed the cyclisation of 81 at low loadings (Table 4.5, 
Entries 7–9), albeit with a large extent of chemical acylation evident. Although there was a 






Alcohol 82 Acetate 87 
cis-82a (%)a trans-82b (%)a cis-87a (%)a trans-87b (%)a 
CAL-B 
(immob) 
12 44 38 3 15 
18.5 43 36 4 17 









Adapted from Deasy1 aConversions were estimated by 1H NMR spectroscopy and were derived from integration of the 1H 
NMR spectrum of the mixture of the crude material, not mass recovery. Starting material was an equimolar mixture of cis-
82a and trans-82b; benantiomeric excess [ee (%)] was determined by chiral HPLC analysis; cthe principal enantiomer was 
(1S,2R)-82a; dthe principal enantiomer was (1S,2S)-82b; ethe principal enantiomer was (1R,2S)-87a; fthe principal enantiomer 
was (1R,2R)-87b. 
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catalysed resolution and the base-catalysed interconversion, that the resolution would 
effectively compete with the chemical acylation. 
Table 4.4 Base mediated cyclisation of aldehyde 81 
 
 



















1 Piperidine 2.0 48 100 − − − − 
2 NaOH (1M) − 48 100 − − − − 
3 DEA 2.0 48 82 8 10 − − 
4 Hünig’s Base 2.0 48 85 5 10 − − 
5 NEt3b 2.0 72 9 24 67 − − 
6 DABCO 2.0 48 − 40 60 − − 
7 DBU 0.1 24 − 11 52 22 15 
8 DBU 0.1 48 − − 30 37 33 
9 DBU 0.05 48 50 16 31 2 1 
10 TMG 0.1 24 69 10 21 − − 
11 TMG 0.1–2.1c 48 6 30 57 5 − 
Adapted from Deasy.1 aConversions were determined by 1H NMR spectroscopy and were derived from integration of the 
1H NMR spectrum of the mixture of the crude material not mass recovery; bcarried out at 40°C; cAt 24 h after analysis by 
1H NMR spectroscopy an additional 2.0 eq. of TMG were added to the reaction vessel and stirred at room temperature 
for a further 24 h. 
 
Table 4.5 Evidence for dynamic interconversion − trans-2-methyl-2-nitrocyclohexanol 82b and TMG (2.0 eq.) in 
CDCl3 
 
Reaction Time (h) 82a (%)a 82b (%)a 
0 - 100 
0.8 14 88 
5.1 26 74 
72 28 72 
Adapted from Deasy.1 a6-Nitroheptanal 81 was not detected in the 1H NMR spectra. 
 
When DBU (0.1 eq.) was combined with CAL-B (immob), the intramolecular cyclisation did not 
proceed, returning only starting material after 72 h (Table 4.6, Entry 1). The use of P. stutzeri 
with this base effectively mediated the ring-closing, however, poor enantioselectivity in the 




changed to TMG, the ring-closing proceeded sluggishly, with aldehyde 81 (15%) still evident 
after 48 hours; and the low extent of conversion to the products cis-87a and trans-87b, was 
disappointing (Entry 4). 



































































Adapted from Foley et al. (supporting information).2 aConversions were determined by 1H NMR spectroscopy and were 
derived from integration of the 1H NMR spectrum of the mixture of the crude material, not mass recovery; benantiomeric 
excess [ee (%)] was determined by chiral HPLC analysis; cthe principal enantiomer was (1S,2R)-82a; dthe principal enantiomer 
was (1S,2S)-82b; ethe principal enantiomer was (1R,2S)-87a; fthe principal enantiomer was (1R,2R)-87b; gwhile chiral HPLC 
indicates high enantiomeric excess for the recovered alcohols (1S,2R)-82a and (1S,2S)-82b, the very low levels present mean 
the enantiopurity should be interpreted with caution. 
 
Both the reversible ring opening/closing and the resolution worked separately, but when the 
two reaction were combined, neither reaction worked effectively. The use of the base and the 
lipase concurrently was not viable; therefore, it was decided to carry out the interconversion 
and the resolution consecutively, in a two-pot reaction. This overcame the base-lipase 
inhibition by separating the reagents and allowed the use of neat vinyl acetate as the solvent 
for the resolution (Figure 4.7). The problems of chemical acylation, and base-lipase inhibition 
were overcome by physically separating the two reactions. This ultimately returned the 
preferred product trans-87b with excellent enantiopurity (>98% ee) which made up 57% of 
the reaction mixture, after three cycles. 
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Deasy made significant progress in the combination of the base-mediated interconversion of 
nitroalcohols 82 and the lipase-catalysed resolution. Several limitations were identified and 
will need to be overcome before the effective combination of the base-catalysed 
interconversion and the lipase mediated resolution. 
The use of DBU is only feasible if the problem of competing chemical acylation could be 
overcome, such as the use of an alternative acylating agent, or introduction of a solvent to 
decrease the effective concentration of the acylating agent. Potentially, reduction of the 
acylating agent loading could also solve this problem. 
Base-lipase inhibition was a significant limitation during Deasy’s work. The simultaneous 
introduction of the base and the lipase meant that the efficiency of both was reduced. A 
potential solution is the use of immobilised reagents, or physical separation of the catalysts. 
CAL-B, an immobilised lipase, gave excellent selectivity in this reaction; the use of an 
immobilised base could also be beneficial, both for physical separation of the catalyst and 
potentially for subsequent separation from the reaction mixture.  
Further work was warranted to improve the system. As a result, the objectives of this project 
are: 
• Synthesis of the substrate alcohols 82 and the acetates 87, as reference standards. 
• Exploration of a wider range of bases for the interconversion step 
• Explore the use of solvents, ideally to find a solvent which works well for both the 
interconversion step and the resolution step 
• Vary the acylating agent, as well as acyl agent loading, as the use of milder acylating 
agents could overcome the potential problem of chemical acylation 
• Vary the reaction conditions 
o Temperature 
o Time 
o Addition time of the reagents 
• Explore the use of a flow-like system to physically separate the catalysts and 
ultimately lead to the high diastereo- and enantioselectivity. 
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4.3 Synthesis of substrates 
The synthesis of the substrates 82a and 82b was carried out using a two-step procedure 
(Scheme 4.7), followed by separation and acylation of the product alcohols to make acetates 
87a and 87b which are used as standards for HPLC method development. 
 
Scheme 4.7 Synthesis of substrates 
The first step was the alkylation of the α-carbon of compound 88 using methyl iodide and 
tetra-n-butyl ammonium hydroxide. This reaction was low yielding, producing two by-
products 90 and 91 which were separated by chromatography (Figure 4.8). These products 
were previously reported by Deasy and were present in roughly the same ratios as previously 
reported.  
 
Figure 4.8 Major products from the alkylation of 88 
The reduction of the ketone 89 was carried out using sodium borohydride as the reducing 
agent. Increasing the reaction time from 1.5 h to 2.5 h at 0°C gave a similar result to 
conducting the reaction at room temperature for 1.5 h, giving almost identical product ratios 
(Scheme 4.7). Separation of diastereomers 82 by chromatography was achieved using 40/60 
diethyl ether/hexane as eluent. If 20/80 ethyl acetate/hexane was used as eluent, then the 




acylated using DMAP and acetic anhydride, giving the acetates 87a and 87b in moderate yields 
without requiring chromatographic purification. 
Deasy previously synthesised aldehyde 81 by a four-step procedure (Scheme 4.8), which 
furnished compound 91 after the second step. This product was a by-product in the synthesis 
of ketone 89 and was easily purified by column chromatography and therefore can potentially 
be utilised in the synthesis of the aldehyde, if required, reducing the waste in the synthesis of 
89 and reducing the amount of reactions required in the synthesis of aldehyde 81. 
 
Scheme 4.8 Synthesis of methyl-6-nitroheptanal 81 
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4.4 Initial screens – base, lipase, solvent and acylating agent 
Deasy developed a two-pot cycling system, where the reagents were repeatedly exposed to 
the alternating reaction conditions. Work completed here built on the data collected by Deasy 
as well as looking at the two reactions individually. A number of experiments were carried out 
to quantify the effects of different components of the reaction. Considering that one of the 
best bases for the interconversion was DBU, immobilised DBU was explored as it would enable 
facile separation from the reaction mixture. Additional bases were explored but with poor 
results. Similarly, CAL-B (immob) was chosen as the lipase, allowing facile separation. 
4.4.1 Solvent screen – towards a one-pot reaction 
In order to combine the two separate systems, careful selection of solvent is critical to ensure 
compatibility with both the base-mediated interconversion, and the lipase-catalysed 
resolution; it is clear that the use of vinyl acetate as solvent is not feasible due to competing 
chemical acylation. 





1 Toluene 4 (>98) 22 (>98) 
2 Hexane 9 (>98) 38 (>98) 
3 MTBE 10 (>98) 33 (>98) 
4 IPA -c 4 (>98) 
5 1-Octanol 2 (>98) 11 (33) 
6 Ethyl Acetate 2 (>98) 23 (>98) 
Entries 1 & 2 were previously carried out by Gavin, and repeated in this work, the results shown are from this work. aRelative 
conversions, determined from ee values of the substrate alcohols (ees) and product acetates (eep), as the presence of some 
solvents made interpretation of the 1H NMR spectrum difficult; bnumbers in parentheses are % ee values, which were 
determined by chiral HPLC analysis; cno cis-87a was detected by 1H NMR. 
 
In the solvent screen, we found that the resolution, mediated by CAL-B (immob), performed 
well in non-polar solvents (toluene and hexane) (Table 4.7, entries 1 and 2) while the 
interconversion is also conveniently favoured by these non-polar solvents (Table 4.8). 




was poorly soluble. Interestingly, while the interconversion catalysed by DBU (immob) was 
sluggish in ethyl acetate (Table 4.8, Entry 6), this solvent provides us with promising 
diastereomeric discrimination in the resolution step (Table 4.7, Entry 6). 
Table 4.8 Solvent screen for the interconversion catalysed by immobilised DBU 
 
Entry Solvent 
Alcohol 82 (%)a 
cis-82a trans-82b 
1 Toluene 68 32 
2 Hexane 87 13 
3 MTBE 87 13 
4 IPA 70 30 
5 1-Octanol -b -b 
6 Ethyl Acetate 84 16 
Entries 1 & 2 were previously carried out by Gavin, and repeated in this work, the results shown are from this work. aValues 
determined by 1H NMR; bvalues could not be determined by 1H NMR due to the presence of the solvent. 
 
4.4.2 Variation of acyl source 
We briefly explored the use of acylating agents other than vinyl acetate in conjunction with 
CAL-B (immob). Ramström et al. reported success in a related one-pot reaction using phenyl 
acetate.12 Various acylating agents, including ethyl acetate, which could potentially be used 
as the solvent and the acylating agent, were explored. For these screens, 50 eq. of the 
acylating agent was used as the acyl source and the solvent; this is less than was used by Deasy 
in previous work.1 All acylating agents provides the acetate products cis-87a and trans-87b 
with excellent enantioselectivity, albeit, some with very limited conversion (Table 4.9). 
Isopropenyl acetate 68, and isopropyl acetate 80, both gave similar results, but with 
conversion <5% for cis-82a and <15% for trans-82b, after 12 hours. Ethyl acetate, similarly, 
showed a low extent of acylation of cis-82a, but showed high diastereoselectivity (1:8, 
favouring trans-87b) when used as the acyl source. 
While vinyl acetate and phenyl acetate performed equally well, including over longer reaction 
times (48 h), use of the higher boiling phenyl acetate did not offer any synthetic advantages 
over vinyl acetate but was difficult to separate from the product on an analytical scale. 
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Table 4.9 Variation of acyl source 
 
Entry Acyl Source Reaction time (h) 
Acetate 87 (%)a,b 
cis-87a trans-87b 
1 Vinyl Acetate 12 5 (>98) 35 (>98) 
2 Vinyl Acetate 48 12 (>98) 46 (>98) 
3 Isopropenyl Acetate 12 3 (>98) 14 (>98) 
4 Isopropyl Acetate 12 3 (>98) 13 (>98) 
5 Phenyl Acetate 12 6 (>98) 34 (>98) 
6 Phenyl Acetate 48 14 (>98) 48 (>98) 
7 Ethyl Acetate 12 2 (>98) 16 (>98) 
aRelative conversions, determined from %ee values of the substrate alcohols (ees) and product acetates (eep); bnumbers in 
parentheses are % ee values, which were determined by chiral HPLC analysis.14 
 
The reaction was carried out again, this time with ethyl acetate as acylating agent, as it is not 
sufficiently reactive to effect chemical acylation. The reaction time was extended to 120 hours 
and the agitation was increased to 750 rpm, and extra lipase was added after 48 hours. The 
acylation proceeded very slowly, giving <10% of the enantiopure acetate trans-87b even after 
extended reaction times (Table 4.10, Entry 1). When using ethyl acetate as solvent the 
interconversion did not proceed (Table 4.8, Entry 6 and Table 4.10, Entry 2), and when the 
interconversion and resolution catalysts were added together (Table 4.10, Entry 3), the 
resolution proceeded enantioselectively. Although the material recovered here was 
enantioenriched, the extent of both the resolution and the interconversion was not sufficient 
to be synthetically useful, even after extended reaction times.  
These experiments showed that the one-pot reaction was not feasible using ethyl acetate as 
solvent and DBU (immob) as base, as both the resolution and the interconversion were very 
inefficient. Although the material recovered here was enantioenriched, the extent of 
conversion was too low to be useful, even after 5 days, as the interconversion catalysed by 
DBU (immobilised) was sluggish in the polar solvent. The use of alternative bases in ethyl 
acetate as solvent was next explored as the diastereoselectivity in the resolution step was 




Table 4.10 One-pot system using ethyl acetate as solvent and acylating agent 
 
Entry Reaction Conditionsa 
Time 
(h) 
Alcohol 82 Acetate 87 
cis-82ab trans-82bb cis-87ab trans-87bb 
1 Lipase, no basec 
24 29 (3) 65 (12) 0 (>99) 6 (>99) 
120 30 (4) 61 (17) 2 (>99) 7 (>99) 
2 Base, no lipase 
24 23 (2) 75 (0) <1 (10) 2 (1) 
120 25 (-) 64 (-) 3 (2) 8 (1) 
3 Base & Lipasec 
24 33 (2) 67 (8) 0 (-) 0 (-) 
120 30 (6) 57 (13) 5 (>99) 9 (>99) 
aEthyl acetate added to give [substrate] = 10 mg/mL; reaction run in the absence of base or lipase returned cis-82a:trans-82b 
28:72 after 120 h i.e. unchanged; b% composition of the reaction mixture, numbers in parentheses are % ee values, which were 
determined by chiral HPLC analysis;14 cextra lipase was added after 48 h. 
 
4.4.3 Exploration of alternative bases using ethyl acetate as solvent 
Based on a recent report of the use of immobilised DMAP for the Henry reaction,15 
investigation of DMAP was next explored, as well as structurally related bases (Table 4.11). 
Ethyl acetate was selected as solvent due to the promising diastereoselectivity in the lipase-
mediated resolution (Table 4.7, Entry 6). DMAP performed poorly when only 1 eq. was used, 
but when the amount of DMAP was increased, up to 10 eq., the interconversion was very 
successful, outperforming DBU (immob) in this solvent (Table 4.11, Entry 3, 4, 1 and 2, 
respectively). Most importantly here, with 10 eq. of DMAP, there was no chemical acylation 
evident even when using 50 eq. of vinyl acetate in ethyl acetate as solvent (Entry 4). The DMAP 
was removed from the reaction mixture by passing through a short column of silica gel; this 
was necessary both for clear 1H NMR analysis, and to remove DMAP before chiral HPLC 
analysis. Use of DMAP (immob) proved to be poorly effective for the interconversion and led 
to significant background acylation in the presence of vinyl acetate, as well as decreased 
efficiency of the interconversion (Entry 6). In the presence of CAL-B and vinyl acetate i.e. a 
one-pot reaction (Entry 7), the acylation proceeded, albeit with very poor enantioselectivity. 
Interconversion of the diastereomers was not seen when using related bases, lutidine and 
pyridine (2 eq.), while chemical acylation was evident with lutidine under these conditions 
(Entry 8 and 9). 
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Table 4.11 Investigation of different bases using ethyl acetate as solvent 
 
Entry Base Eq. Base Eq. Vinyl Acetate 
Alcohol 82 Acetate 87 
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(immob) 



























Ethyl acetate added to make [substrate] = 10 mg/mL. aNumbers in parentheses are % ee values, which were determined by 
chiral HPLC analysis.14 
 
4.4.4 Vinyl acetate loading 
As the combination of DBU (immob) and vinyl acetate led to background chemical acylation, 
this approach was not feasible as it led to reduced enantiopurity of the final product. 
Predictably, decreasing the concentration of vinyl acetate, as a solution in toluene, 
significantly reduced the problem of background chemical acylation (5 eq. of vinyl acetate 
gave <5% chemical acylation after 12 hours) (Table 4.12).  
Fortunately, when the loading of vinyl acetate was decreased from 50 eq. to 3 eq. the 
resolution was equally effective (Scheme 4.9 and Table 4.7, Entry 1 and Table 4.9, Entry 1). 
This allowed the reduction of the vinyl acetate loading, reducing the extent of competing 
chemical acylation. It is important to note here that, even though the majority of the starting 




trans material, trans-82b, was processed preferentially by the lipase, despite making up only 
a minority of the material. 
Table 4.12 Investigation of the effect of vinyl acetate loading on interconversion and chemical acylation 
 
Entry Eq. Vinyl Acetate 
Alcohol 82 (%)a Acetate 87 (%)a 
cis-82a trans-82b cis-87a trans-87b 
1 0 68 32 - - 
2 5 68 28 3 1 
3 10 66 28 5 1 
4 20 69 24 6 1 
5 30 67 22 10 2 
6 40 69 20 9 2 
7 50 69 20 9 2 
a% determined by 1H NMR 
 
Scheme 4.9 Resolution of 2-methyl-2-nitrocyclohexanol 82 
4.4.5 Temperature 
The next factor explored was the impact of reaction temperature. Both the interconversion 
and the resolution were carried out separately with varying amounts of vinyl acetate in 
toluene, at three different temperatures: 30°C, 40°C and 50°C (Table 4.13 and Table 4.14, 
respectively). The interconversion was much faster at the higher temperatures (Table 4.13). 
As shown in Table 4.14, the enantioselectivity of the lipase-mediated transesterification of 
cis-82a and trans-82b was unchanged when the temperature was increased from 30°C to 
50°C. However, there was a decrease in diastereoselectivity at the higher temperature with a 
higher proportion of cis-87a formed at 50°C than at 30°C (Table 4.14). 
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1 0 68 32 - - 66 34 - - 52 48 - - 
2 5 68 28 3 1 70 28 2 1 59 37 3 1 
3 10 66 28 5 1 71 25 3 1 49 42 7 2 
4 20 69 24 6 1 69 24 6 2 55 33 9 3 
a% of mixture, determined by 1H NMR by comparison of the areas of the integrals for to relevant 
alcohols and acetates; bdata is the same as Table 4.12, Entries 1−4. 
 





30°Ca,b 40°Ca,b 50°Ca,b 
cis-87a trans-87b cis-87a trans-87b cis-87a trans-87b 
1 5 7 (>98) 34 (>98) 9 (>98) 38 (>98) 16 (>98) 43 (>98) 
2 10 9 (>98) 38 (>98) 14 (>98) 43 (>98) 16 (>98) 40 (>98) 
3 20 6 (>98) 27 (>98) 10 (>98) 37 (>98) 15 (>98) 35 (>98) 
aRelative conversions (%), determined by 1H NMR by comparison of the areas of the integrals for to relevant alcohol and acetate; 






4.5 Towards a one-pot dynamic kinetic resolution 
Following this, a series of one-pot and “two-pot” reactions were attempted with the same 
solvent conditions for both the interconversion and the resolution (Table 4.15). 










Alcohol 82a Acetate 87a 







































5 A & B 12 4:96 30 8 (3) 79 (13) 1 (ND) 12 (12) 
















aGiven as % composition of the reaction mixture, numbers in parentheses are % ee values, which were determined by chiral 
HPLC analysis; bentry 2 included a filtration to remove the DBU (immob) before addition of the lipase; centry 9 included 
molecular sieves. 
 
Entry 1 shows evidence of a dynamic system. The DBU (immob) was not removed prior to 
CAL-B (immob) addition, and the amount of trans-82b is less than the amount of trans-87b. 
This indicated that the reaction continued past the kinetic limit, also suggesting that the 
interconversion reaction continued after the addition of the lipase. In the case of Entry 2, the 
DBU (immob) was removed by filtration before the addition of the CAL-B (immob). If the base 
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was inactivated by the lipase when they were both present together, then the results for both 
Entry 1 and Entry 2 should be similar. These experiments showed, for the first time, evidence 
of a dynamic system when both the base and the lipase were present together, albeit this 
required a time-delayed addition, key to this system. It also showed that the base and lipase 
could be present in the reaction mixture at the same time. 
The reaction was also carried out where both catalysts were introduced at the same time 
(Table 4.15). Entries 3 and 4 are identical except for the ratio of starting material. Using 
predominantly trans-82b starting material (Entry 4) we saw a much greater conversion, with 
the conversion essentially at the kinetic limit with some evidence of a dynamic process, as 
there are equal amounts of trans-82b and trans-87b but the % ee of trans-82b is not >98%, as 
would be expected from a non-dynamic system.  
The one-pot procedure, where both the catalysts were added in at the same time, was 
repeated at lower temperature, 30°C, using trans-82b and cis-82a enriched material (Entries 
5-7). The conversions in this case were poorer compared to the higher temperature but still 
retained high stereoselectivity, as expected. 
The effect of water was also investigated at this temperature (Entries 8 and 9). The reaction 
was run with (Entry 9) or without (Entry 8) molecular sieves, again with both the catalysts 
introduced at the same time. Interestingly, the presence of molecular sieves reversed the 
diastereoselectivity of the reaction, with the cis-87a diastereomer being preferred here, but 
no change in the interconversion efficiency, showing that the presence of small amounts of 
water is not affecting the DBU (immob) efficiency.  
As the time delayed addition of the catalysts was shown to be effective, the cycling of the 
material through the two different reaction conditions consecutively was investigated. 
In the first reaction cycle (Table 4.16, Entry 1), the material was cycled through the two steps, 
removing one catalyst prior to addition of the next by a simple filtration through a plug of 
Celite® and magnesium sulfate, and removal of the vinyl acetate by rotary evaporation at the 
end of the resolution step, before addition of toluene and DBU (immob) to start the cycle 
again. Here, the equivalents of vinyl acetate were reduced to 3, to minimise the amount of 
chemical acylation. For the initial cycles, the first procedure (Entry 1) performed both the 




two cycles, (trans-82b:trans-87b = 1:1), there was evidence of a dynamic system i.e. that 
trans-82b was being interconverted albeit slowly (76% ee, >98% ee, respectively). The 
diastereoselectivity was poor, giving equal amounts of the acetates cis-87a and trans-87b at 
the end of the third cycle, with, overall, a poor conversion for a dynamic system (acetate 87 
making up just over 50% of the mixture). It was assumed that the elevated temperature was 
the major cause of the reduced diastereoselectivity, as observed previously (Table 4.14). 





Alcohol 82a Acetate 87a 













































































































Step A, interconversion: DBU (immob) (0.5 eq.), toluene (10mg/mL substrate). Step B, resolution: CAL-B (immob), vinyl 
acetate (3 eq.), toluene (1mL/10mg). Each step was carried out for 12 hours, except step 1A for Entry 2 & Entry 3 which 
were 18 h. aExpressed as a % determined by integration of the relevant 1H NMR signals, numbers in parentheses are % ee 
values, which were determined by chiral HPLC analysis; bevaporation step was omitted 
 
Following this, the same cycling system was maintained, this time with the resolution being 
carried out at the lower temperature of 30°C (Table 4.16, Entry 2), and the initial 
interconversion step being extended from 12 hours to 18 hours, which gave a greater 
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proportion of trans-82b present for the first resolution step (34:66, compared to 56:44 after 
12 h). Again, before the addition of each catalyst, the previous catalyst was removed by 
filtration, and the vinyl acetate was removed by rotary evaporation at the end of the cycle. 
Throughout three cycles the enantioselectivity remained consistently high, with enantiopure 
cis-87a and trans-87b observed by HPLC analysis. In this case, acetate 87 again made up over 
50% of the reaction mixture, but the product trans-87b was strongly preferred (47% trans-
87b, 11% cis-87a, >98% ee for both). Here, there was no evidence that the reaction was 
complete (alcohol 82b << 98% ee), but when it was continued through another cycle the 
product started to hydrolyse. The presence of a removable impurity made the spectra more 
difficult to interpret; it was shown that the impurity could be removed by chromatography on 
silica gel, and that it arose from the immobilised lipase. Here, it was shown that the resolution 
proceeded better at the lower temperature, and thus, it was decided to continue under these 
conditions.  
As a result of the sustained excellent enantioselectivity, the reaction was carried out again, 
this time removing the evaporation step, resulting in the DBU (immob) being exposed to vinyl 
acetate but giving an overall simpler process from a work-up point of view (Table 4.16, Entry 
3). Only a modest decrease in enantiopurity was observed, suggesting that the removal of the 
evaporation step was well tolerated. At the end of 3 cycles the 1H NMR and HPLC showed 43% 
of the reaction mixture made up of the acetate trans-87b (97% ee), and 12% acetate cis-87a 
(>98% ee). While this is lower than when the evaporation step is included, it is not significantly 
lower. 
Encouraged by the success of the “two-pot” procedures, as well as previous evidence that the 
interconversion continued after the addition of CAL-B (immob), we decided to attempt a 
series of sequential one-pot reactions, where both catalysts were present at the same time, 
albeit after a staggered addition. In these reactions, the DBU (immob) was added, reacted for 
32 hours, at 50°C, followed by a decrease in temperature, and the addition of CAL-B (immob) 




Table 4.17 One-pot reactions 
 
Entry Step Notes 
Alcohol 82a Acetate 87a 
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Step A, interconversion: DBU (immob) (0.5 eq.), toluene (1mL/10mg substrate), 50°C, 500 rpm. Step B, resolution: CAL-B (immob), 
vinyl acetate (3 eq.), toluene (1mL/10mg), 30°C, 400 rpm. Each step was carried out for 12 hours, except step 1A for which was 
32 h. aExpressed as a % determined by integrating of the relevant 1H NMR signals. Numbers in parentheses are % ee values, which 
were determined by chiral HPLC analysis. 
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When no evaporation step was carried out (Table 4.17, Entry 1) the overall enantiopurity of 
the products cis-87a and trans-87b were reduced (95% ee, 90% ee, respectively), as well as 
reduced conversion overall. When both the filtration and the evaporation step were removed, 
the overall amount of acetate 87 after 3 cycles was reduced (Table 4.17, Entry 4). In this case, 
extra catalyst was added to the reaction mixture after each step, but without the removal of 
the previous catalysts, it gave a similar result to when no additional catalyst was added (Entry 
3). This suggests that the presence of the old catalyst is detrimental to the reaction, resulting 
in hydrolysis of the product acetates cis-87a and trans-87b during each racemisation step, as 
well as evidence of chemical acylation, for both Entry 3 and 4. Although the presence of the 
catalysts is tolerated through one reaction cycle, removal of the old catalysts is essential 
before starting the cycle again.  
Table 4.17, entry 2 shows the optimised one-pot procedure. It was found that the addition of 
the catalysts needed to be staggered, as DBU (immob) is less effective in the presence of CAL-
B (immob). The DBU (immob) was added first, in this case interconversion was carried out for 
32 h at 50°C for step 1A. Although it was subsequently shown that 32 hours was not required 
and that the same cis-82a:trans-82b ratio (~36:64) was reached after only 18 hours. Critically, 
due to staggered addition of reagents, it was possible to conduct the interconversion at 50°C 
and then cool the reaction mixture to 30°C for the lipase-mediated resolution, carried out in 
the same reaction vessel, with the vinyl acetate and the CAL-B (immob) added after the 
interconversion and cooling to 30°C. 
The starting material used was a mixture of cis-82a and trans-82b (87:13) instead of aldehyde 
81. In the presence of DBU only, aldehyde 81 will cyclise, and in this case, the mixture of 
nitroalcohols 82 or aldehyde 81 would be expected to give the same outcome under the 
conditions for step 1A. 
These results are promising, showing, for the first time, a one-pot, dynamic system for the 
resolution of alcohol 82. While this is not the desired one-pot reaction, it represents a 
significant move towards a one-pot procedure (Scheme 4.10). In order to achieve this, several 
parameters were examined, and their role evaluated. Filtration (after step B) is necessary to 
remove the immobilised catalysts but does not need to be carried out after each step (A and 
B), only the end of each cycle (after step B). Sequential addition of the catalysts was found to 
be key to this one-pot procedure, where the immobilised base was added to the reaction 




immobilised lipase, to carry out the resolution. While the evaporation step (after B) was 
shown to give better enantiopurity after three cycles as well as more product (~60% vs ~50%) 
than without the evaporation step, it could be removed if necessary to simplify the procedure. 
 
Scheme 4.10 Optimised conditions for the cycling system 
The final ratio of the products and substrates show, that, although not a “traditional” one-pot 
reaction, a dynamic system has been engineered, through extensive optimisation of the 
individual steps. 
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4.6 Conclusion 
Significant progress has been made in the individual elements of the dynamic resolution 
process for trans-87b. Efficient kinetic resolution has been effected for both the trans-2-
methyl-2-nitrocyclohexanol 82b and cis-2-methyl-2-nitrocyclohexanol 82a. Significantly, CAL-
B (immob) displayed high diastereoselectivity, selectively acetylating trans-82b efficiently and 
with excellent enantioselectivity.  
The conditions were further explored, focusing on conditions which work for the individual 
parts. Conditions were developed which furnished a dynamic system albeit with poor 
efficiency. Key to this was the timing of the reagent addition, by first adding the base, to carry 
out the interconversion, then the lipase for the resolution, we successfully demonstrated a 
dynamic system was possible. 
In conclusion, achieving DKR in the intramolecular nitroaldol reaction is extremely challenging 
due to the number of competing processes arising. By careful exploration of the process 
conditions including variation of biocatalyst, base and solvent, as well as reducing the loading 
of the acylating agent, we have demonstrated for the first time the feasibility of this process. 
Key to this system was the time delayed addition of the catalysts, which not only avoided base-
lipase inhibition, but also allowed the reaction halves to be carried out at different 
temperatures.  
Although extensive work has been carried out to demonstrate the utility of this dynamic 
kinetic resolution, further work, to extend the substrate scope was not carried out, as the 
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6.1 General procedures 
Solvents were distilled prior to use as follows: dichloromethane (DCM) was distilled from 
phosphorus pentoxide, ethyl acetate was distilled from potassium carbonate, THF and toluene 
were distilled from sodium and benzophenone. Hexane was distilled prior to use. Molecular 
sieves were activated by heating at 150 °C overnight. Organic phases were dried over 
anhydrous magnesium sulfate or anhydrous sodium sulfate. Infrared spectra were recorded 
neat using a Perkin Elmer FTIR UATR2 spectrometer. 1H (300 MHz) and 13C (75.5 MHz) NMR 
spectra were recorded on a Bruker Avance 300 MHz NMR spectrometer, and all spectra were 
recorded at room temperature (~20 °C) in deuterated chloroform (CDCl3) using 
tetramethylsilane (TMS) as an internal standard. Chemical shifts (δH & δC) are reported in parts 
per million (ppm) and coupling constants are expressed in Hertz (Hz). Low resolution mass 
spectra were recorded on a Waters Quattro Micro triple quadrupole spectrometer in 
electrospray ionisation (ESI) mode using 50% water/acetonitrile containing 0.1% formic acid 
as eluent. High resolution mass spectra (HRMS) were recorded on a Waters LCT Premier Time 
of Flight spectrometer in electrospray ionisation mode (ESI) using 50% water/acetonitrile 
containing 0.1% formic acid as eluent. Flash chromatography was performed using Kieselgel 
Silica Gel 60, 0.040–0.063 mm (Merck). Thin layer chromatography (TLC) was carried out on 
precoated silica gel plates (Merck 60 PF254). Visualisation was achieved by UV (254 nm) light 
detection and KMnO4 staining. Optical rotation was measured on a Perkin-Elmer 141 
polarimeter at 589 nm in a 1 cm cell; concentrations (c) are expressed in g/100 mL. [α]D
20 is 
the specific rotation and is expressed in units of 10−1 deg cm2 g−1. Hydrolases were from Almac 
Sciences except Amano PS Lipase, CAL-B (on ImmoBead 150), Hog pancreas lipase, 
Pseudomonas fluorescens (immobilised on Sol-gel), and Lipase from Candida cylindracea 
which were purchased from Sigma Aldrich chemical company. Transaminases were obtained 
as whole cell preparations from BIOMERIT in UCC. All biotransformations were performed on 
a VWR Incubating Mini Shaker 4450. All reagents are analytical grade and purchased from 
Sigma-Aldrich, Acros Organics, Alfa Aesar, Fluorochem or TCI. HPLC analysis was performed 
on a Waters alliance 2690 separations module with a PDA detector. Enantiomeric excess 
values were measured determined using Chiralcel® chiral columns (5 × 250 mm) purchased 
from Daicel Chemical Industries, Japan or Phenomenex Cellulose and Amylose columns 
(5 × 250 mm), purchased from Phenomenex Inc., UK. Mobile phase and flow rate, detector 




6.2 Towards the lipase-mediated resolution of 2-phenyl-1-
propanol 1 
2-Phenylpropyl benzoate 211 
Benzoyl chloride (3.960 g, 28.2 mmol) in DCM (20 mL) was 
added slowly to a stirring solution of 2-phenyl-1-propanol 1 
(4.0 mL, 3.98 g, 29.2 mmol) and triethylamine (4.67 mL, 3.40 
g, 33.6 mmol) in DCM (20 mL) at 0 °C. The ice bath was 
removed, and the reaction mixture was stirred at room temperature overnight. The reaction 
mixture was diluted with DCM (90 mL). The solution was washed with water (2 × 100 mL), aq. 
HCl (10%, 2 × 100 mL), brine (150 mL), dried, filtered and concentrated to give the crude 
product 21 as a pale yellow oil. The product was purified by column chromatography on silica 
gel using hexane/ethyl acetate (95/5) as eluent, giving the pure ester 21 (4.434 g, 66%) as a 
colourless oil.  
ѵmax (ATR) 2969 (C–H), 1716 (C=O), 1268, 1110 (C–O), 698 (C–H Ar) cm−1; δH (300 MHz) 1.40 
(d, 3H, J = 7.0, CH3), 3.17–3.33 (sym m, 1H, CH), 4.33–4.48 (sym m, 2H, C(1)H2), 7.19–7.46 (m, 
7H, ArH), 7.49–7.57 (m, 1H, ArH), 7.94–8.04 (m, 2H, ArH) ppm; δC (75 MHz) 18.1 (CH3), 39.1 
(CH), 69.9 (CH2), 126.7, 127.4, 128.3, 128.5, 129.6 (5 × aromatic CH), 130.4 (aromatic C), 132.9 
(aromatic CH), 143.2 (aromatic C), 166.5 (C=O) ppm; HRMS (ES+): [M+H]+ 241.1229 
(calculated: 241.1223); enantiomers separated using Chiralcel OB-H [conditions: 
n-hexane/iPrOH = 99/1, flow rate = 1 mL min−1], Rt = 10.0 min (R)-21, 12.4 min (S)-21. 
All data are in agreement with previously reported data except signal for C(1)H2 is reported as 
a doublet, and the signal here is a symmetrical multiplet. 
2-Phenylpropyl acetate 222 
Anhydrous pyridine (2.7 mL, 2.61 g, 33.0 mmol, 1.5 eq.) and acetyl 
chloride (1.6 mL, 1.73 g, 22.0 mmol, 1.0 eq.) were sequentially 
added to a stirring solution of 2-phenyl-1-propanol 1 (3.0 g, 22.0 
mmol, 1.0 eq.) and DMAP (134 mg, 1.1 mmol, 5 mol%) in DCM (75 
mL) at 0 °C. The solution was removed from ice bath and was stirred for 24 h at room 
temperature. The reaction was quenched with sat. aq. NaHCO3 (40 mL) and was stirred until 
no more gas was evolved (approx. 40 mins). The layers were separated, and the organic layer 




with DCM (50 mL). The organic layers were combined and washed with water (2 × 100 mL), 
sat. aq. NaHCO3 (100 mL), brine (100 mL), dried, filtered and concentrated to give the crude 
product as a colourless oil. Purification by column chromatography on silica gel using 
hexane/ethyl acetate (95/5) as eluent gave pure ester 22 (2.16 g, 55%) as a colourless oil. 
ѵmax (ATR) 2968 (C–H), 1737 (C=O), 1373, 1227 (C–O), 699 (C–H Ar) cm−1; δH (300 MHz) 1.30 
(d, 3H, J = 7.1, CH3), 2.00 (s, 3H, COCH3), 3.00–3.19 (sym m, 1H, CH), 4.05–4.27 (sym m, 2H, 
CH2), 7.11–7.41 (m, 5H, ArH) ppm; δC (75 MHz) 18.1 (CH3), 20.9 (COCH3), 38.9 (CH), 69.4 (CH2), 
126.7, 128.5, 127.3 (3 × aromatic CH), 143.2 (aromatic C), 171.0 (C=O) ppm; enantiomers 
separated using Chiralcel OB-H [conditions: n-hexane/iPrOH = 99.5/0.5, flow rate = 0.5 mL 
min−1], Rt = 30.1 min (S)-22, 34.5 min (R)-22. 
Data is in agreement with previous reports.3 
2-Phenylpropyl pivalate 23 
Prepared following the procedure for 22 using anhydrous 
pyridine (2.7 mL, 2.61 g, 33.0 mmol, 1.5 eq.), pivaloyl chloride 
(2.7 mL, 22.0 mmol, 1.0 eq.), 2-phenyl-1-propanol 1 (3.04 g, 22.0 
mmol, 1.0 eq.) and DMAP (134 mg, 1.1 mmol, 5 mol%) in DCM 
(75 mL) to give the crude product 23 as a colourless oil. Purification by column 
chromatography on silica gel using hexane/ethyl acetate (95/5) as eluent gave pure ester 23 
(3.273 g, 68%) as a colourless oil. 
ѵmax (ATR) 2971 (C–H), 1727 (C=O), 1282, 1150 (C–O), 699 (C–H) cm−1; δH (300 MHz) 1.13 [9H, 
s, C(CH3)3], 1.31 (d, 3H, J = 6.9, CH3), 3.02–3.29 (sym m, 1H, CH), 4.15 (qd, 2H, J = 10.8, 6.9, 
CH2), 7.15–7.37 (m, 5H, ArH) ppm; δC (75 MHz) 16.9 (CH3), 26.1 [C(CH3)3], 37.7 [C(CH3)3], 38.0 
(CH), 68.2 (CH2), 125.6, 126.3, 127.4 (3 × aromatic CH), 142.3 (aromatic C), 177.3 (C=O) ppm; 
HRMS (ES+): [M+H]+ 221.1541 (calculated: 221.1542); enantiomers separated using Chiralcel 
OB-H [conditions: n-hexane/iPrOH = 99/1, flow rate = 0.5 mL min−1], Rt = 9.5 min (S)-23, 13.1 
min (R)-23. 
This compound is novel and has been fully characterized in this investigation. 
2-Phenylpropyl isobutyrate 24 
Prepared following the procedure for 22 using anhydrous 
pyridine (1.05 mL, 0.98 g, 15.0 mmol, 1.5 eq.), isobutyryl chloride 




mmol, 1.0 eq.) and DMAP (61 mg, 0.5 mmol, 5 mol%) in DCM (35 mL) to give the crude 
product 24 as a colourless oil. Purification by column chromatography on silica gel using 
hexane/ethyl acetate (90/10) as eluent gave pure ester 24 (1.862 g, 90%) as a colourless oil. 
ѵmax (ATR) 2972 (C–H), 1732 (C=O), 1190, 1153 (C–O), 699 (C–H Ar) cm−1; δH (300 MHz) 1.09 
[d, 3H, J = 7.0, CH(CH3)2], 1.11 [d, 3H, J = 7.0, CH(CH3)2], 1.31 [d, 3H, J = 7.0, C(4)H3], 2.50 (sept, 
1H, J = 7.0, COCH), 3.00–3.22 (sym m, 1H, CHCH2), 4.00–4.32 (sym m, 2H, C(1)H2), 7.10–7.43 
(m, 5H, ArH) ppm; δC (75 MHz) 18.0 [C(4)H3], 18.9 [CH(CH3)2], 34.0 [CH(CH3)2], 39.0 (CHCH2), 
69.1 (CH2), 126.6, 127.3, 128.4 (3 × aromatic CH), 143.3 (aromatic C), 177.0 (C=O) ppm; HRMS 
(ES+): [M+H]+ 207.1381 (calculated: 207.1380); enantiomers separated using Chiralcel OB-H 
[conditions: n-hexane/iPrOH = 99/1, flow rate = 1 mL min−1], Rt = 6.6 min (R)-24, 11.1 min (S)-
24. 
This compound is novel and has been fully characterized in this investigation. 
2-Phenylbutyl isobutyrate 25 
Prepared following the procedure for 22 using anhydrous 
pyridine (0.49 mL, 0.48 g, 6.1 mmol, 1.5 eq.), isobutyryl chloride 
(0.42 mL, 4.0 mmol, 1.0 eq.) 2-phenyl-1-butanol 3 (0.6 mL, 3.9 
mmol, 1.0 eq.), and DMAP (27 mg, 0.2 mmol, 5 mol%) in DCM (22 
mL) to give the crude product 25 as a colourless oil. Purification by column chromatography 
on silica gel using hexane/ethyl acetate (95/5) as eluent gave pure ester 25 (0.428 g, 50%) as 
a colourless oil. 
ѵmax (ATR) 2969 (C–H), 1732 (C=O), 1190, 1153 (C–O), 699 (C–H Ar) cm−1; δH (300 MHz) 0.83 
(t, 3H, J = 7.4, CH2CH3), 1.06 [d, 3H, J = 7.0, CH(CH3)2], 1.09 [d, 3H, J = 7.0, CH(CH3)2], 1.52–1.71 
[m, 2H, CH2CH3], 2.47 [sept, 1H, J = 7.0, CH(CH3)2], 2.75–2.92 (sym m, 1H, CHCH2O), 4.21 (d, 
2H, J = 7.0, CH2O), 7.00–7.48 (m, 5H, ArH) ppm; δC (75 MHz) 11.8 [C(4)H3], 18.9 [CH(CH3)2], 
25.3 [C(3)H2], 34.0 [CH(CH3)2], 46.8 [C(2)H], 68.0 (CH2O), 126.6, 128.0, 128.4 (3 × aromatic 
CH), 141.9 (aromatic C), 177.1 (C=O) ppm; HRMS (ES+): [M+H]+ 221.1537 (calculated: 
221.1542); enantiomers separated using Chiralcel OJ-H [conditions: n-hexane/iPrOH = 98/2, 
flow rate = 1 mL min−1], Rt = 6.1 min, 8.3 min. 




3-Methyl-2-phenylbutyl isobutyrate 26 
Prepared following the procedure for 22 using anhydrous 
pyridine (0.31 mL, 0.304 g, 3.8 mmol, 1.5 eq.), isobutyryl chloride 
(0.27 mL, 0.28 g, 2.6 mmol, 1.0 eq.), 
3-methyl-2-phenyl-1-butanol 3 (0.413 g, 2.5 mmol, 1.0 eq.) and 
DMAP (16 mg, 0.13 mmol, 5 mol%) in DCM (10 mL) to give the crude product 26 as a colourless 
oil. Purification by column chromatography on silica gel using hexane/ethyl acetate (95/5) as 
eluent gave pure ester 26 (0.212 g, 35%) as a colourless oil. 
ѵmax (ATR) 2969 (C–H), 1732 (C=O), 1190, 1154 (C–O), 700 (C–H Ar) cm−1; δH (300 MHz) 0.76 
[d, 3H, J = 6.7, C(4)H3], 0.89–1.10 [m, 9H, C(4)H3 & CH(CH3)2], 1.88–2.10 [m, 1H, CH2CH(CH3)2], 
2.41 (sept, 1H, J = 7.0, COCH), 2.57–2.79 (sym m, 1H, CHCH2), 4.35 (d, 2H, J = 6.8, CH2), 7.00–
7.48 (m, 5H, ArH) ppm; δC (75 MHz) 18.8, 20.7, 20.9 (3 × CH3 signals for 4 × CH3), 30.4 [C(3)H], 
34.0 (COCH), 51.8 [C(2)H], 66.2 (CH2), 126.4, 128.1, 128.5 (3 × aromatic CH), 141.6 (aromatic 
C), 177.1 (C=O) ppm; HRMS (ES+): [M+H]+ 235.1687 (calculated: 235.1698); enantiomers 
separated using Chiralcel OJ-H [conditions: n-hexane/iPrOH = 99/1, flow rate = 1 mL min−1], Rt 
= 6.0 min, 8.4 min. 
This compound is novel and has been fully characterized in this investigation. 
3-Methyl-2-phenylbutan-1-ol 34 
Grignard reaction:5 In a flame dried 2-neck flask equipped with a reflux 
condenser, magnesium (1.505 g, 61.9 mmol) and a crystal iodine were 
vigorously stirred in diethyl ether (5 mL) for 1.5 h under a blanket of 
nitrogen. To this mixture isopropylbromide 45 (5.15 mL, 6.747 g, 54.9 
mmol) in diethyl ether (15 mL) was added slowly to maintain a gentle reflux. On completion 
of the addition the solution was heated to reflux. After 40 mins, the solution was cooled to 
0 °C using an ice bath, and a solution of styrene oxide 44 (5.72 mL, 6.006 g, 50.0 mmol) in 
diethyl ether (15 mL) was added over 25 mins and the solution was allowed to warm to room 
temperature and stirred for 40 mins, after which TLC showed the disappearance of styrene 
oxide 44. The reaction solution was poured onto ice-water mixture (35 mL) and acidified to 
pH = 1 using conc. H2SO4. The layers were separated, and the aqueous layer was extracted 
with diethyl ether (2 × 20 mL). The organic layers were combined and washed with sat. aq. 
Na2CO3 (2 × 20 mL), water (3 × 20 mL), brine (40 mL), dried, filtered and concentrated to give 




gel using hexane/ethyl acetate (90/10) gave the product 3 as a yellow oil (1.70 g, 21%, Rf = 
0.1). 
ѵmax (ATR) 3368 (OH), 2957 (C–H), 1494, 1453, 1366, 1056, 1031, 699 (C–H) cm−1; δH (300 MHz) 
0.74 [d, 3H, J = 6.9, C(4)H3], 0.99 [d, 3H, J = 6.9, C(4)H3], 1.82–2.03 [m, 1H, C(3)H], 2.51 [td, 
1H, J = 8.7, 5.0, C(2)H2], 3.72–4.02 (m, 2H, CH2), 7.16–7.37 (m, 5H, ArH) ppm; δC (75 MHz) 21.0 
(2 × CH3), 30.1 [C(3)H], 55.8 [C(2)H], 65.2 [C(1)H2], 126.7, 128.5, 128.7 (3 × aromatic CH), 
141.7 (aromatic C) ppm; enantiomers separated using Chiralcel OJ-H [conditions: 
n-hexane/iPrOH = 99/1, flow rate = 1 mL min−1], Rt = 21.9 min, 28.2 min. 
All data is in agreement with previously reported data.4 
Another product was also isolated from the column (1.687 g, 21%, Rf = 0.2) and was identified 
as the Meinwald rearrangement product, 3-methyl-1-phenylbutan-2-ol 47, and agrees with 
previously reported data for this compound.6 
ѵmax (ATR) 3408 (OH), 2956 (C–H), 1495, 1453, 1367, 1075, 1031, 698 
(C–H) cm−1; δH (300 MHz) 1.00 [d, 6H, J = 6.8, CH(CH3)2], 1.69–1.85 
[sym m, 1H, CH(CH3)2], 2.59 (dd, 1H, J = 13.6, 9.5, one of CH2Ph), 2.85 
(dd, 1H, J = 13.6, 3.0, one of CH2Ph), 3.48–3.68 (m, 1H, CHOH), 7.03–7.50 (m, 5H, ArH) ppm; 
δC (75 MHz) 17.7, 19.4 (2 × CH3), 33.1 (CHCH3), 40.9 (CH2Ph), 77.6 (CHOH), 125.9, 127.3, 128.6, 
(3 × aromatic CH), 143.6 (aromatic C) ppm. 
3-Methyl-1-phenylbutan-1-ol 46 
Magnesium (1.46 g, 60.0 mmol) and iodine (1 crystal) were stirred at 
high speed with small amount of diethyl ether (1.5 mL) for approx. 90 
mins. 1-Bromo-2-methylpropane 48 (6.00 mL, 7.53 g, 55.0 mmol) was 
added dropwise as solution in diethyl ether (15 mL) and was stirred at reflux for 40 mins upon 
completion of the addition. The reaction mixture was cooled to 0 °C and benzaldehyde (5.0 
mL, 5.20 g, 49.0 mmol) in ether (15 mL) was added slowly, over 15 mins. The reaction was 
warmed to room temperature and stirred for 90 mins. The mixture was poured onto ice and 
water and quenched by adding dilute HCl dropwise. The layers were separated and the 
aqueous phase was extracted with EtOAc (2 × 25 mL). The organic layers were combined and 
washed with water (3 × 20 mL), brine (75 mL), dried, filtered and concentrated. Purification 
by column chromatography on silica gel using hexane/ethyl acetate (95/5) as eluent gave pure 




ѵmax (ATR) 3344, 3086, 3029, 2955, 2925 (C–H), 1494, 1453 (C=C) cm−1; δH (300 MHz) 0.95 [dd, 
6H, J = 6.3, 1.4, CH(CH3)2], 1.40–1.61 [m, 1H, CH(CH3)2], 1.62–1.90 (m, 2H, CH2CH), 4.73 (d, 1H, 
J = 8.1, CHOH), 4.75 (d, 1H, J= 8.1, CHOH), 7.20–7.40 (m, 5H, ArH) ppm; δC (75 MHz) 22.3 
(2 × CH3), 24.8 [CH(CH3)2], 48.3 [CH(CH3)2], 72.8 (CHOH), 127.5, 128.5, 125.9 (3 × aromatic 
CH), 145.2 (aromatic C) ppm. 
Methyl 3-methyl-2-phenylbutanoate 424 
Potassium tert-butoxide (8.705 g, 77.7 mmol) was suspended in dry 
DMF (100 mL) at 0 °C under a nitrogen atmosphere and methyl 
phenylacetate 43 (9.4 mL, 10 g, 66.6 mmol) was added at once, 
followed by isopropyl bromide (6.30 mL, 8.25 g, 67.1 mmol) after 2 
min. The ice bath was removed and the reaction allowed warm to room temperature (ca. 
20 °C) and stirring was continued for 1 h. The reaction was quenched with water (50 mL) and 
diluted with DCM (40 mL), and stirred overnight. The solution was extracted with DCM (2 × 40 
mL). The organic layer was washed with sat. aq. NH4Cl solution (40 mL) and water (40 mL), 
dried, filtered and concentrated to give crude 42 as a pale yellow oil. Purification by column 
chromatography on silica gel using hexane/diethyl ether (90/10) as eluent gave pure ester 42 
(8.358 g, 68%) as a colorless oil. 
δH (300 MHz) 0.70 [d, 3H, J = 6.6, one of C(4)H3], 1.03 [d, 3H, J = 6.6, one of C(4)H3], 2.25–2.45 
[m, 1H, C(3)H], 3.15 [d, 1H, J = 10.5, C(2)H], 3.65 (s, 3H, OCH3), 7.18–7.41 (m, 5H, ArH) ppm; 
δC (75 MHz) 20.2 [one of C(4)H3], 21.5 [one of C(4)H3], 28.0 [C(2)H], 51.7 (OCH3), 60.0 [C(1)], 
127.2, 128.4, 128.5 (3 × aromatic CH), 138.4 (aromatic C), 174.4 (C=O) ppm. 
All data is in agreement with previously reported data.4 
3-Methyl-2-phenylbutan-1-ol 34 
Methyl 3-methyl-2-phenylbutanoate 42 (8.0 g, 41.6 mmol) in diethyl 
ether (40 mL) was added slowly to a stirring suspension of LiAlH4 
(3.30 g, 87.0 mmol) in diethyl ether (80 mL). The reaction was 
monitored by TLC and after complete consumption of the ester (6 h), 
the reaction was quenched with ethyl acetate (40 mL). The solution was stirred, water (40 mL) 
was added and the volatiles removed. The layers were separated, and the aqueous layer was 
extracted with DCM (3 × 100 mL). The combined organic layers were washed with brine (100 
mL), dried, filtered and concentrated to give the alcohol 3 (6.83 g, 100%) as a colourless oil, 




The spectroscopic characteristics were identical to the ones listed above. 
Lipase-catalysed reactions 
Lipase-catalysed hydrolysis reactions 
In a typical experiment 8 mg of powdered lipase, or 18 mg of immobilised lipase, was added 
to the ester substrates (50 mg) in 0.1 M phosphate buffer, pH 7 (4.5 mL). Cosolvents (HPLC 
grade, obtained from Sigma Aldrich) were added (0.77 mL, 17% v/v) as indicated. The small 
test tubes were sealed and agitated at 750 rpm at 30 °C for 65 h, unless otherwise stated. The 
aqueous layer was extracted with diethyl ether (3 × 5 mL) and the combined organic extracts 
were filtered through Celite® and concentrated under reduced pressure. The conversion was 
determined by 1H NMR; the sample was reconcentrated and dissolved in n-hexane/iPrOH 
(90/10, HPLC grade) and enantioselectivity was determined by chiral HPLC analysis.  
Lipase-catalysed transesterification reactions 
In a typical experiment 8 mg of powdered lipase, or 18 mg of immobilised lipase, was added 
to the substrate alcohol (10 mg) in the appropriate vinyl ester (0.5 mL), with crushed 4Å 
molecular sieves, as indicated. A solvent (HPLC grade, Sigma Aldrich) was added if required 
and the test tubes were sealed and agitated at 150 rpm for at 30 °C for the times specified in 
the relevant tables. The reaction mixture was diluted with ether (~5–10 mL), filtered through 
Celite® and concentrated under reduced pressure. The conversion was determined by 
1H NMR; the sample was reconcentrated and dissolved in n-hexane/iPrOH (90/10, HPLC 
grade) to a concentration of ~1 mg/mL and enantioselectivity was determined by chiral HPLC 
analysis as indicated. 
Preparative scale lipase-mediated hydrolysis of 24 
Candida antarctica Lipase B (immobilised) (52 mg, 25% w/w) was 
added to a solution of 2-phenylpropyl isobutyrate 24 (200 mg, 
1.0 mmol) in phosphate buffer (0.1M, pH 7, 10 mL) and 
tert-butanol (1.7 mL, 17% v/v). The solution was sealed in a 
conical flask and shaken at 750 rpm for 72 h. The reaction 
mixture was filtered through Celite® to remove the lipase and 
the filter cake was washed with diethyl ether (5 × 10 mL). The resulting solution was 
separated, and the aqueous layer was extracted with diethyl ether (2 × 10 mL). The organic 
layers were combined and washed with brine (50 mL) and concentrated to give a crude 




was purified by column chromatography on silica gel using hexane/ethyl acetate as eluent 
(95/5) to give the pure ester (R)-24 (106 mg, 53%) as a colourless oil [α]𝐷
20 −24.2 (c 0.72 in 
methanol), 70% ee and the pure alcohol (S)-1 (45 mg, 34%) as a colourless oil [α]𝐷
20 −119.5 (c 
0.2 in methanol), 90% ee.  
1H NMR data for the enantioenriched (R)-24 were identical to that of the racemic sample 
previously described. Data for (S)-1: 
δH (300 MHz) 1.25 (d, 3H, J = 7.1, CH3), 1.73 (broad s, 1H, OH), 2.75–3.05 (sym m, 1H, CH3), 
3.65 (d, 2H, J = 7.1, CH2OH), 7.10–7.43 (m, 5H, ArH) ppm. 
6.3 Synthesis & resolution of 6-methylchroman-2-ol 51 
6-Methylchromanone 75 
Method 1:7 Pd/C (10 wt%, 0.072 g) was added to a stirring solution 
of 6-methylcoumarin 74 (1.030 g, 6.4 mmol) in acetic acid (18.5 mL) 
and the mixture was stirred under an atmosphere of hydrogen 
overnight. Reaction completion was shown by disappearance of starting material by TLC 
(12 h). The crude reaction mixture was filtered through Celite® to remove the catalyst, diluted 
with water (20 mL) and neutralized by slow addition of solid sodium carbonate. The mixture 
was extracted with DCM (3 × 25 mL) and the combined organic layers were washed with water 
(30 mL), brine (30 mL), dried, filtered and concentrated to give the product as a white solid 
(0.258 g, 25%) which required no further purification (m.p. 78–79 °C, lit. 78–79 °C).8 
Method 2:9 Pd/C (10 wt%, 0.556 g, 5 mol%) was added to a stirring solution of 6-methyl 
coumarin 74 (2.77 g, 16.7 mmol) in ethyl acetate (17.5 mL) and the mixture was stirred under 
an atmosphere of hydrogen until TLC showed disappearance of starting material (48 h). The 
suspension was filtered through a bed of Celite® using ethyl acetate (10 mL) and concentrated 
to give a yellow oil, which solidified on cooling. The solid residue was dissolved in ethyl acetate 
(10 mL), filtered through Celite®, and concentrated to give a white solid (2.704 g, 97%) which 
was used without further purification (m.p. 77–78 °C, lit. 78–79 °C).8 
ѵmax (ATR) 1740 (C=O), 1500 (C–C), 1209 (C–O), 810 cm−1; δH (300 MHz) 2.31 (s, 3H, CH3), 2.72–
2.81 (m, 2H, CH2), 2.90–3.00 (m, 2H, CH2), 6.90–7.10 (m, 3H, ArH); δC (75 MHz) 20.7, 23.8, 
29.4, 116.7, 122.3, 128.5, 128.7,134.0, 150.0 (6 × aromatic C), 168.8 (C=O) ppm. 





Method 1: Diisobutylaluminium hydride (1 M in toluene, 5.8 mL, 5.8 
mmol) was added dropwise to a solution of 6-methylchromanone 
75 (0.84 g, 5.2 mmol) in distilled toluene (18 mL) at −78 °C under an 
atmosphere of nitrogen. The mixture was stirred at −78 °C for 3 h. TLC showed that the 
starting material was still present and an additional portion of DIBAL (3 mL, 3.0 mmol) was 
added, and the reaction mixture stirred for a further 2 h. The reaction was quenched with 
water (7 mL) and allowed to warm to room temperature. The mixture was filtered through 
Celite®, and the filter cake washed with diethyl ether (30 mL) and the filtrate layers were 
separated. The aqueous layer was extracted with diethyl ether (20 mL) and the organic layers 
were combined. The organic layer was washed with water (50 mL), brine (2 × 50 mL), dried, 
filtered, and concentrated to give the product as a yellow oil (0.427 g, 50%). A portion of the 
product (0.297 g) was purified by column chromatography using hexane/ethyl acetate as an 
eluent (1/1) giving the pure product 51 (0.213 g) as a yellow oil. The other portion of the 
product was acylated directly without purification. 
ѵmax (ATR) 3401 (OH), 2939 (C–H), 1498, 1206 (C–O), 950, 811 cm−1; δH (300 MHz) 1.85–2.11 
(m, 2H, CH2), 2.25 (s, 3H, CH3), 2.66 (dt, J = 16.4, 5.3, 1H, CH2), 2.82–3.04 (m, 1H, CH2), 3.25 
(br s, 1H, OH), 5.58 (br s, 1H, CHOH), 6.71 (d, J = 8.1, 1H, ArH), 6.78–7.00 (m, 2H, ArH) ppm; 
δC (75 MHz) 20.3, 20.5, 27.1, 92.1, 116.6, 121.7, 128.0, 129.6, 130.1, 149.7 ppm; HRMS (ES+): 
[M−H2O]+ 147.0808 (calculated: 147.0810). 
Data for this compound matches previously reported data.10 The signal at 5.58 ppm 
sometimes appears as an unresolved quartet (J = 3.0)#. 
A minor product (0.109g) was also recovered from the column, 
Rf = 0.4. It was identified as the diol 76, corresponding to the 
reduction of the aldehyde, which exists in equilibrium with the lactol 
product 51 above. It is believed to have been a result of the extra DIBAL added, and the 1H 
NMR data matches previously reported data for this compound.12 
δH (300 MHz) 1.80–1.92 (m, 2H, CH2CH2OH), 2.25 (s, 3H, ArCH3), 2.74 (t, 2H, J = 6.9, ArCH2), 
3.63 (t, 2H, J = 5.8, CH2OH), 6.64–6.80 (m, 1.7 H, 1 × ArH & ArOH), 6.84–6.97 (m, 2H, ArH) 




Method 2: Diisobutylaluminium hydride (1 M in toluene, 11.2 mL, 
11.2 mmol) was added dropwise to a stirring solution of 
6-methylchromanone 75 (1.56 g, 9.6 mmol) and powdered 3Å 
molecular sieves in distilled toluene (30 mL) at −78 °C under an atmosphere of nitrogen. The 
mixture was stirred for 6 h. The reaction was quenched with water (5 mL) and allowed to 
warm to room temperature. The solution was filtered through Celite®, the filter cake washed 
with diethyl ether (50 mL) and the filtrate layers were separated. The aqueous layer was 
extracted with diethyl ether (50 mL). The combined organic layer was washed with water 
(2 × 50 mL), brine (100 mL), dried, filtered, and concentrated to give the product 51 as a 
colourless oil (0.93 g, 59%). 
The spectroscopic data were identical to those reported above. 
6-Methylchroman-2-yl acetate 62 
Acetic anhydride (0.6 mL, 0.648 g, 6.4 mmol, 6.7 eq.), DMAP (1.1 
mg, 0.01 mmol) and pyridine (0.34 mL, 0.334 g, 4.2 mmol, 4.5 
eq.) were added to a solution of lactol 51 (154.9 mg, 0.944 mmol) 
in DCM (3.5 mL). The resulting solution was stirred for 22 h. Sat. aq. NaHCO3 (10 mL) was 
added to the solution and stirred vigorously until effervescence ceased (approx. 30 mins). The 
layers were separated, and the aqueous layer was extracted with DCM (10 mL). The combined 
organic layer was washed with sat. aq. copper sulfate solution (20 mL), water (20 mL), sat. aq. 
NaHCO3 (20 mL), brine (20 mL), dried, filtered and concentrated to give an orange/yellow oil 
(0.291 g). Excess pyridine was removed by azetropic distillation with heptane (3 × 10 mL) to 
give the crude product 62 (0.161 g, 83%) as a dark yellow oil. The product was purified by 
chromatography on silica gel using hexane/ethyl acetate (5/1) as an eluent, which gave the 
pure product 62 as a pale yellow oil (0.085 g, 44%). 
ѵmax (ATR) 2933 (C–H), 1748, (C=O), 1498, 1199, 1179 cm−1; δH (300 MHz) 1.90–2.18 (m, 5H, 
CH2 & CH3), 2.26 (s, 3H, CH3), 2.57–2.74 (m, 1H, CH2), 2.86–3.03 (m, 1H, CH2), 6.50 (t, 1H, 
J = 2.6, 1H, CHOCH3), 6.76 (d, 1H, J = 8.2, ArH), 6.84–6.98 (m, 2H, ArH) ppm; δC (75.5 MHz) 
19.7, 20.5, 21.2, 25.2, 90.3, 116.8, 121.3, 128.2, 129.6, 130.7, 149.3, 169.9 ppm; HRMS (ES+): 
[M−OAc]+ 147.0816 (calculated: 147.0816); enantiomers separated using Phenomenex 
Cellulose 4 [conditions: n-hexane/iPrOH = 95/5, flow rate = 1 mL min−1], (−)-62 Rt = 6.0, (+)-62, 
Rt = 6.5 min. 





General procedure for enzymatic transesterification screens 
The substrate 51 (10 mg) was added to a small test tube. The acyl source (0.5 mL) and solvent 
(2 mL, if applicable) were then added, along with a spatula tip of enzyme (~8mg powdered, or 
18 mg immobilised). The reaction was sealed and incubated in a mini-shaker at 30 °C, at 150 
rpm. When the stipulated time period had elapsed, the solution was passed through a Pasteur 
pipette containing a layer each of Celite® and MgSO4, using diethyl ether as eluent. The solvent 
was removed under reduced pressure and the resulting crude mixture was analysed by 1H 
NMR spectroscopy for conversion data and chiral HPLC for enantioselectivity. 
Preparative scale resolution of (+)-6-methylchroman-2-yl acetate (+)-62 
6-Methylchromanol 51 (50 mg) was added to a small test tube. 
Vinyl acetate (50 eq.) and hexane (4 mL) were added to a test tube 
with lipase from Thermomyces lanuginosus (40 mg) as the 
biocatalyst. The test tube was sealed, and the reaction was incubated at 30 °C for 4 days. The 
crude reaction mixture was passed through a Pasteur pipette, as above, and the solvent was 
removed in under reduced pressure. 1H NMR analysis of the crude mixture indicated a 65% 
conversion. The crude mixture was purified using column chromatography with hexane/ethyl 
acetate (5/1) as eluent to give pure 62 in 32% yield and 94% ee. [α]D





6.4 Synthesis & resolution of 2-methyl-2-nitrocyclohexanol 85a 
& 85b 
2-Methyl-2-nitrocyclohexanone 8913 
2-Nitrocyclohexanone 88 (2.09 g, 14.6 mmol) in DCM (19 mL) was added in 
one portion to a vigorously stirring solution of tetrabutylammonium 
hydroxide (11.33 g, of a 40% aq. solution, 17.5 mmol) in water (17 mL) 
under nitrogen. The reaction mixture was stirred for 10 min, and then 
methyl iodide (4.4 mL, 10.03 g, 70.7 mmol) was added in one portion. The reaction mixture 
was stirred vigorously for 48 h at room temperature. The reaction mixture was then 
transferred to a separating funnel and layers separated. The organic layer was washed with 
water (20 mL). The aqueous phase was extracted with DCM (2 × 30 mL) and the combined 
organic fractions were dried, filtered and concentrated under reduced pressure at room 
temperature. Diethyl ether (50 mL) was added to precipitate the tetrabutylammonium iodide 
salt, the supernatant was filtered and concentrated under reduced pressure at room 
temperature to give a crude mixture (2.08 g) of 2-methyl-2-nitrocyclohexanone 89 and ring 
cleavage products, methyl 6-nitrohexanoate 90 and methyl 6-nitroheptanoate 91 (77:15:8 
respectively) as a viscous brown oil. Purification by column chromatography on silica gel using 
hexane/ethyl acetate 90/10 as eluent gave the pure -nitro ketone 89 (0.754 g, 33%) as a 
colourless oil. 
vmax (ATR) 2946, 2872, 1726 (C=O), 1543 (NO2), 1386 (NO2) cm−1; H (300 MHz) 1.67 [s, 3H, 
C(2)CH3], 1.69–1.85 (m, 4H, ring protons), 1.98–2.10 (m, 1H, ring protons), 2.55–2.64 (m, 2H, 
ring protons), 2.86–2.90 (1H, m, ring protons); δC (75.5 MHz) 21.5, 22.4, 26.6, 38.4, 39.2, 93.9, 
200.7 ppm. 
The second fraction isolated from the column was methyl 
6-nitroheptanoate 91 as a pale yellow oil (269 mg). 
vmax (ATR) 2951, 1733 (C=O), 1546 (NO2), 1390 (NO2) cm−1; H 
(300 MHz) 1.30–1.45 (m, 1H, CH2), 1.53 (d, 3H, J = 6.6, CH3), 1.57–1.83 [m, 3H, C(5)H & C(3)H2], 
1.91–2.13 [m, 1H, C(5)H], 2.32 [t, 2H, J = 7.4, C(2)H2], 3.67 (s, 3H, OCH3), 4.47–4.67 [sym m, 




The third fraction isolated from the column was methyl 
6-nitrohexanoate 90 as a yellow oil (197 mg). 
vmax (ATR) 2951, 1733 (C=O), 1548 (NO2), 1382 (NO2) cm−1; 
H (300 MHz) 1.33–2.19 (m, 5H, alkyl CH), 2.34 [t, 2H, J = 7.4, C(5)H2], 3.68 (s, 3H, OCH3), 4.39 
[t, 2H, J = 7.0, C(2)H2] ppm; δC (75.5 MHz) 24.2, 25.7, 27.0, 33.5, 51.6, 75.4, 173.6 ppm. 
Data is consistent with literature values.14 
2-Methyl-2-nitrocyclohexanol 82a & 82b15 
A solution of 2-methyl-2-nitrocyclohexanone 89 (1.01 g, 
6.4 mmol) in ethanol (11 mL) was added dropwise over 
10 min to a stirred suspension of NaBH4 (0.267 g, 
7.1 mmol) in ethanol (11 mL) at 0 °C under nitrogen and 
stirring was continued for 1.5 h at 0 °C. The ice bath was then removed and aq. HCl (10%) was 
added to adjust to pH 1. The solution was concentrated under reduced pressure and the 
resulting residue was partitioned between water (20 mL) and DCM (20 mL). The aqueous 
phase was extracted with DCM (3 × 20 mL) and the combined organic extracts were washed 
with brine (30 mL), dried, filtered and concentrated under reduced pressure to give a crude 
mixture (1.00 g) of nitroalcohols cis-82a and trans-82b (3:1 respectively) as a yellow oil. 
Purification by column chromatography on silica gel using hexane/diethyl ether 60/40 as 
eluent gave cis-2-methyl-2-nitrocyclohexanol 82a (0.450 g, 44%) as a viscous light yellow oil. 
vmax (ATR) 3429 (OH), 2944 (C–H), 1533 (NO2), 1357 (NO2) cm−1; δH (300 MHz) 1.36–1.57 [m, 
3H, one of C(5)H2 & C(4)H2], 1.63 [s, 3H, C(2)CH3], 1.66–1.94 [m, 4H, one of C(5)H2, one of 
C(3)H2 and C(6)H2], 2.46 [dt, 1H, J = 13.9, 6.0, one of C(3)H2], 2.79 [d, 1H, J = 8.3, OH], 3.91 [td, 
1H, J = 8.0, 3.6, C(1)H] ppm; δC (75.5 MHz) 21.6 [CH2, C(5)], 21.9[CH2, C(4)], 24.2[CH3, C(2)CH3], 
30.6 [CH2, C(6)], 33.0 [CH2, C(3)], 73.1[CH, C(1)], 91.4 [qC, C(2)] ppm; enantiomers separated 
using Chiralcel OJ-H [conditions: n-hexane/iPrOH = 98.5/1.5, flow rate = 0.5 mL min−1], Rt = 
40.1 min, 44.1 min. 
A fraction containing both cis-82a and trans-82b (70:30) was also isolated, this was used for 
enzymatic screens, as it is approximately equal to the thermodynamic ratio which is achieved 





trans-2-Methyl-2-nitrocyclohexanol 82b (81 mg, 8%) was isolated as a colourless oil. 
vmax (ATR) 3429 (OH), 2944 C–H), 1537 (NO2), 1357 (NO2) cm−1; δH (300 MHz) 1.29–1.53 [m, 
3H, one of C(4)H2, one of C(5)H2 and one of C(6)H2], 1.61 [s, 3H, C(2)CH3], 1.66–2.05 [m, 4H, 
one of C(4)H2 & one of C(5)H2 & one of C(3)H2 & one of C(6)H2], 2.05–2.23 [m, 1H, one of 
C(3)H2], 2.77 [br s, 1H, OH], 4.21–4.34 [m, 1H, C(1)H] ppm; δC (75.5 MHz) 16.3 [CH3, br, 
C(2)CH3], 22.1 [CH2, C(4)H2], 23.5 [CH2, C(5)H2], 30.6 [CH2, C(6)H2], 35.9 [CH2, br, C(3)H2], 72.4 
[CH, C(1)H], 93.0 [qC, C(2)] ppm; enantiomers separated using Chiralcel OJ-H [conditions: 
n-hexane/iPrOH = 98.5/1.5, flow rate = 0.5 mL min−1], Rt = 47.1 min, 53.5 min. 
cis-2-Methyl-2-nitrocyclohexyl acetate 87a 
DMAP (1 mg) was added to a stirring solution of 
cis-2-methyl-2-nitrocyclohexanol 82a (41 mg, 0.3 mmol), acetic anhydride 
(0.15 mL, 1.6 mmol) and pyridine (0.1 mL, 1.2 mmol) in DCM (2 mL). The 
reaction mixture was stirred at room temperature for 21 h. Saturated aq. 
NaHCO3 (3 mL) was added and the mixture stirred for 30 min. The solution was transferred to 
a separating funnel and washed with sat. aq. CuSO4 (6 mL), water (6 mL), sat. aq. NaHCO3 (6 
mL) and brine (6 mL). The organic extract was dried, filtered and concentrated under reduced 
pressure to give crude acetate 87a (27 mg, 51%) as a colourless oil which was sufficiently pure 
to use without further purification. 
H (300 MHz) 1.33–1.56 [m, 3H, C(5)H2, and one of C(4)H2], 1.65 [s, 3H, C(2)CH3], 1.59–1.90 
[m, 2H, one of C(4)H2 and one of C(6)H2], 2.03 [s, 3H, COCH3], 1.91–2.22 [m, 3H, one of C(6)H2 
and C(3)H2], 5.53 [dd, 1H, J = 9.9, 4.5, C(1)H] ppm; enantiomers separated using Chiralcel OJ-
H [conditions: n-hexane/iPrOH = 98.5/1.5, flow rate = 0.5 mL min−1], Rt = 23.5 min, 26.8 min. 
trans-2-Methyl-2-nitrocyclohexyl acetate 87b 
This was prepared following the procedure for 82a, from DMAP (1 mg), 
trans-2-methyl-2-nitrocyclohexanol 82b (43 mg, 0.3 mmol), acetic 
anhydride (0.15 mL, 1.6 mmol) and pyridine (0.1 mL, 1.2 mmol) in DCM (2 
mL) to give the crude acetate 87b (26 mg, 48%) as a light yellow oil which 
was sufficiently pure to use without further purification. 
H (300 MHz) 1.34–1.57 [m, 3H, one of C(4)H2, one of C(5)H2 and one of C(6)H2], 1.61 (s, 3H, 
CH3), 1.62–1.93 [m, 2H, one of C(5)H2 and one of C(4)H2], 2.02 (s, 3H, OCH3), 1.95–2.14 [m, 




Chiralcel OJ-H [conditions: n-hexane/iPrOH = 98.5/1.5, flow rate = 0.5 mL min−1], Rt = 17.8 min, 
19.1 min. 
Lipase-mediated kinetic resolution 
General procedure for the development of one-pot procedures: lipase-mediated 
transesterification of 2-methyl-2-nitrocyclohexanol 82a or 82b with vinyl acetate as 
acetylating agent and dynamic interconversion process (analytical scale) 
In a typical experiment, the following were added as appropriate to a solution of nitroalcohols 
cis-82a and trans-82b (typically 15 mg) in the appropriate solvent (10 mg/mL): DBU (immob) 
(0.5 eq.) (18 mg) or vinyl acetate, and CAL-B (immob) (approx. 15 mg). The small test tube was 
sealed and agitated as appropriate for the specified length of time (generally 12 h). The 
solutions were filtered through Celite® and concentrated under reduced pressure. The sample 
was analysed by 1H NMR spectroscopy, reconcentrated and dissolved in a mixture of 
n-hexane/iPrOH (90/10, HPLC grade) and enantioselectivity determined by chiral HPLC 
analysis.  
General procedure for the development of two-pot procedures: dynamic interconversion 
process and lipase-mediated transesterification of 2-methyl-2-nitrocyclohexanol cis-82a and 
trans-82b with vinyl acetate 65 as acetylating agent (analytical scale) 
In a typical experiment, DBU (immob) (0.5 eq., ~90 mg) was added to a solution of 
nitroalcohols cis-82a and trans-82b in toluene (5 mL, 10 mg/mL) and the test tube was sealed 
and shaken at 500 rpm for the required amount of time at the specified temperature. The 
reaction solution was filtered through Celite®, concentrated under reduced pressure and 
redissolved in the appropriate amount of solvent, if applicable. CAL-B (immob) and vinyl 
acetate were added and the solution shaken at the appropriate speed and temperature for 
the required amount of time in a sealed test tube. The solution was filtered through a plug of 
Celite® and concentrated under reduced pressure if applicable. The samples were taken 
before each filtration and filtered through Celite®, concentrated under reduced pressure. The 
samples were analysed by 1H NMR spectroscopy, reconcentrated and dissolved in a mixture 
of n-hexane/iPrOH (90/10, HPLC grade) and enantioselectivity determined by chiral HPLC 
analysis. 
General procedure for the development of one-pot procedures: dynamic interconversion 
process and lipase-mediated transesterification of 2-methyl-2-nitrocyclohexanol cis-82a and 
trans-82b with vinyl acetate as acetylating agent (analytical scale)–cycling procedure 
In a typical experiment, immobilised DBU (0.5 eq., ~90 mg) was added to a solution of 
nitroalcohols cis-82a and trans-82b in toluene (5 mL, 10 mg/mL) and the test tube was sealed 




w/w) and vinyl acetate 65 (3.0 eq.) was added and the test tube was sealed, shaken at 400 
rpm for 12 h at 30 °C. At the end of the cycle the solution was filtered through a plug of Celite® 
if appropriate and the filtrate was recycled through the process again. Before the addition of 
each reagent an aliquot was taken, filtered through Celite®, concentrated under reduced 
pressure. The samples were analysed by 1H NMR spectroscopy, reconcentrated and dissolved 
in a mixture of n-hexane/iPrOH (90/10, HPLC grade) and enantioselectivity determined by 
chiral HPLC analysis. 
Diastereoselective lipase-mediated transesterification of 2-methyl-2-nitrocyclohexanol 82 
CAL-B (immob) (88.6 mg) was added to an equimolar mixture of cis- and trans-
2-methyl-2-nitrocyclohexanol (±)-82a and (±)-82b (105.4 mg, 0.7 mmol) dissolved in vinyl 
acetate (5 mL). The reaction mixture was shaken at 750 rpm at room temperature. Reaction 
monitoring was conducted as follows: an aliquot (0.5 mL) of reaction mixture was isolated and 
filtered through Celite®, washed with ethyl acetate and concentrated under reduced pressure 
and the sample was analysed by 1H NMR spectroscopy. The final extraction following 1H NMR 
spectroscopy was dissolved in a mixture of n-hexane/iPrOH (90/10, HPLC grade) and 
enantioselectivity determined by chiral HPLC analysis. 
6.5 Synthesis of transaminase substrates 
2-Methyl-1-phenylpropan-1-amine 114 
A mixture of 2-methylpropiophenone (0.740 g, 5.0 mmol), titanium(IV) 
ethoxide (2.1 mL, 2.28 g, 10.0 mmol) and ammonia (2 M in methanol, 
12.5 mL, 25.0 mmol) was stirred under nitrogen, at ambient temperature 
for 15 h. Sodium borohydride (0.288 g, 7.6 mmol) was added and the 
resulting mixture was stirred at room temperature for an additional 3 h. The reaction was 
quenched by pouring onto ammonium hydroxide (2 M, 12.5 mL), the resulting inorganic 
precipitate was removed by filtration, and washed with ethyl acetate (2 × 15 mL). The aqueous 
solution was extracted with ethyl acetate (2 × 15 mL). The combined organic solution was 
extracted with aq. HCl (10%, 15 mL). The acidic aqueous extracts were washed with ethyl 
acetate (25 mL), then treated with aq. NaOH (2 M) to pH 10–12 and extracted with ethyl 
acetate (3 × 25mL). The combined organic extracts were washed with brine (25 mL), dried 
(Na2SO4), filtered and concentrated to give the primary amine 114 as a colourless oil (0.368 g, 




ѵmax (ATR) 2957, 2870, 1465, 1451, 701 cm−1; δH (300 MHz) 0.77 (d, 3H, J = 6.7, CH3), 0.98 (d, J 
= 6.7, 3H, CH3),1.50 (br s, 2H, NH2), 1.75–1.96 (sym m, 1H, CH(CH3)2), 3.60 (d, 1H, J = 7.3, 
CHNH2), 7.06–7.53 (m, 5H, ArH) ppm; δC (75.5 MHz) 18.9 (CH3), 19.8, 35.5, 62.5, 126.8, 127.0, 
128.2 (3 × aromatic CH), 145.5 (aromatic C) ppm. 
All data is in agreement with previously reported data.16 
Cyclohexyl(phenyl)methanamine 115 
Prepared following the procedure for 114 using 
cyclohexyl(phenyl)ketone (1.878 g, 10.0 mmol), titanium(IV) ethoxide 
(4.2 mL, 4.56 g, 20.0 mmol), ammonia (2 M in methanol, 25 mL, 50.0 
mmol) and sodium borohydride (0.567 g, 15.0 mmol) to give the 
product amine 115 as a white solid (0.437 g, 23%), which required no further purification, 
(m.p. 99–102 °C). 
ѵmax (ATR) 3421, 2922, 2849, 1552, 1453, 1357, 704, 528 cm−1; δH (300 MHz) 0.73–1.71 (m, 
12H, ring CH & NH2), 1.71–1.83 (m, 1H, ring CH), 1.86–2.04 (m, 1H, ring CH), 3.60 (d, 1H, J = 
7.5, CHNH2), 7.10–7.48 (m, 5H, ArH) ppm; δC (75.5 MHz) 26.2, 26.4, 29.5, 30.1 (4 × CH2), 45.2, 
61.7 (2 × CH), 126.8, 127.1, 128.2 (3 × aromatic CH), 145.5 (aromatic C) ppm. 
13C signal at 145.5 ppm is very weak and was confirmed by HMBC correlation experiments. 
Carbon assignments were aided by DEPT experiments. 
All data is in agreement with previously reported data.17 Melting point was not previously 
reported. 
1-(4-Methoxyphenyl)propan-2-amine 12118 
Prepared following the procedure for 114 using 
4′-methoxyphenylacetone 148 (1.640 g, 10.0 mmol), titanium(IV) 
ethoxide (4.2 mL, 4.56 g, 20.0 mmol), ammonia (2 M in methanol, 
25 mL, 50.0 mmol) and sodium borohydride (0.575 g, 15.2 mmol) to give the product amine 
121 as a pale yellow oil (0.559 g, 34%), which required no further purification. 
ѵmax (ATR) 2957, 2835, 1611, 1510, 1242, 1176, 1033, 802 cm−1; δH (300 MHz) 1.10 (d, 3H, J = 
6.3, CH3), 2.46 (dd, 1H, J = 13.4, 8.0, one of CH2), 2.65 (dd, 1H, J = 13.4, 5.3, one of CH2), 3.04–
3.21 (m, 1H, CHNH2), 3.79 (s, 3H, OCH3), 6.70–6.94 (m, 2H, ArH), 7.02–7.33 (m, 2H, ArH) ppm; 




using Amylose 1 column [conditions: n-hexane/iPrOH (containing 1% DEA) = 90/10, flow rate 
= 0.4 mL min−1], Rt = 16.0, Rt = 16.8 min, Rt (ketone) = 14.4 min. 
All data is in agreement with previously reported data.19 
1,2,3,4-Tetrahydronaphthalen-2-amine 130 
Prepared following the procedure for 114 using 2-tetralone 131 (1.472 
g, 10.1 mmol), titanium(IV) ethoxide (4.2 mL, 4.56 g, 20.0 mmol), 
ammonia (2 M in methanol, 25 mL, 50.0 mmol) and sodium 
borohydride (0.584 g, 15.4 mmol) to give the product amine 130 as a dark green oil (0.713 g, 
48%), which was used without further purification. 
ѵmax (ATR) 3354, 2918, 2841, 741 cm−1; δH (300 MHz) 1.51–1.74 [m, 3H, one of C(3)H2 and NH2 
(1.66, br s)], 1.91–2.10 [m, 1H, one of C(3)H2], 2.56 [dd, 1H, J = 16.1, 9.4, one of C(1)H2], 2.77–
2.94 [m, 2H, C(4)H2], 3.00 [ddd, 1H, J = 16.2, 5.0, 1.3, one of C(1)H2], 3.18 (tdd, 1H, J = 9.5, 5.0, 
3.1, CHNH2), 6.87–7.22 (m, 4H, ArH) ppm; δC (75.5 MHz) 28.1, 33.0, 39.5 (3 × CH2), 47.3 (CH), 
125.7, 125.8, 128.7, 129.3 (4 × aromatic CH), 135.3, 135.9 (2 × aromatic C) ppm.  
All data is in agreement with previously reported data.20 Proton and carbon assignments were 
aided by 2D NMR and DEPT experiments. 
1,4-Diphenylbutan-1-amine 116 
Prepared following the procedure for 114 using 
1,4-diphenylbutanone (0.451 g, 2.0 mmol), titanium(IV) 
ethoxide (0.84 mL, 0.91 g, 4.0 mmol), ammonia (2 M in 
methanol, 5 mL, 10.0 mmol) and sodium borohydride 
(0.122 g, 3.2 mmol) to give the product amine 116 as a colourless oil (0.074 g, 16%), which 
required no further purification. 
ѵmax (ATR): 2934, 1265, 732, 699 cm−1; δH (300 MHz) 1.38–1.98 [m, 6H, 2 × CH2 & NH2 (1.69, s)], 
2.48–2.71 (m, 2H, CH2), 3.77–3.97 (m, 1H, CHNH2), 6.91–7.51 (m, 10H, ArH) ppm; δC (75.5 
MHz), 28.4, 35.8, 39.1 (3 × CH2), 56.3 (CH), 125.7, 126.4, 127.0, 128.3, 128.4, 128.5 
(6 × aromatic CH), 142.3, 146.3 (2 × aromatic C) ppm; HRMS (ES+): [M+H]+ 226.1589 
(calculated: 226.1596). 





A solution of 4-phenyl-2-aminobutane 120 (16.18 μL, 0.1 mmol) in 
DCM (2 mL) was added to a solution of di-tert-butyl-dicarbonate 
(21.83 mg, 0.1 mmol, 1.0 eq.) in DCM (2 mL). The reaction solution 
was stirred for 3 h at room temperature. The solvent was 
evaporated to give the crude N-Boc-amine 158 as a colourless oil which was used without 
further purification for chiral HPLC method development. 
δH (300 MHz) 1.16 [d, 3H, J = 6.2, C(1)H3], 1.45 [s, 9H, C(CH3)3], 1.62–1.82 (m, 2H, CH2), 2.55–
2.80 (m, 2H, CH2), 3.72 (br s, 1H, CHNH2), 4.37 (br s, 1H, NH2), 7.07–7.37 (m, 5H, ArH) ppm. 
All data is in agreement with previous reports.22 
(4′-Chlorophenyl)(phenyl)methanamine 118 
Prepared by Gavin following the procedure for 114 using 
4′-chlorobenzophenone (1.08 g, 5.0 mmol), titanium(IV) ethoxide 
(2.1 mL, 2.28 g, 10.0 mmol), ammonia (2 M in methanol, 12.5 mL, 
25.0 mmol) and sodium borohydride (0.3 g, 8.0 mmol) to give the 
product 118 as a colourless oil. 
δH (300 MHz) 1.73 (v br s, 2H, NH2), 5.12 (br s, 1H, CHNH2), 7.49–7.09 (m, 9H, ArH) ppm; 
All data is in agreement with previously reported data.23 
Ethyl 3-amino-3-phenylpropanoate 117 
Sulfuric acid (conc., 2.4 mL, 4.42 g, 45.0 mmol) was added to a 
solution of 3-amino-3-phenylpropanoic acid 133 (2.48 g, 15.0 
mmol) in absolute ethanol (50 mL) and heated under reflux for 
24 h. Excess ethanol was evaporated under reduced pressure and 
the crude product was dissolved in DCM (50 mL) and washed with water (2 × 50 mL), sat. aq. 
NaHCO3 (2 × 50 mL), brine (50 mL), dried, filtered and concentrated to give the ester 117 as a 
colourless oil (0.999 g, 34%) which was used without further purification. 
ѵmax (ATR) 3381, 1726 (C=O), 1178, 1031, 699, 539 cm−1; δH (300 MHz) 1.23 (t, 3H, J = 7.1, 




(dd appears as a t, 1H, J = 6.8, CHNH2), 7.14–7.48 (m, 5H, ArH) ppm; δC (75.5 MHz) 14.2, 44.2, 
52.6, 60.6, 126.2, 127.4, 128.6, 144.7 (4 × aromatic C), 172.1 (C=O) ppm. 
All data is in agreement with previously reported data.24 
4-Phenyl-3,4-dihydronaphthalen-1(2H)-one 13425  
Triflic acid (50 g, 333.0 mmol) was added slowly to a stirring solution of 
trans-styrylacetic acid 142 (11.35 g, 70.0 mmol) and benzene (6.3 mL, 
5.47 g, 70.0 mmol) in DCM (50 mL), at 0 °C. The reaction solution was 
allowed to warm to room temperature and stirred for 24 h. The reaction 
solution was quenched by pouring onto a mixture of water and ice (50 mL) 
and the layers separated. The solution was extracted with DCM (3 × 50 mL), 
and the combined extracts were dried, filtered, and concentrated to give the crude product 
(14.808 g) which was purified by column chromatography using hexane/ethyl acetate (90/10) 
as eluent to give the pure product 134 (5.53 g, 36%) as a white solid (m.p.: 69–72 °C, lit.: 70–
72 °C).26 
ѵmax (ATR) 2917 (C-H), 1682 (C=O), 762, 702 cm−1; δH (300 MHz) 2.20–2.38 [m, 1H, one of 
C(3)H2], 2.38–2.54 [m, 1H, one of C(3)H2], 2.54–2.81 [sym m, 2H, C(2)H2], 4.30 [dd, 1H, J = 8.0, 
4.6, 1H, C(4)H], 6.98 (d, 1H, J = 7.7, 1H, ArH), 7.06–7.16 (m, 2H, ArH), 7.19–7.49 (m, 5H, ArH), 
8.12 (dd, 1H, J = 7.6, 1.1, ArH) ppm; δC (75.5 MHz) 31.9 [C(3)H2], 36.8 [C(2)H2], 45.3 [C(4)H], 
126.8, 127.06, 127.13, 128.6, 128.7, 129.6 (6 × aromatic CH), 132.9 (aromatic C), 133.6 
(aromatic CH), 143.7, 146.3 (2 × aromatic C), 198.1 (C=O) ppm; enantiomers separated using 
Chiralcel OJ-H [conditions: n-hexane/iPrOH (containing 1% DEA) = 90/10, flow rate = 0.5 mL 
min−1], Rt = 18.5 min; 31.9 min. 
All data is in agreement with previously reported data. 26,27 
cis-4-Phenyl-1,2,3,4-tetrahydronaphthalen-1-ol cis-137a & trans-4-phenyl-
1,2,3,4-tetrahydronaphthalen-1-ol trans-137b28 
Sodium borohydride (0.697 g, 18.4 mmol) was added to a 
stirring solution of ketone 134 (3.823 g, 16.7 mmol) in 
methanol (50 mL) at 0 °C. The solution was allowed to slowly 
warm to room temperature and was stirred overnight. The 
reaction mixture was acidified to pH = 5 using aq. HCl (10%), 




solution was extracted with ethyl acetate (2 × 50 mL). The organic layer was washed with brine 
(50 mL), dried, filtered and concentrated to give the crude material as a viscous yellow oil 
(4.533 g) containing a mixture of cis-137a and trans-137b diastereomers (46:54). The product 
trans-137b (1.46 g, 39%) was obtained as a white solid (m.p.: 121–122 °C, lit.: 122–123 °C)29 
by recrystallisation of the crude mixture from diethyl ether and hexane. The cis-enriched 
material (24:76) which remained in the mother liquor was subjected to column 
chromatography using diethyl ether/hexane (15/85) as eluent to give the pure product 
cis-137a as a colourless oil (0.754 g, 20%). 
cis-137a: ѵmax (ATR) 3307, 760, 731, 699 cm−1; δH (300 MHz) 1.81 (br s, 1H, OH), 1.89–2.25 [m, 
4H, C(2)H2 & C(3)H2], 4.02 [dd, 1H, J = 8.3, 5.6, C(4)H], 4.87 [br s, 1H, C(1)H], 6.85 (d, 1H, J = 
7.7, ArH), 7.07–7.38 (m, 7H, ArH), 7.46 (m, 1H, ArH) ppm; δC (75.5 MHz) 28.3 (CH2), 30.3 (CH2), 
45.8 [C(4)H], 68.2 [C(1)H], 126.3, 126.6, 127.9, 128.4, 128.8, 128.9, 130.0 (7 × aromatic CH), 
139.0, 139.8, 146.6 (3 × aromatic C) ppm; HRMS (ES+): [M+H]+ 225.1279 (calculated: 
225.1274). 
1H NMR data matches previously reported data.30 13C NMR data was not previously reported 
and assignments were aided by DEPT and 2D experiments. 
trans-137b: ѵmax (ATR) 3230 (OH), 745, 696 cm−1; δH (300 MHz) 1.66–1.96 [m, 3H, one of C(2)H2 
and one of C(3)H2 and OH (1.73, d, J = 6.0)], 2.08–2.25 [m, 1H, one of C(2)H2], 2.27–2.43 [m, 
1H, one of C(3)H2], 4.13–4.22 [m, 1H, C(4)H], 4.85–4.96 [m, 1H, C(1)H], 6.88 (d, 1H, J = 7.9, 
ArH), 6.99–7.06 (m, 2H, ArH), 7.09–7.37 (m, 5H, ArH), 7.55 (d, 1H, J = 7.6, ArH) ppm; δC (75.5 
MHz) 29.2 [C(3)H2], 30.3 [C(2)H2], 45.3 [C(4)H], 68.5 [C(1)H], 126.1, 126.7, 127.7, 127.9, 128.3, 
128.7, 130.2 (7 × aromatic CH), 139.1, 139.7, 146.5 (3 × aromatic C) ppm; elemental analysis 
(Found C 85.44; H 7.17. C16H16O requires C 85.68, H 7.19%).  
1H NMR data matches previously reported data.30 13C NMR data was not previously reported 
and assignments were aided by DEPT spectra and 2D experiments. 
trans 1-Azido-4-phenyl-1,2,3,4-tetrahydronaphthalene cis-140b31  
Diphenylphosphoryl azide (1.05 mL, 1.34 g, 4.9 mmol, 1.2 eq.) was added to 
a solution of cis-137a (0.914 g, 4.1 mmol) in dry toluene (10 mL) under 
nitrogen. The reaction mixture was cooled to 0 °C and stirred for 10 mins. 
DBU (0.73 mL, 0.74 g, 4.9 mmol) was added dropwise to the stirring solution. 
The mixture was stirred at 0 °C for 2 h, and at room temperature for 20 h. 




DCM/hexane (1/2) and filtered through a short silica gel pad (approx. 100 mL solvent used), 
and the solvent was removed in vacuo to give the crude product as a yellow oil (1.065 g). The 
product was purified by column chromatography using hexane/ethyl acetate (95/5) as eluent 
to give the pure product trans-140b (902 mg, 90%) as a colourless oil. 
ѵmax (ATR) 2939, 2091, 1491, 1239, 749, 700 cm−1; δH (300 MHz) 1.80–1.96 [2H, m, one of 
C(2)H2 and one of C(3)H2], 2.05–2.23 [1H, m, one of C(2)H2], 2.30–2.49 [1H, m, one of C(3)H2], 
4.22 [t, 1H, J = 5.8, C(4)H], 4.67 [t, 1H, J = 5.4, C(1)HN3], 6.94 (d, 1H, J = 7.8, ArH), 6.96–7.03 
(m, 2H, ArH), 7.15–7.32 (m, 5H, ArH), 7.38–7.45 (m, 1H, ArH) ppm; δC (75.5 MHz) 26.1 (CH2), 
28.9 (CH2), 44.5 [C(4)H], 59.7 [C(1)HN3], 126.2, 126.7, 128.32, 128.34, 128.63, 128.64, 130.7 
(7 × aromatic CH), 134.6, 139.3, 146.4 (3 × aromatic C) ppm; HRMS (ES+): [M−N3]+ 207.1168 
(calculated: 207.1170). 
This compound is novel and has been fully characterized in this investigation. NMR 
assignments were aided by DEPT and 2D experiments. 
cis-1-Azido-4-phenyl-1,2,3,4-tetrahydronaphthalene cis-140a31 
Diphenylphosphoryl azide (1.30 mL, 1.66 g, 6.0 mmol, 1.2 eq.) was added 
to a solution of trans-137b (1.131 g, 5.0 mmol) in dry toluene (12.5 mL) 
under nitrogen. The reaction mixture was cooled to 0 °C and stirred for 10 
mins. DBU (0.90 mL, 0.918 g, 6.0 mmol, 1.2 eq.) was added dropwise to the 
stirring solution. The solution was stirred at 0 °C for 2 h, and at room 
temperature for 20 h. The solvent was removed in vacuo and the residue 
was dissolved in DCM/hexane (1/1) and filtered through a short silica gel pad (approx. 150 mL 
solvent used), and the solvent was removed in vacuo to give the crude product as a brown oil 
(4.01 g). The product was purified by column chromatography using hexane/ethyl acetate 
(95/5) as eluent to give the pure product cis-140a (966 mg, 77%) as a yellow solid (m.p.: 80–
82 °C). 
ѵmax (ATR) 2943 (CH), 2091 (N3), 1486, 755, 699 cm−1; δH (300 MHz) 1.85–2.32 [m, 4H, C(2)H2 
and C(3)H2], 4.04 [t, 1H, J = 6.7, C(4)H], 4.64 [t, 1H, J = 4.7, C(1)H], 6.89 (d, 1H, J = 7.7, ArH), 
7.03–7.42 (m, 8H, ArH) ppm; δC (75.5 MHz) 28.1 (CH2), 28.9 (CH2), 45.6 [C(4)H], 59.7 [C(1)H], 
126.4, 126.5, 128.5, 128.8, 129.3, 130.4 (6 × signals for 7 × aromatic CH), 133.9, 140.2, 146.3 
(3 × aromatic C) ppm; elemental analysis: (Found C 77.06; H 6.13; N 16.55. C16H15N3 requires 
C 77.08; H 6.06; N 16.85%). 





Polystyrene-bound triphenyl phosphine [4.296 g (1.4–2.0 mmol/g loading), 
~7.3 mmol, 2.0 eq.] was added to a solution of cis-130a (0.854 g, 3.4 mmol) 
in dry THF (50 mL) and stirred for 16 h. Water (10 mL) was added and the 
reaction solution stirred for an additional 4 h. The reaction mixture was 
filtered and extracted with DCM (3 × 50 mL). The combined organic layers 
were dried (Na2SO4) and concentrated under reduced pressure to give a 
mixture of the azide cis-130a and the amine cis-93a. The reaction product and the polymer-
bound catalyst were resuspended in THF (50 mL) and water (5 mL) and stirred for 4d, after 
which cis-130a was still evident by IR. The reaction solution was heated to reflux for 2d and 
worked up as previously described to give the crude amine cis-93a and unreacted azide cis-
130a as an orange oil. The mixture was dissolved in DCM and aq. HCl (5M) was added until pH 
1. The mixture was extracted with DCM and the residue evaporated to give the azide cis-130a. 
The aqueous layer was adjusted to pH > 9, extracted with DCM (3 × 10 mL) and evaporated to 
give the cis-amine cis-93a as a brown oil (0.070 g, 9%).  
ѵmax (ATR) 3279, 2928, 1489, 1447, 759, 726, 700 cm−1; δH (300 MHz) 1.66 (br s, 2H, NH2), 
1.75–1.88 [m, 1H, one of C(2)H2], 1.92–2.22 [m, 3H, one of C(2)H2 and C(3)H2], 3.99–4.11 [m, 
2H, C(1)H and C(4)H], 6.84 (d, 1H, J = 7.7, ArH), 7.00–7.35 (m, 7H, ArH), 7.43 (d, 1H, J = 7.0, 
ArH) ppm; δC (75.5 MHz) 28.9 (CH2), 30.9 (CH2), 45.8 [C(4)H], 49.4 [C(1)H], 126.1, 126.5, 126.8, 
128.2, 128.3, 128.9, 130.0 (7 × aromatic CH), 139.0, 141.6, 146.9 (3 × aromatic C) ppm; HRMS 
(ES+): [M+H]+ 224.1434 (calculated 224.1443); enantiomers separated using Chiralcel AS-H 
[conditions: n-hexane/iPrOH (containing 1% DEA) = 90/10, flow rate = 0.5 mL min−1], Rt = 10.7, 
Rt = 11.5 min, Rt (ketone 134, no separation) = 14.6 min. 
This compound is novel and has been fully characterized in this investigation. 
trans-4-Phenyl-1,2,3,4-tetrahydronaphthalen-1-amine trans-93b 
Triphenylphosphine 145 (555 mg, 2.1 mmol, 1.1 eq.) and water (68.4 µL, 2.0 
eq.) were added to a stirring solution of trans-140b (479 mg, 1.9 mmol) in 
THF (20 mL, HPLC grade). The solution was heated to reflux and stirred for 
16 h. The reaction mixture was cooled, and the solvent removed by rotary 
evaporation to give the crude reaction mixture containing the amine trans-
93b and triphenylphosphine oxide 146 (1.253 g). The residue was 




was removed by filtration. The filtrate was evaporated to dryness. The residue was dissolved 
in DCM (10 mL) and aq. HCl (5 M) was added dropwise. The solution was stirred for approx. 5 
mins and the resulting precipitate was isolated by vacuum filtration using a porosity 4 sintered 
glass funnel and washed with DCM. The precipitate was suspended in water (10 mL), the pH 
was adjusted to 14 with aq. NaOH (5M), and the solution stirred for 30 mins. The mixture was 
extracted with ethyl acetate (3 × 20 mL) and the combined organic layers were washed with 
brine (30 mL), dried (Na2SO4), filtered and concentrated to give the product trans-93b as a 
yellow oil (313 mg, 52%). 
ѵmax (ATR) 3357, 2925, 1491, 1450, 749, 700 cm−1; δH (300 MHz) 1.57–1.73 (m, 1H, one of 
C(2)H2), 1.79–1.95 [m, 1H, one of C(3)H2], 2.09–2.20 [m, 1H, one of C(2)H2], 2.24–2.37 [m, 1H, 
one of C(3)H2], 4.11 [t, 1H, J = 6.1, C(1)H], 4.15 [t, 1H, J = 6.8, C(4)H], 6.85 (d, 1H, J = 7.8, ArH), 
7.05 (d, 2H, J = 7.1, ArH), 7.10 (d, 1H, J = 7.3, ArH), 7.15–7.35 (m, 4H, ArH), 7.51 (d, 1H, J = 7.7, 
ArH) ppm; δC (75.5 MHz) 30.1 [C(3)H2], 31.8 [C(2)H2], 45.7 [C(4)H], 49.8 [C(1)H], 126.1, 126.5, 
126.7, 127.5, 128.3, 128.7, 130.2 (7 × aromatic CH), 139.0, 147.0 (3 × aromatic C) ppm; HRMS 
(ES+): [M+H]+ 224.1435 (calculated 224.1434); enantiomers separated using Chiralcel OJ-H 
[conditions: n-hexane/iPrOH (containing 1% DEA) = 90/10, flow rate = 0.5 mL min−1], Rt = 17.7, 
Rt = 23.1 min. 
This compound is novel and has been fully characterized in this investigation. The carbon 
assignments were aided by DEPT and 2D experiments and by comparison to the related 
compounds ketone 134, alcohol trans-137b, and azide trans-140b. 
3-(3,4-Dichlorophenyl)-2,3-dihydro-1H-inden-1-one 13533 
Triflic acid (50 g, 333.0 mmol) was added slowly to a stirring solution of 
trans-cinnamic acid 20 (7.60 g, 51.0 mmol) and dichlorobenzene 110 
(35 mL, 45.5 g, 310.0 mmol) at 0 °C. The reaction solution was heated 
to reflux and stirred for 3d. The reaction solution was cooled and 
poured onto a mixture of water and ice (70 mL) to quench, stirred for 
approx. 1 h, and the layers separated. The aqueous layer was extracted 
with DCM (2 × 50 mL). The combined organic layers were washed with sat. aq. NaHCO3 
(2 × 50 mL), water (100 mL) and concentrated to give the crude product 135 as a solution in 
dichlorobenzene. The dichlorobenzene was removed by vacuum distillation (b.p. 106–108 °C, 




from DCM/hexane to give the pure product 135 (8.908 g, 63%) as a white solid m.p. 110–
112 °C, lit.: 113–115 °C.34  
ѵmax (ATR) 2919, 1698 (C=O), 762 cm−1; δH (300 MHz) 2.62 [dd, 1H, J = 19.2, 3.9, one of C(2)H2, 
3.23 [dd, 1H, J = 19.2, 8.2, one of C(2)H2,], 4.55 [dd, 1H, J = 8.2, 3.9, C(3)H], 6.95 (dd, 1H, J = 
8.3, 2.1, ArH), 7.20–7.29 (m, 2H, ArH), 7.38 (d, 1H, J = 8.3, ArH), 7.41–7.53 (m, 1H, ArH), 7.61 
(td,1H, J = 7.5, 1.3, ArH), 7.77–7.88 (m, 1H, ArH) ppm; δC (75.5 MHz) 43.6 [C(3)H], 46.5 
[C(2)H2], 123.7, 126.7, 127.0, 128.4, 129.7, 130.9 (6 × aromatic CH), 131.2, 133.0 
(2 × aromatic C), 135.4 (aromatic CH), 136.8, 144.0, 156.5 (3 × aromatic C), 204.9 (C=O) ppm; 
enantiomers separated using Chiralcel OB-H [conditions: n-hexane/iPrOH (containing 1% DEA) 
= 90/10, flow rate = 0.5 mL min−1], Rt = 34.9, Rt = 37.8 min and using Chiralcel OJ-H [conditions: 
n-hexane/iPrOH (containing 1% DEA) = 90/10, flow rate = 0.5 mL min−1], Rt = 35.3, Rt = 38.4 
min. 
All data is in agreement with previously reported data.35,36 
cis-3-(3,4-Dichlorophenyl)-2,3-dihydro-1H-inden-1-ol cis-138a28,34,35 
Ketone 135 (8.908 g, 32.1 mmol) in THF (100 mL) was cooled to 
−15 °C using a salt/ice bath. A solution of sodium borohydride (2.450 
g, 64.8 mmol, 2.0 eq.) in water (10 mL) was slowly added to the 
stirring solution, maintaining the temperature below 0 °C. When the 
addition was complete the reaction solution was allowed warm to 
room temperature and stirred for 3 h. The solution was diluted with 
ice-water (50 mL) and stirred for 1 h. The THF was removed under reduced pressure and the 
aqueous layer was extracted with ethyl acetate (2 × 50 mL). The organic layer was washed 
with water (2 × 50 mL) and brine (1 × 75 mL) and concentrated to give the crude product 138 
as a mixture of diastereomers (91:9). The product was purified by column chromatography 
using diethyl ether/hexane (25/75) as eluent which gave the pure product cis-138a as a 
colourless oil (4.975 g, 55%) and the minor diastereomer trans-138b as a colourless oil 
(0.358 g, 4%)  
cis-138a: ѵmax (ATR) 3306 (OH), 1468, 1030, 756, 742 cm−1; δH (300 MHz) 1.89 [ddd, 1H, J = 
13.1, 8.9, 7.3, one of C(2)H2], 1.99 (d, 1H, J = 7.0, OH), 3.01 [ddd, 1H, J = 13.1, 7.6, 7.0, one of 
C(2)H2], 4.15 [dd appears as t, 1H, J = 8.2, C(3)H], 5.30 [m, 1H, C(1)H], 6.94 (d, 1H, J = 7.7, ArH), 
7.07 (dd, 1H, J = 8.3, 2.1, ArH), 7.22–7.36 (m, 3H, ArH), 7.38 (d, 1H, J = 8.3, ArH), 7.48 (d, 1H, 




127.68, 128.7, 130.2, 130.55 (7 × aromatic CH) 130.59, 132.6, 144.4, 144.7, 145.2 
(5 × aromatic C) ppm. 
All data is in agreement with previously reported data.33 
trans-138b: ѵmax (ATR) 3306 (OH), 1469, 1032, 755 cm−1; δH (300 
MHz) 2.24–2.40 [1H, m, one of C(2)H2], 2.45–2.63 [1H, m, 7.7, 2.9, 
one of C(2)H2], 4.59 [1H, t, J = 7.4, C(3)H], 5.38 [1H, dd, J = 6.2, 2.7, 
C(1)H], 6.96 (1H, dd, J = 8.3, 2.1, ArH), 6.98–7.05 (1H, m, ArH), 7.21 
(1H, d, J = 2.1, ArH), 7.27–7.39 (3H, m, ArH), 7.44–7.53 (1H, m, ArH) 
ppm; δC (75.5 MHz) 46.3 [C(2)H2], 48.2 (CH), 75.1 (CH), 124.6, 125.3, 
127.4, 127.8, 129.3, 129.8 (6 × aromatic CH), 130.5 (aromatic C), 130.6 (aromatic CH), 132.6, 
144.9, 145.1, 145.6 (4 × aromatic C) ppm. 
All data is in agreement with previously reported data.33 
trans-1-Azido-3-(3,4-dichlorophenyl)-2,3-dihydro-1H-indene trans-141b 
Diphenylphosphoryl azide (0.92 mL, 1.178 g, 4.3 mmol, 1.2 eq.) was 
added to a stirring solution of cis-138a (0.99 g, 3.5 mmol) in dry 
toluene (4 mL) under a nitrogen flow. The mixture was cooled to 0 °C, 
stirred for 10 mins, and DBU (0.64 mL, 4.3 mmol, 1.2 eq.) was added 
slowly. The mixture was stirred for 2 h at 0 °C and 16 h at room 
temperature. The solvent was removed, and the residue passed 
through a column of silica gel using hexane/ethyl acetate (95/5) as eluent to give the pure 
product trans-141b as an orange oil (0.928 g, 86%). 
ѵmax (ATR) 2935, 2092 (N3), 1474, 1237, 757 cm−1; δH (300 MHz) 2.30 [ddd, 1H, J = 13.7, 8.3, 
6.8, one of C(2)H2], 2.61 [ddd, 1H, J = 13.7, 7.5, 2.4, one of C(2)H2], 4.53 [t, 1H, J = 7.9, C(3)H], 
5.03 [dd, 1H, J = 6.8, 2.3, C(1)H], 6.94–7.05 (m, 2H, ArH), 7.23 (d, 1H, J = 2.1, ArH), 7.28–7.42 
(m, 3H, ArH), 7.42–7.52 (m, 1H, ArH) ppm; δC (75.5 MHz) 43.4 [C(2)H2], 48.5 (CH), 64.7 (CH), 
124.8, 125.4, 127.4, 127.8, 129.7, 129.9, 130.7 (7 × aromatic CH), 130.8, 132.7, 140.7, 144.1, 
145.8 (5 × aromatic C) ppm. 





Method 1: Sodium iodide (1.504 g, 10.0 mmol, 12.5 eq.) and cerium 
chloride heptahydrate (453 mg, 1.2 mmol, 1.5 eq.) were added to a 
solution of azide trans-141b (246 mg, 0.8 mmol) in acetonitrile 
(10 mL). The suspension was stirred at reflux for 24 h. The reaction 
mixture was cooled, diluted with diethyl ether (25 mL) and washed 
with water (3 × 25 mL), sat. aq. sodium bicarbonate (2 × 25 mL), sat. 
aq. sodium thiosulfate (25 mL, decolourised solution), brine (30 mL) and dried (Na2SO4) to give 
the crude mixture, comprising of the unreacted azide trans-141b and the amine product 
trans-94b (242 mg). The residue was treated with aq. HCl (10%, 25 mL), washed with DCM 
(3 × 25 mL) and treated with aq. NaOH (5M) until pH > 9. The aqueous solution was extracted 
with DCM (3x20 mL) and evaporated to give the impure amine trans-94b as a green oil (67 
mg, 30%).  
Method 2: Triphenylphosphine 145 (617 mg, 2.45 mmol, 1.1 eq.) and water (77.0 µL, 2.0 eq.) 
were added to a stirring solution of azide trans-141b (650 mg, 2.1 mmol) in THF (20 mL, HPLC 
grade). The solution was heated to reflux and stirred for 16 h. The reaction mixture was cooled 
and the solvent removed by rotary evaporation to give the crude reaction mixture containing 
the amine trans-94b and triphenylphosphine oxide 146. The residue was suspended in diethyl 
ether (20 mL) and the insoluble triphenylphosphine oxide by-product 146 was removed by 
filtration. The filtrate was evaporated to dryness. The residue was dissolved in DCM and aq. 
HCl (5M) was added dropwise. The solution was stirred for approx. 5 mins and the resulting 
precipitate was isolated by vacuum filtration using a porosity 4 sintered glass funnel and 
washed with DCM. The precipitate was suspended in water (10 mL) and the pH was adjusted 
to 14 with aq. NaOH (5M), and the suspension stirred for 30 mins. The mixture was extracted 
with ethyl acetate (3 × 20 mL) and the combined organic layers were washed with brine (30 
mL), dried (Na2SO4), filtered and concentrated to give the product trans-94b as a yellow oil 
(265 mg, 45%). 
ѵmax (ATR) 3364, 3007, 1469, 1264, 732, 703 cm−1; δH (300 MHz) 2.22–2.46 [m, 2H, C(2)H2], 
4.51 [dd, 1H, J = 8.0, 6.0, C(3)H], 4.57 [dd appears as t, 1H, J = 6.0, C(1)H], 6.93 (dd, 1H, J = 8.3, 
2.1, ArH), 7.02 (d, 1H, J = 7.5, ArH), 7.18 (d, 1H, J = 2.1, ArH), 7.20–7.37 (m, 3H, ArH), 7.40 (d, 
1H, J = 7.3, ArH) ppm; δC (75.5 MHz) 46.9 [C(2)H2], 48.2 [C(3)H], 55.8 [C(1)H], 123.9, 125.2, 
127.2, 127.7, 128.2, 129.7 (6 × aromatic CH), 130.3 (aromatic C), 130.4 (aromatic CH), 132.5, 




278.0498); enantiomers separated using Chiralcel OJ-H [conditions: n-hexane/iPrOH 
(containing 1% DEA) = 95/5, flow rate = 0.5 mL min−1], Rt = 23.1, Rt = 27.1 min. 
This compound is novel and has been fully characterized in this investigation. The carbon 
assignments were aided by DEPT and 2D experiments. 
trans-3-(3,4-Dichlorophenyl)-2,3-dihydro-1H-inden-1-yl 4-(tert-butyl)benzoate 
trans-14437 
A solution of cis-3-(3,4-dichlorophenyl)-2,3-dihydro-1H-inden-
1-ol cis-141a (1.413 g, 5.1 mmol), triphenylphosphine 145 
(2.593 g, 9.9 mmol, ~2.0 eq.), diethyl azodicarboxylate (1.780 
g, 10.2 mmol, 2.0 eq.) and 4-tert-butylbenzoic acid 143 (1.82 
g, 10.2 mmol, 2.0 eq.) in dry THF was stirred overnight at room 
temperature. The organic solvent was removed to give the 
crude product as a viscous orange oil. Purification by 
chromatography on silica gel using diethyl ether/ hexane (4/96) furnished a mixture of the 
product trans-144 and the benzoic acid 143 as an orange oil. The mixture was dissolved in 
hexane, stirred with basic alumina for 5 mins, and filtered through a pad of Celite®. The 
residue was washed with hexane (100 mL), hexane/diethyl ether (99/1) (100 mL) and ethyl 
acetate (50 mL). All three fractions were free of benzoic acid 143 and were combined to give 
the product trans-144 as a viscous orange oil (1.295g, 58%). 
ѵmax (ATR) 2964, 1713 (C=O), 1268, 731, 694 cm−1; δH (300 MHz) 1.31 [s, 9H, C(CH3)3], 2.36–
2.54 [m, 1H, one of C(2)H2], 2.76 [ddd, 1H, J = 14.3, 7.6, 2.3, one of C(2)H2], 4.64 [dd appears 
as t, 1H, J = 7.7, C(3)H], 6.54 [dd, 1H, J = 6.5, 2.2, C(1)H], 6.92–7.07 (m, 2H, ArH), 7.24–7.38 
(m, 4H, ArH), 7.38–7.48 (m, 2H, m-ArH of acid moiety), 7.54–7.66 (m, 1H, ArH), 7.91–8.02 (m, 
2H, o-ArH of acid moiety) ppm; δC (75.5 MHz) 31.2 (3 × CH3), 35.2 [qC, C(CH3)3], 43.3 [C(2)H2], 
48.7 [C(3)H], 77.5 [C(1)H], 125.1, 125.4, 126.4, 127.5 (4 × aromatic CH), 127.6 (aromatic C), 
127.8, 129.8, 130.0 (3 × aromatic CH), 130.7, 132.7 (2 × aromatic C), 133.7, 133.9 
(2 × aromatic CH), 141.5, 144.7, 146.9 (3 × aromatic C), 156.8 [aromatic C, CC(CH3)3], 166.5 
(C=O) ppm; HRMS (ES+): [M+Na]+ 461.1040 (calculated 461.1046). 
This compound is novel and has been fully characterized in this investigation, data closely 





Aqueous potassium hydroxide (3M, 8 mL) was added to a stirring 
solution of trans-3-(3,4-dichlorophenyl)-2,3-dihydro-1H-inden-1-yl 4-
(tert-butyl)benzoate trans-144 (0.430 g, 1.0 mmol) in methanol (16 
mL) and THF (16 mL). The reaction mixture was stirred for 3 h. The pH 
was adjusted to 3 using conc. HCl, followed by addition of water 
(20 mL). The aqueous layer was extracted with diethyl ether 
(3 × 20 mL) and the combined organic layers evaporated to give the crude reaction product, 
a mixture of the benzoic acid 143 and the alcohol trans-138b. The mixture was suspended in 
aq. KOH (3M, 10 mL) and stirred for 3 h, the suspension was extracted with diethyl ether 
(3 × 10 mL), dried, filtered and concentrated to give the product trans-143b as an orange oil 
(0.250 g, 92%). 
Spectroscopic data were identical to those reported above. 
cis-1-Azido-3-(3,4-dichlorophenyl)-2,3-dihydro-1H-indene cis-141a 
Diphenylphosphoryl azide (2.22 mL, 2.84 g, 10.4 mmol, 2.4 eq.)4 was 
added to a solution of trans-143b (1.19 g, 4.3 mmol) in dry toluene 
(12 mL) under nitrogen. The reaction mixture was cooled to 0 °C and 
stirred for 10 mins. DBU (0.77 mL, 0.78 g, 5.1 mmol, 1.2 eq.) was 
added dropwise to the stirring solution. The solution was stirred at 
0 °C for 2 h, and at room temperature for 20 h. The solvent was 
removed in vacuo. The residue was passed through a short column of silica gel using 
hexane/diethyl ether (95/5) as eluent. The solvent was removed in vacuo to give the pure 
product cis-141a (691 mg, 53%) as a dark orange oil. 
ѵmax (ATR) 2929, 2090 (C–N3), 1468, 1254, 758, 747 cm−1; δH (300 MHz) 2.02 [ddd, 1H, J = 13.3, 
8.4, 7.7, one of C(2)H2], 3.01 [ddd appears as dt, 1H, J = 13.3, 7.7, one of C(2)H2], 4.24 [dd 
appears as t, 1H, J = 8.2, C(3)H], 4.93 [dd appears as t, 1H, J = 7.3, C(1)H], 6.97 (d, 1H, J = 7.3, 
ArH), 7.05 (dd, 1H, J = 8.2, 2.1, ArH), 7.26–7.52 (m, 5H, ArH) ppm; δC (75.5 MHz) 42.6 [C(2)H2], 
48.1 [C(3)H], 64.3 [C(1)H], 124.3, 125.2, 127.6, 127.9, 129.2, 130.2, 130.7 (7 × aromatic CH), 
                                                          
4 Due to error, twice the required amount of DPPA was added during this reaction. The initial purification using 
ethyl acetate and hexane (95/5) as eluent resulted in coelution with the DPPA. Switching to a less polar solvent 




130.9, 132.7, 141.2, 144.2, 144.6 (5 × aromatic C) ppm; HRMS (ES+): [M−N3]+ 261.0237 
(calculated 261.0232). 
This compound is novel and has been fully characterized in this investigation. 
cis-3-(3,4-Dichlorophenyl)-2,3-dihydro-1H-inden-1-amine cis-94a 
Triphenylphosphine 145 (658 mg, 2.5 mmol, 1.2 eq.) and water 
(81.8 µL, 2.0 eq.) were added to a stirring solution of azide cis-141b 
(691 mg, 2.3 mmol) in THF (20 mL, HPLC grade). The solution was 
heated to reflux and stirred for 16 h. The reaction mixture was cooled 
and the solvent removed by rotary evaporation to give the crude 
reaction mixture containing the amine cis-94a and 
triphenylphosphine oxide 146. The residue was suspended in diethyl ether (30 mL) and the 
insoluble triphenylphosphine oxide by-product 146 was removed by filtration. The filtrate was 
evaporated to dryness. The residue was dissolved in DCM and aq. HCl (5M) was added 
dropwise. The solution was stirred for approx. 5 mins and the resulting precipitate was 
isolated by vacuum filtration using a porosity 4 sintered glass funnel and washed with DCM. 
The precipitate was suspended in water (10 mL) and the pH was adjusted to 14 with aq. NaOH 
(5M), and the mixture stirred for 30 mins. The mixture was extracted with ethyl acetate (3 × 20 
mL) and the combined organic layers were washed with brine (30 mL), dried (Na2SO4), filtered 
and concentrated to give the product cis-94a as a yellow oil (313 mg, 52%). 
ѵmax (ATR) 3372, 2957, 1468, 762, 731 cm−1; δH (300 MHz) 1.67 [ddd, 1H, J = 12.4, 10.6, 9.5, 
one of C(2)H2], 2.94 [ddd appears as dt, 1H, J = 12.4, 7.0, one of C(2)H2], 4.14 [dd, 1H, J = 10.6, 
7.3, C(3)H], 4.37 [dd, 1H, J = 9.0, 7.2, C(1)H], 6.88 (d, 1H, J = 7.4, ArH), 7.07 (dd, 1H, J = 8.3, 
2.1, ArH), 7.16–7.50 (m, 5H, ArH) ppm; δC (75.5 MHz) 48.0 [C(3)H], 48.7 [C(2)H2], 55.9 [C(1)H], 
123.2, 124.6 (2 × aromatic CH), 127.3 (aromatic C), 127.4, 127.7, 127.8 (3 × aromatic CH), 
128.6 (aromatic C), 130.3, 130.5 (2 × aromatic CH), 132.0, 132.5, 144.6 (3 × aromatic C) ppm; 
HRMS (ES+): [M+H]+ 278.0504 (calculated 278.0498); enantiomers separated using Chiralcel 
OB-H [conditions: n-hexane/iPrOH (containing 1% DEA) = 95/5, flow rate = 0.5 mL min−1], Rt = 
16.5, Rt = 19.2 min. 
This compound is novel and has been fully characterized in this investigation. The carbon 




Procedures for biotransformations 
General procedure for oxidative deamination reactions 
E. Coli cells containing overexpressed transaminase (30 mg or 50 mg, as indicated in the 
appropriate tables) were suspended in 50 mM sodium phosphate buffer (pH 8.5, 400 μL) in a 
15 mL centrifuge tube, the suspension was sonicated if required using a probe for 10 s, 
followed by 30 s on ice, this was repeated five times to lyse the cells. PLP solution (100 L 
buffer, overall conc. 1mM) and sodium pyruvate (in 100 L buffer, overall 1 eq.) solutions 
were added, followed by the amine substrate (20 mM or 50 mM, as indicated, in 100 L 
DMSO), any additional buffer or DMSO was added as required to total reaction volume 1 mL. 
The solution was shaken at 30 °C, 400 rpm for 16 h or 24 h as indicated in the corresponding 
tables. The reaction was stopped through the addition of aqueous NaOH solution (5M, 400 
μL). Ethyl acetate ( 4 mL) was added and the tubes were centrifuged to pellet the cells. The 
organic phase was passed through a plug of Na2SO4 and the solvent was removed in vacuo. 
The crude products were analysed by 1H NMR and chiral HPLC, except when amine 120 was 
used as substrate (Table 5.3, Entry 12), in this case the reaction mixture containing ketone 
159 and amine 120 was derivatized (procedure for preparation of 158) before chiral HPLC 
analysis (conditions in Appendix I). 
Results are shown in Table 5.3, Table 5.4, Table 5.9, Table 5.10, Table 5.11. 
General procedure for reductive amination reactions 
Using isopropylamine 97 as amine donor: E. Coli cells containing overexpressed CV-TA (30 mg) 
were suspended in 1M isopropylamine solution (pH adjusted to 10 using conc. HCl), in a 15 mL 
centrifuge tube. PLP was solution (in 100 μL of iPrNH2 solution, overall conc. 1 mM), substrate 
(in 100 μL DMSO, overall conc. 20 mM or 50 mM) solutions were added, additional buffer was 
added to total reaction volume 1 mL. The solution was shaken at 30 °C, 400 rpm for 24 h. The 
reaction was stopped, worked up and analysed as above.  
The results are shown in Table 5.5. 
Using AlaDH system:38 E. Coli cells containing overexpressed transaminase (50 mg) were 
suspended in 50 mM sodium phosphate buffer (pH 7.5, 400 μL) in a 15 mL centrifuge tube. 
PLP solution (100 μL buffer, overall conc. 1 mM), L-alanine (in 100 L buffer, overall 5.0 eq.), 
NAD+ (in 100 μL buffer, overall 1 mM), ammonium formate (in 100 μL buffer, overall 150 mM), 
substrate (in 100 μL DMSO, overall conc. 50 mM) solutions were added, followed by the 




buffer was added to total reaction volume 1 mL. The solution was shaken at 30 °C, 400 rpm 
for 24 h. The reaction was stopped, worked up and analysed as above. 
Results are shown in Table 5.6. 
Using the LDH system:38 E. Coli cells containing overexpressed transaminase (50 mg) were 
suspended in 50 mM sodium phosphate buffer (pH 7.5, 400 μL) in a 15 mL centrifuge tube. 
PLP solution (100 μL buffer, overall conc. 1 mM), L-alanine (in 100 L buffer, overall 5.0 eq.), 
NAD+ (in 100 μL buffer, overall 1 mM), glucose (in 100 μL buffer, overall 150 mM), substrate 
(in 100 μL DMSO, overall conc. 50 mM) solutions were added, followed by the auxiliary 
enzymes lactate dehydrogenase (90 U), glucose dehydrogenase (30 U). The reaction mixture 
as shaken at 30 °C, 400 rpm for 24 h. The reaction was stopped, worked up and analysed as 
above. 
Results are shown in Table 5.7. 
Use of alternative amine sources:39 E. Coli cells containing overexpressed CV-TA (30 mg) were 
suspended in sodium phosphate buffer (pH 8.5, 50 mM), in a 15 mL centrifuge tube. PLP was 
added (in 100 μL of buffer, overall conc. 1 mM), ketone 148 (in 100 μL DMSO, overall conc. 50 
mM) and amine donor (added neat or in 100 μL buffer, overall conc 250 mM) solutions were 
added. The solution was shaken at 30 °C, 400 rpm for 24 h. The reactions were stopped, 
worked up and analysed as above. 
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(S)-123  14.8 
152 25.8 



























































 (4S)-108 26.8 



























 (4S)-108 31.0 






















































































































































Appendix II: List of Abbreviations
Ac2O acetic anhydride 
ADH alcohol dehydrogenase 
AlaDH alanine dehydrogenase 
API active pharmaceutical ingredient 
approx. approximately 
aq. aqueous  
Ar aryl 
ATA amine transaminase 
atm atmospheres 
b.p.  boiling point 
br s broad singlet 
CAL-B Candida antarctica lipase B 
(immobilised) 
conv. Conversion 






dd doublet of doublets 
ddd doublet of doublet of doublets 
de diastereomeric excess 
DEA diethylamine 
DEAD diethyl azodicarboxylate 
DEPT distortionless enhancement of 
polarisation transfer 
DIP-Cl B-Chlorodiisopinocamphenylborane 
DKR dynamic kinetic resolution 
DMAP N,N-dimethylaminopyridine 
DMF dimethyl formamide 
DMSO dimethylsulfoxide 
DNA deoxyribonucleic acid 
DPPA diphenylphosphoryl azide 
dt doublet of triplets 
E. coli Escherichia coli 
ee enantiomeric excess 
eq.  equivalents 
ERED ene-reductase 
Et ethyl 
Et2O diethyl ether 
EtOAc ethyl acetate 
EtOH ethanol  
EtONa sodium ethoxide 
FDH formate dehydrogenase 
g gram 
GDH glucose dehydrogenase 
Gl glycine 
h hour 
HHDH halohydrin dehalogenase 
His histidine 
HMBC heteronuclear multiple bond 
correlation 
HNL hydroxynitrile lyase 
HPLC high performance liquid 
chromatography 











IRED imine reductase 
KOH potassium hydroxide 
KR kinetic resolution 
KRED ketoreductase 










m.p.  melting point 
MTBE methyl tert-butyl ether 
NaBH4 sodium borohydride 
NAD+ Nicotinamide adenine dinucleotide 
NAD(P)H nicotinamide adenine 
dinucleotide (phosphate) 
NaOH sodium hydroxide 
NEt3 triethylamine 
NMR nuclear magnetic resonance 
NSAIDs Non-steroidal anti-inflammatory 
drugs 
PCC pyridinium chlorochromate 
PDA photodiode array  
Ph phenyl 
PLP pyroxidal 5′-phosphate 
PMP pyroxamine 5′-phosphate 
PPL porcine pancreatic lipase 
ppm  parts per million 
psi pounds per square inch 
q quartet 
qd quartet of doublets 
Rf retention factor 
rpm revolutions per minute 









td triplet of doublets 





TLC thin layer chromatography 
TMG 1,1,3,3-tetramethylguanidine 
TMS tetramethylsilane 
TPPO triphenylphosphine oxide 
% v/v volume per volume 





Appendix III: Additional tables for chapter 2 
Table 21 Supplementary data for the transesterification of 1 using vinyl benzoate 
 
Enzyme Source 
Conversion (%) ee (%) 
E 
1H NMR Ecalc ees eep 
No enzyme 0 -a -a -a -a 
Hog Pancreas Lipase 0 -a -a -a -a 
Candida antarctica Lipase B (immobilised) 0 -a -a -a -a 
Pseudomonas fluorescens (immobilised) 0 -a -a -a -a 
Amano PS Lipase 0 -a -a -a -a 
Lipase from Candida cylindracea 100 -a -a -a -a 






Shown below is the data from the time screen for hydrolysis of 22, supplement to the data in 






Conversion (%) ee (%) 
E 1H NMR Ecalc ees eep 
Blank 65 4 -a -a -a -a 
48 0 -a -a -a -a 
24 0 -a -a -a -a 
18 0 -a -a -a -a 
6 0 -a -a -a -a 
Hog pancreas 
Lipase 
65 60 55 54 65 6 
48 56 56 55 71 7 
24 72 72 35 92 6 
18 62 63 46 79 6 




65 87 62 16 26 2 
48 69 70 38 87 6 
24 55 54 61 72 9 
18 56 47 55 73 7 




65 87 62 6 10 1 
48 57 59 13 19 2 
24 52 53 15 17 2 
Amano PS Lipase 65 100 -a -a -a -a 
48 100 -a -a -a -a 
24 100 -a -a -a -a 
18 100 -a -a -a -a 




(R)-1 as product) 
65 87 60 2 3 1 
48 56 47 4 4 1 
24 62 58 5 7 1 
18 66 64 4 7 1 
6 42 38 5 3 1 






Shown below is the data from the time screen for transesterification of 1 with vinyl acetate, 
supplement to the data in Table 2.4, entries marked in blue are also shown in Table 2.4. 





Conversion (%) ee (%) 
E 1H NMR Ecalc ees eep 
Blank 
24 0 -a -a -a -a 
18 0 -a -a -a -a 
8 0 -a -a -a -a 
6 0 -a -a -a -a 
4 0 -a -a -a -a 
2 0 -a -a -a -a 
Hog pancreas lipase 
24 78 79 99 27 7 
18 58 47 85 63 11 
8 38 37 45 75 11 




24 100 -a -a -a -a 
18 100 -a -a -a -a 
6 93 -b 3 0 -b 
4 92 -b 7 0 -b 




24 99 -a -a -a -a 
18 100 -a -a -a -a 
6 80 81 14 3 1 
4 72 72 12 4 1 
2 46 43 4 5 1 
Amano PS Lipase 
24 79 80 45 11 2 
18 65 67 31 15 2 
8 28 23 7 24 2 
6 44 45 16 20 2 
4 -a -a -a -a -a 
2 -a -a -a -a -a 
Lipase from 
Candida cylindracea 
(gives (R)-1 as 
product) 
24 100 -a -a -a -a 
18 99 -a -a -a -a 
6 98 -a -a -a -a 
4 96 96 45 2 1 
2 58 89 31 4 1 
aWhen conversion was 100% or 0% enantioselectivity values were not measured, and as a result, Ecalc, and E were not 






Table 24 Supplemental data for the hydrolysis of 23 
 
Enzyme Source 
Conversion (%) ee (%) 
E 1H NMR Ecalc ees eep 
No Lipase 0 -a -a -a -a 
Hog pancreas Lipase 3 29 4 10 (R) 1 
Candida antarctica Lipase B (immobilised) 0 -a -a -a -a 
Pseudomonas fluorescens (immobilised) 0 -a -a -a -a 
Amano PS Lipase 15 13 14 90 (S) 22 
Lipase from candida cylindracea 9 11 0 8 (R) 1 
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